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Summary 
Background: Cognitive decline is commonly reported in Parkinson’s disease (PD), with some 
deficits evident even at the onset of PD. Executive functions (EF) are extensively studied in 
PD and emerge as the domain involving the most profound deficits. Nevertheless, there are 
some inconsistencies in the literature with regard to the exact pattern of executive deficits 
and their impact on everyday life in PD. The aim of the literature review presented in this 
thesis was to synthesise and clarify existing research evidence on EF in early stage PD, and 
to explore what are the possible factors affecting the consistency of research findings. The 
empirical studies had three distinct aims: to clarify the pattern of EF deficits in PD; to 
determine how accurately PwPD appraise potential EF-related difficulties; and to identify 
how executive deficits impact on people with PD (PwPD) and their families.  
Method: Studies of EF in PD were systematically reviewed and the findings were 
synthesised in a series of meta-analyses. Three empirical studies drew on cross-sectional 
data collected from PwPD and their caregivers, and from healthy older controls. Sixty-five 
PwPD in mild to moderate stages of PD completed an assessment of EF, awareness, quality 
of life, and health status, and 43 healthy older controls completed assessment of EF and 
awareness. Fifty caregivers of PwPD rated the EF of the PwPD and their own burden 
associated with caring for a PwPD. A sub-group of 34 PwPD, identified as having potential EF 
deficits, completed a more extensive neuropsychological assessment of executive abilities. 
Results: The systematic review included 33 studies of EF in early stage PD, and meta-
analysis of data from 5 commonly-used tests of EF revealed consistent evidence for 
executive deficits. The review suggested that the consistency of the research evidence may 
  
 
 
 
be improved by more precision in defining EF and more careful selection and interpretation 
of EF measures. A data-driven analysis examining the pattern of EF impairment 
distinguished differences between two groups of standard tests of EF, with attentional 
control tests more frequently compromised than abstract thinking in early stage PD. PwPD 
were found to be accurate when making general evaluative judgments about their own 
functioning, but in specific tasks PwPD with executive deficits overestimated their 
performance in comparison to PwPD without EF deficits and healthy controls. EF-related 
behavioural difficulties were shown to impact on subjective quality of life in PwPD and on 
burden in their caregivers. 
Conclusions: The results of this thesis suggest that EF-related difficulties are frequently 
present in early stage PD, with attentional control aspects of EF particularly affected, that it 
may be difficult for PwPD to accurately appraise their own ability to carry out specific 
activities, and that EF-related difficulties have a significant impact on quality of life in PwPD 
and their families. A thorough understanding of executive deficits in PD is important in the 
provision of adequate person-centred care for PwPD and their family members, and could 
help to inform the development of PD-specific rehabilitative interventions aimed at 
reducing activity limitation and restrictions on social participation and supporting PwPD in 
living well with the condition. 
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1.1 Introduction 
Parkinson’s disease (PD) not only affects movement, but is also associated with numerous 
non-motor symptoms, including cognitive decline. Extensive research into cognition in PD 
demonstrates that deficits in the executive function (EF) domain are common even at the 
earliest stages of the disease. However, there are certain limitations in the existing 
literature. The reported prevalence rates and characteristics of executive deficits differ 
substantially between studies. There is limited understanding of how people diagnosed with 
PD (PwPD) perceive their executive functioning and how accurate they are in acknowledging 
potential EF-related difficulties. Finally, we know surprisingly little about the impact of EF 
deficits on the quality of life of PwPD and their families.  
Thorough understanding of the nature of EF deficits and their impact on PwPD is 
crucial for providing adequate person-centred care for PwPD, as  it may facilitate 
development of targeted medication and may provide a basis for developing non-
pharmacological treatments (Schrag, Hovris, Morley, Quinn, & Jahanshahi, 2006; Wurtman, 
2012). While it might not be possible to address underlying executive impairment directly, it 
might be possible to improve self-management of the deficits and reduce activity limitation 
(functional disability) and restrictions on social participation (handicap) through a 
rehabilitative approach (Clare, 2008; World Health Organisation, 1998). For example, 
cognition-focused interventions can help to reduce the secondary consequences of 
cognitive impairment, such as loss of confidence or restriction of activities (Reifler & Larson, 
1990). 
Chapter 1. Introduction  5    
 
 
 
This thesis aims to address the above-mentioned limitations, extend our 
understanding of executive deficits in PD, and assist development of adequate person-
centred support for people with PD. 
The following sections will introduce background information relevant for the studies 
presented in this thesis. First, prevalence, neuropathology and symptoms of Parkinson’s 
disease (PD) will be briefly summarised. Then, definitions of executive functions (EF), the 
neuronal basis of EF, and methods for assessing EF will be described. Finally, research on EF 
in PD will be discussed, and research questions and methodology for this thesis will be 
introduced.  
Following the introductory chapter, one chapter outlines a systematic review and 
meta-analysis and three chapters report findings from an empirical study. In the final 
chapter the results from the empirical chapters are summarised and discussed in the 
context of existing evidence. 
1.2 Prevalence, neuropathology and symptoms of Parkinson’s 
disease  
Parkinson’s disease (PD) is, after Alzheimer’s disease, the second most common 
neurodegenerative disease, with the prevalence rate in Europe estimated as 108 to 257 per 
100,000 people. The prevalence of PD is higher in older age, with a prevalence rate of 1280 
to 1500 per 100,000 in people over 60 (von Campenhausen et al., 2005). It is estimated that 
in 2005 there were around 4.5 million PwPD in the five most populous nations of Western 
Europe and the world’s ten most populous nations, and this number is expected to double 
by 2030 (Dorsey et al., 2007).  
Chapter 1. Introduction  6    
 
 
 
The central pathological feature of PD is loss of dopaminergic neurons in the 
substantia nigra pars compacta, which leads to dopaminergic deficiency in the striatum and 
subsequently affects other brain regions (Dauer & Przedborski, 2003). The cell loss occurs in 
various brain areas, including non-dopaminergic structures, for example the nucleus basalis 
of Meynert (acetylcholine) and the raphe nucleus (serotonin). There are numerous 
processes leading to cell death in PD, some of which are also observed in other age-related 
neurodegenerative conditions as well as in normal aging. These processes include the 
presence of intraneuronal proteinacious cytoplasmic inclusions (Lewy Bodies) in brain 
tissue, protein misfolding and aggregation related to ubiquitin-proteasomal system 
dysfunction. Other pathologies are associated with mitochondrial dysfunction, impaired 
lysosome- and chaperone-mediated autophagy, as well as glutamate-related excitotoxicity 
and oxidative stress (Hindle, 2010). In contrast to relatively well-described pathological 
changes, the causes of PD are less clear. There is evidence for genetic factors in some cases, 
classed as familial, as opposed to sporadic, PD. It has also been observed that the 
neurodegenerative process may be provoked by the exposure to environmental (e.g. 
pesticides and herbicides) or endogenous neurotoxins(Dauer & Przedborski, 2003). 
However, the exact causes of PD are unknown. 
The clinical presentation of PD is multifaceted and clinically heterogeneous, with 
numerous symptoms affecting various aspects of functioning. There are four cardinal motor 
symptoms of PD: resting tremor, bradykinesia, rigidity, and impaired postural reflexes 
(Jankovic, 2008). Resting tremor in PD is described as supination–pronation tremors with 4-
6 Hz frequency most commonly starting in one hand and later affecting the other hand, or 
another part of body, for example legs or jaw. Bradykinesia means slowness of movement, 
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and refers to difficulties in planning, initiating and executing movement. It manifests in 
longer reaction time, slowness in task performance and loss of spontaneous movements, for 
example blinking, arm swing while walking, and facial expression. Rigidity means increased 
resistance in a muscle, typically associated with jerky movements when the muscle is 
passively stretched (cogwheel rigidity). Postural instability refers to impaired postural 
reflexes and is associated with a higher risk of falls. Other motor features of PD include 
abnormal axial postures (stooped posture), and freezing of gait, which is a sudden and 
transient inability to move. 
The above mentioned cardinal motor symptoms are accompanied by a plethora of 
non-motor disturbances and there are various approaches to categorising PD, for example, 
PD can be characterised with regard to age at onset, side of onset, and rate of progression 
or aetiology. On the basis of clinical presentation related to the cardinal motor symptoms, 
three subtypes of PD have been identified: tremor dominant, postural instability gait 
disorder (PIGD) and akinetic-rigid. 
Non-motor symptoms in PD include neuropsychiatric problems (e.g. cognitive 
deficits, depression and apathy), sleep disturbances, gastrointestinal problems, and bladder 
dysfunction (Chaudhuri, Yates, & Martinez-Martin, 2005; Poewe, 2008). These have a major 
impact on the overall quality of life of PwPD and their caregivers, and increase the risk of 
early institutionalisation. However, they tend to be under-recognised and under-treated in 
routine healthcare, as treatment concentrates on alleviating motor symptoms (Chaudhuri, 
Healy, & Schapira, 2006).  
Cognitive deficits are frequent in PD, even at the onset of the disease, with 
increasing rates of cognitive impairment and dementia in later stages of PD (Perez et al., 
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2012). Hely, Morris, Reid, and Trafficante (2005) reported that among those surviving 15 
years from PD onset, 84% had some cognitive impairment, and 48% of them met diagnostic 
criteria for dementia. Impairments are detected in various cognitive domains, including 
memory, language, attention, visuospatial and visuoconstructive abilities, and executive 
functions (Zgaljardic, Borod, Foldi, & Mattis, 2003). Severity ranges from mild single-domain 
difficulties, sometimes referred to as Mild Cognitive Impairment (PD-MCI, Litvan et al., 
2012), to dementia (Mindham & Hughes, 2000; Owen, 2004; Zgaljardic et al., 2003). 
Dysfunction in the area of EF is particularly common and is described as possibly 
contributing to deficits observed in other cognitive domains (McKinlay, Grace, Dalrymple-
Alford, & Roger, 2009; Muslimovic, Post, Speelman, & Schmand, 2005). PwPD with certain 
types of cognitive impairment may be at greater risk for more rapid progression to 
dementia (Janvin, Larsen, Aarsland, & Hugdahl, 2006; Williams-Gray et al., 2009; Woods & 
Tröster, 2003), and there is growing evidence that executive deficits may have predictive 
value in identifying those at risk of dementia (Janvin et al., 2006; Woods & Tröster, 2003). 
Varying prevalence rates for cognitive impairment are reported in the literature, and this 
variability may reflect methodological differences. It has been demonstrated that with 
different criteria for diagnosing PD-MCI the prevalence rates change from 9.9% to 92.1% in 
the same group of PwPD (Liepelt-Scarfone et al., 2011). Most studies report that around 
25% of PwPD have some cognitive deficits, classified as mild cognitive impairment (Aarsland 
et al., 2010; Jellinger, 2013) and 24 to 31% of PwPD meet diagnostic criteria for dementia 
(Aarsland, Zaccai, & Brayne, 2005).  
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1.3 Executive functions (EF) 
1.3.1 Definitions and historical background of executive functions 
The term ‘executive functions’ (EF) serves as an umbrella term to describe a number of 
attentional control processes and higher level cognitive processes, which play an 
overarching role in regulating thoughts, emotions and actions in order to enable successful 
goal-oriented behaviour. The role of EF is particularly prominent when a person is faced 
with novel situations requiring non-automatic actions (Burgess & Alderman, 2004; Lezak, 
2004; Strauss, Sherman, & Spreen, 2006). The use of the term executive function in its 
singular form suggests that there might be a core executive ability, and indeed EF is often 
investigated as a homogenous ability. However, most researchers acknowledge the 
heterogeneity of the concept and distinguish various abilities that may contribute to overall 
executive control (Baddeley, 1998; Jurado & Rosselli, 2007; Miyake et al., 2000). There are 
numerous definitions of EF that list various EF-related abilities (Jurado & Rosselli, 2007). The 
well-known conceptualisation of Lezak (2004) distinguishes four EF components: volition, 
planning, purposive action, and effective performance. Another frequently cited 
classification by Smith and Jonides (1999) proposes five components of EF: i) attention and 
inhibition, which refers to focusing attention on the most relevant task and inhibiting less 
relevant responses; ii) task management,  including switching attention between tasks; iii) 
planning; iv) monitoring; and v) coding. Attention-inhibition and task management were 
considered by the authors as highly interrelated and elementary for executive control. Stuss 
and Alexander (2000) suggested that although the great majority of recent studies seem to 
concentrate on ‘cognitive’ aspects of behavioural control (e.g. attention, set-shifting, 
inhibition, and task management), there are also other concepts at least equally important 
for successful goal-oriented behaviour, such as personality, emotions, motivation, and 
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awareness. It has been suggested that EF may be characterised by unity as well as internal 
diversity. Miyake et al. (2000) suggested that EF refers to abilities that are “separable but 
moderately correlated” (p. 87) and hypothesized that while particular components may be 
clearly separated, other processes (e.g. maintaining task-relevant information in working 
memory, or inhibitory processes) may constitute the underlying unitary EF factor. Salthouse 
(2005) found that EF-related abilities are strongly related to reasoning and perceptual 
speed.  
Executive functions were first described following observations of the consequences 
of frontal lobe damage. The case of Phineas Gage, whose personality and behaviour was 
dramatically changed following severe damage to the frontal lobe, is frequently mentioned 
as a ground-breaking  case for understanding the contribution of the frontal lobe to human 
functioning (Wilgus & Wilgus, 2009). The accident revealed that anterior parts of the brain 
may influence those aspects of behaviour, including morality, social appropriateness, will, 
judgment and abstraction, that are crucial for achieving relevant personal goals in a socially 
appropriate manner (Ardila, 2008; Lezak, 2004). Alexander Luria examined a number of 
brain-injured soldiers, and on the basis of his studies identified the anterior part of the brain 
as playing  a crucial role in programming and regulating mental activity and behaviour, 
abilities now seen as synonymous with EF (Luria, 1973). In recent decades the abilities 
related to frontal lobe functioning have been extensively studied and a number of EF 
conceptualisations have emerged. The Supervisory Attentional System (SAS) proposed by 
Norman and Shallice (1986) is one of the most influential models linked to the concept of 
EF. It distinguishes two aspects of cognitive functioning: routine activity and a non-routine, 
executive multicomponent system (the Supervisory System). Another influential model 
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comes from the context of working memory, specifically the multi-component model of 
working memory introduced by Baddeley and Hitch (1974). They described three 
components of working memory: the visuospatial sketchpad, the phonological loop and a 
central executive that controls attention and enables manipulation of information (Baddeley 
& Hitch, 1994). In a subsequent reformulation, the authors distinguished the episodic buffer 
as a function that enables communication between the other three components of working 
memory and long term memory (Baddeley, 2000). A concept closely related to the central 
executive and the SAS is attention, which refers to efficient distribution of cognitive 
resources and may be seen as an ability crucial for managing behaviour (Krpan, Levine, 
Stuss, & Dawson, 2007). Stuss and colleagues (1995) described seven aspects of attention 
that are related to frontal lobe function: sustaining, concentrating, sharing, suppressing, 
switching, preparing and setting of attention. Further observations of the consequences of 
frontal lesions led the authors to postulate that EF is only one category of frontal functions. 
They defined EF as ‘a collection of anatomically and functionally independent but 
interrelated attentional control processes’ (Krpan et al., 2007, p. 901), and distinguished 
three main processes contributing to this frontal attentional control: energization, task 
setting and monitoring.  
In summary, there are numerous definitions and conceptualisations of abilities 
responsible for successful purposive behaviour, referred to as executive functions. Some 
models refer to relatively specific attentional control abilities, while other definitions include 
highly complex phenomena of human behaviour, such as will, motivation, and insight. 
Theories of EF are constantly evolving in the light of growing evidence from clinical, 
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experimental and neuroimaging studies, and to date no definition or conceptualisation has 
been agreed upon to serve as a point of reference for various studies of EF. 
1.3.2 Neuronal basis of executive functions 
Results of neuroimaging studies suggest that there is no direct overlap between cognitive 
abilities regarded as executive and abilities known to be related to frontal lobe functioning 
(Alvarez & Emory, 2006). However, it is now well documented that the prefrontal cortex 
(PFC) plays a crucial role in behaviour regulation. The prefrontal cortex (PFC) is typically 
divided into two regions: anterior PFC, also referred to as the frontopolar or rostrolateral 
prefrontal cortex, and posterior PFC, further divided into the dorsolateral, ventral, medial, 
and orbitofrontal regions (Alexander, DeLong, & Strick, 1986; Christoff & Gabrieli, 2000). 
The activity of the PFC is modulated by multiple neurotransmitters, with extensive 
interconnections with sensory and motor cortical systems and subcortical structures 
(Alvarez & Emory, 2006; Tekin & Cummings, 2002). As described by Alexander, DeLong, and 
Strick (1986), specific aspects of motor, cognitive and behavioural control are mediated by 
five frontostriatal circuits that interconnect specific areas of the prefrontal cortex with 
separate, well-defined areas of the striatum (Dubois & Pillon, 1997). The disruption of 
circuits involving the PFC may result in particular cognitive, emotional and motivational 
deficits. More specifically, disruption of the orbitofrontal circuit is reported to cause 
disinhibited behaviour and other personality changes, while disruption of the anterior 
cingulate circuit is frequently associated with apathy, and disruption of the dorsolateral 
prefrontal circuit seems to be central for executive deficits (Tekin & Cummings, 2002).  
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1.3.3 Measuring executive functions 
There are a number of measures commonly employed to assess frontal-type abilities; 
however, there is no gold standard for measure selection to ensure a comprehensive 
assessment of various aspects of EF (Chan, Shum, Toulopoulou, & Chen, 2008; Strauss et al., 
2006). Well-known tests of executive abilities include verbal fluency tasks (Strauss et al., 
2006), Stroop tests (Jensen & Rohwer Jr, 1966), and the Wisconsin Card Sorting test (Jensen 
& Rohwer Jr, 1966), and variations on these (Lezak, 2004). Some of these tests were 
designed to capture specific aspects of executive control, such as the Stroop test assessing 
ability to inhibit unwanted automatic reactions (Delis, Kaplan, & Kramer, 2001). Other tests 
aim to assess EF in a more general sense, for example the Brixton test (Burgess & Shallice, 
1997). Assessment of EF is complicated because of the uncertainty surrounding the concept 
(Manchester, Priestley, & Jackson, 2004). As there is no agreement with regard to what 
ability or abilities constitute EF, it is not clear what precisely should be measured as EF. For 
example, Lezak’s conceptualisation of EF (2004) does not include concept formation or 
reasoning, although these abilities are included in other classifications of EF (Delis et al., 
2001; Lafleche & Albert, 1995). Furthermore, performance on a single test of EF may involve 
various executive processes as well as lower level cognitive functions (e.g. visuospatial 
abilities, memory, and language), and to draw conclusions about a particular aspect of EF 
the assessment needs to be detailed and well-structured. Having a well-defined structure, 
however, might mean that a test places fewer demands on abilities regarded as central for 
EF, for example problem solving, coping with novelty, and decision making.  
Another problem with EF assessment is the limited correspondence between test 
results and how people with frontal-type impairment function in everyday life. Low 
ecological validity may be related to the limitations of the measures themselves, or may 
Chapter 1. Introduction  14    
 
 
 
reflect issues in defining EF. For example, in the assessment of EF, only specific aspects of 
attentional control are typically assessed (e.g. switching, inhibition), without including a 
broader range of abilities relevant for successful goal-oriented behaviour (Ardila, 2008). 
Some of these limitations may be overcome by including questionnaires developed 
specifically to capture EF-related behavioural difficulties experienced by those with frontal 
lesions in everyday life. The Behavior Rating Inventory of Executive Function (BRIEF; Roth, 
Isquith, & Gioia, 2005) provides two parallel versions, a self-rating form for an individual 
with suspected EF deficits and an informant rating form for a person that knows that 
individual very well. Inclusion of an informant rating is useful in controlling for potential 
limitations in the accuracy of self-appraisal, frequently observed in individuals with brain 
injuries (Ownsworth, Clare, & Morris, 2006), and offers a more clinically comprehensive 
picture of executive functioning in everyday life. 
1.4 Executive functions in Parkinson’s disease 
1.4.1 Mechanisms and characteristics of executive deficits in EF 
Executive functions have been extensively studied in PD, but the evidence is equivocal. For 
example, many studies report that PwPD perform worse than healthy controls on verbal 
fluency tasks (Euteneuer et al., 2009; Muslimovic et al., 2005; Price, 2010; Zgaljardic et al., 
2006), while other studies report no significant differences between PwPD and controls 
(Colman et al., 2009; Cools, Barker, Sahakian, & Robbins, 2001; Kehagia, Cools, Barker, & 
Robbins, 2009; Saltzman, Strauss, Hunter, & Archibald, 2000). Similar inconsistencies are 
observed in other tests used to assess EF in PD. For example, there are reports of impaired 
performance in PwPD on the Wisconsin Card Sorting Test (WCST) and the Stroop test 
(Colman et al., 2009; Euteneuer et al., 2009; Price, 2010; R. Tomer, Fisher, Giladi, & Aharon-
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Peretz, 2002; Witt et al., 2006), while other studies report no differences between PwPD 
and controls on these tests (Dujardin, Defebvre, Grunberg, Becquet, & Destee, 2001; Kliegel, 
Phillips, Lemke, & Kopp, 2005; Muslimovic et al., 2005; Price & Shin, 2009; Saltzman et al., 
2000). Some EF deficits seem to be present even in people with early stage PD with normal 
general cognition (i.e. performing in the normal range on screening tests covering lower 
level cognitive functions), but it is not clear how common, severe or specific these deficits 
are. The differences between studies might to some extent result from the methodological 
challenges involved in studying EF. Alternatively, they may reflect the clinical heterogeneity 
of PD, as cognition might be differently affected by different neurodegenerative processes 
in the brain, in the same way that motor symptoms vary among  people with PD (Dauer & 
Przedborski, 2003). Deficits seem to arise as a consequence of a general dopaminergic 
imbalance affecting the activity of frontostriatal circuitry (Dauer & Przedborski, 2003; Royall 
et al., 2002; Zgaljardic, Foldi, & Borod, 2004). The disruption may reflect PD-specific 
dopaminergic depletion in the striatum and cortical areas as well as the effects of 
dopaminergic medication. For example, dopaminergic drugs may ‘overdose’ brain regions 
with relatively preserved dopamine levels (Cools, Miyakawa, Sheridan, & D'Esposito, 2010). 
Executive deficits in PD may also be associated with deficient cholinergic projections to 
various cortical areas and to the hippocampus (Bohnen et al., 2006; Klein et al., 2010). It has 
been proposed that the striatum and the mesocortical dopaminergic projection may be 
crucially involved in goal-oriented behaviour by regulating the balance between 
responsiveness to changing circumstances and resistance to distraction, the executive 
processes underling appropriate updating of goal representation in PFC (E. K. Miller & 
Cohen, 2001; Seamans & Yang, 2004). 
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1.4.2 Impact of executive deficits on quality of life in Parkinson’s disease 
Quality of life (QoL) is a term referring to the subjective evaluation of one’s current situation 
in the context of one’s individual needs and expectations (WHOQOL group, 1998). With 
person-centredness becoming a priority in healthcare, measures of QoL are more frequently 
used in health-related research to incorporate the subjective perception of the overall 
impact of the illness. However, such measures tend to focus on physical health and as such 
they provide a rating of subjectively perceived health status rather than QoL (Den Oudsten, 
Van Heck, & De Vries, 2007a). Non-motor symptoms are reported to have a significant 
impact on everyday life in PD (Hely et al., 2005), but their mechanisms are not well 
understood, and they are less likely than motor symptoms to be diagnosed and  treated. To 
adequately support PwPD, we need to have a full understanding of various factors that 
impact on their subjective quality of life. Only then might it be possible to specifically target 
those aspects of PD that are most important to PwPD and most likely to result in positive 
changes if addressed effectively. 
People with PD complain about forgetfulness, slowness of thinking and difficulty in 
maintaining concentration (Brod, Mendelsohn, & Roberts, 1998; Poliakoff & Smith-Spark, 
2008), and the presence of attention or memory complaints has been associated with 
poorer quality of life (Barone et al., 2009). Several studies have reported that executive 
deficits might be associated with problems in everyday functioning (Bronnick et al., 2006; 
Cahn et al., 1998; Hobson, Holden, & Meara, 1999; Schrag, Jahanshahi, & Quinn, 2000), but 
the evidence is not consistent (Muslimovic, Post, Speelman, Schmand, & de Haan, 2008). 
One limitation of the existing literature is that many studies that refer to quality of life in PD 
in fact assess subjective perception of the severity of physical symptoms rather than a 
broader concept of quality of life (Den Oudsten et al., 2007a). The second limitation is that 
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cognitive assessment typically includes only a brief screening tool to evaluate general 
cognition, which is not sensitive to mild cognitive deficits and executive dysfunction (Lee, 
Walker, Hildreth, & Prentice, 2006; Schestatsky et al., 2006).  
When considering the impact of PD on a person’s life, it is important to acknowledge 
the role of family members and close friends. Their role increases as the disease progresses, 
and is likely to have a crucial impact on the quality of life of PwPD. The availability of 
informal caregiving has serious economic implications for healthcare, as it is the care 
provided by family members that enables PwPD to continue living at home in the more 
advanced stages of PD. In this thesis the terms caregiver, carer and informant are used 
interchangeably, as all tend to be used in the literature to refer to a person that supports 
and cares for PwPD, and may provide additional information about the health and 
functioning of PwPD to the clinicians or in research project. Caring for PwPD may be 
associated with significant physical and emotional strains (Martínez-Martín et al., 2007; 
Roland, Jenkins, & Johnson, 2010) and it is crucial to support them in their caregiving work 
(A'Campo, Wekking, Spliethoff-Kamminga, Le Cessie, & Roos, 2010; Secker & Brown, 2005). 
Better understanding of the factors affecting caregivers in PD may help improve existing 
interventions and contribute to development of new approaches. The burden associated 
with caring for PwPD may be influenced by the severity of motor symptoms (Cifu et al., 
2006; Happe & Berger, 2002; Martínez-Martín et al., 2007) as well as various non-motor 
difficulties, for example depression and sleep disturbances (Aarsland, Larsen, Karlsen, Lim, & 
Tandberg, 1999; Martinez-Martin et al., 2005; E. Miller, Berrios, & Politynska, 1996). The 
impact of EF deficits on caregiver burden is not clear, as EF-specific measures are rarely 
employed, and studies investigating the relationship between cognition and caregiver 
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burden produce mixed findings (D’Amelio et al., 2009; Leroi, Harbishettar, et al., 2012; 
Martinez-Martin et al., 2005; Peters, Fitzpatrick, Doll, Playford, & Jenkinson, 2011; Schrag et 
al., 2006).  
1.4.3 Awareness of executive functioning in PD 
Accuracy in appraising one’s own functioning, sometimes referred to as awareness or 
insight, relies on various higher level meta-cognitive processes frequently included within 
the umbrella term of EF, such as judgment, comparison, and decision-making (Clare, 2002). 
Awareness may be compromised in conditions involving brain damage and cognitive 
impairment, particularly when the frontal lobe is affected (Leritz, Loftis, Crucian, Friedman, 
& Bowers, 2004; Northoff & Bermpohl, 2004; Ries et al., 2007). Inaccuracies in 
acknowledging one’s own deficits are frequently observed in traumatic brain injury and 
dementia (Ownsworth et al., 2006), but the level of awareness found in PwPD has been less 
extensively studied. There are reports suggesting that PwPD may express adequate 
awareness in some areas of functioning, for example with regard to their deficits in facial 
expression (Mikos et al., 2009) and severity of dyskinesia (Sitek, Sołtan, et al., 2011), but 
there are also studies reporting that reduced awareness of limitations impacts negatively on 
driving abilities and medication compliance in PD (Devos et al., 2007; Grosset, Bone, Reid, & 
Grosset, 2006; Kulkarni et al., 2008; Rizzo, Uc, Dawson, Anderson, & Rodnitzky, 2010; Uc et 
al., 2007). There are a few studies of awareness of cognitive functioning in PD, with 
ambiguous findings (Ivory, Knight, Longmore, & Caradoc-Davies, 1999; Seltzer, Vasterling, 
Mathias, & Brennan, 2001; Sitek, Soltan, Wieczorek, Robowski, & Slawek, 2011).  
Reduced awareness might have implications for treatment outcomes in PwPD and 
for overall functioning. Poor response to medication could be associated with forgetting to 
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take medication, but if a person does not acknowledge the problem, it would not be 
reported to the clinician and no action would be taken to enhance treatment compliance 
(Koerts et al., 2012). The view of cognitive functioning held by the PwPD might be 
discrepant from that held by the caregivers, resulting in particular stresses in the caregiving 
relationship. PwPD who are unaware of their executive difficulties might not adjust their 
behaviour by employing compensatory strategies or asking for assistance, or avoiding 
dangerous situations (e.g. driving), and might benefit less from available support. In 
particular, PwPD with reduced awareness of their own deficits would not seek advice on 
how to cope better, and might decline available help, creating a false impression about how 
well they are able to manage. While some difficulties might be observable by family 
members and clinicians, others, such as mild cognitive decline, might be less obvious. 
Reduced awareness of one’s own limitations may therefore constitute a barrier to more 
efficient treatment, and might have implications for quality of life. This area certainly needs 
to be better understood in order to provide appropriate support.  
1.5 Aims of the thesis and research questions 
The aim of this thesis is to extend our understanding of EF in PD by clarifying the pattern of 
executive impairment in early stage PD, assessing the impact of executive deficits on quality 
of life in PwPD and their families, and investigating the accuracy of PwPD in recognising 
potential EF-related difficulties. 
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The following research questions (RQ) are addressed in this thesis: 
RQ 1. What pattern of executive impairment can be identified from the research literature 
on EF in people with early stage PD without dementia, and what are the critical issues for 
improving consistency in this field? 
RQ 2. Which areas of EF are particularly problematic in early stage PD?  
RQ 3. How do EF deficits affect quality of life and health status for the PwPD, and the 
caregiver stress associated with caring for PwPD? 
RQ 4. How accurate are PwPD in assessing their overall executive functioning and their 
performance in a given task?  
The following methods are used to address each of the research questions posed in this 
thesis: 
RQ 1 is addressed by conducting a meta-analysis (Chapter 3). 
RQ 2 is addressed with quantitative analyses based on cross-sectional data from a subgroup 
of PwPD identified as having EF deficits (Chapter 4). 
RQ 3 is addressed with quantitative analyses based on cross-sectional data from PwPD and 
their caregivers (Chapter 5).  
RQ 4 is addressed with quantitative analyses based on cross-sectional data from PwPD and 
their caregivers, and data from healthy controls in similar age (Chapter 6).   
Research methodology employed for conducting a systematic literature review and a 
meta-analysis (RQ 1) and the empirical studies (RQ 2, RQ 3, and RQ 4), including the design, 
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procedures relating to recruitment and assessment study participants, and to data analyses, 
is presented in Chapter 2 Method. Further details are presented in the method sections of 
the subsequent chapters (chapters 3 – 6). 
1.6 Structure of the thesis 
The thesis consists of seven chapters: the general introduction, method, a systematic review 
and meta-analysis, three empirical chapters, and the final discussion of the results. The 
systematic review and empirical chapters are presented in the format of journal articles; in 
each case, these articles have been published or accepted for publication in peer-reviewed 
academic journals (see below). The following is a summary of the content of each chapter: 
Chapter 2 – Research methodology  
Chapter 2 presents an extended description of methodology employed in the empirical 
studies presented in chapters 4, 5, and 6. As the empirical chapters are based on data from 
the same study and presented in the format of journal articles, there will be some repetition 
in the method sections where the study groups and measures are described. 
Chapter 3 – Executive functions in Parkinson’s disease: Systematic review and meta-analysis 
Chapter 3 presents the results of a systematic literature review and meta-analysis of studies 
examining EF in people who have early stage PD without dementia. The review provides a 
structured overview of the current state of research in this area, identifies some gaps and 
inconsistencies in the literature, and suggests critical issues for improving consistency in the 
field.  The meta-analysis synthesises data from five commonly used tests of EF drawn from 
18 studies, and reveals consistent evidence for deficits in the EF domain.  
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Chapter 4 – Pattern of executive impairment in early stage Parkinson’s disease 
Chapter 4 examines the relationships among different executive abilities in early stage PD. 
The study employs a comprehensive set of standard EF measures, and focuses exclusively 
on people with mild to moderate PD, without dementia, but with frontal-type deficits 
indicated by screening using the Frontal Assessment Battery. A data-driven approach reveals 
a possible dissociation in executive functioning in early stage PD, with the attentional 
control aspect of EF being affected to a greater extent than the abstract reasoning aspect of 
EF. 
Chapter 5 – Quality of life, health status and caregiver burden in Parkinson’s disease: 
Relationship to executive functioning 
Chapter 5 examines how EF deficits contribute to quality of life and health status for the 
PwPD, and to burden for the caregiver. The study suggests that EF-related behavioural 
problems may contribute to quality of life and health status in PwPD, and affect caregiver 
burden. The findings support the view that the concepts of subjective QoL and self-assessed 
health status are only partially related and that assessing the two concepts separately is 
relevant to understanding what factors impact on QoL in PD. 
Chapter 6 – Awareness of executive deficits in people with Parkinson's disease 
Chapter 6 presents findings from an evaluation of awareness of executive functioning in 
PwPD with and without EF deficits, and in healthy controls. The results suggest that while 
PwPD may accurately acknowledge their deficits at a general level, they are less accurate in 
appraising their performance on specific tasks.  
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Chapter 7 – General discussion 
The final chapter summarises the results from the systematic review and empirical studies 
and discusses the findings in the context of the existing literature. 
1.7 Dissemination of findings 
Chapters 3 – 6 have all been submitted for publication in peer-reviewed academic journals.  
Chapter 3 has been published in Movement Disorders: 
Kudlicka, A., Clare, L., & Hindle, J. V. (2011). Executive functions in Parkinson's 
disease: Systematic review and meta-analysis. Movement Disorders, 26(13), 2305-2315. doi: 
10.1002/mds.23868 
Chapter 4 has been accepted for publication in Dementia and Geriatric Cognitive Disorders: 
Kudlicka, A., Clare, L., & Hindle, J. V. (in press). Pattern of executive impairment in 
mild to moderate Parkinson’s disease. Dementia and Geriatric Cognitive Disorders. 
Chapter 5 has been published in the International Journal of Geriatric Psychiatry:  
Kudlicka, A., Clare, L., & Hindle, J. V. (2013). Quality of life, health status and 
caregiver burden in Parkinson’s disease: Relationship to executive functioning. International 
Journal of Geriatric Psychiatry. Advance online publication. doi:10.1002/gps.3970 
Chapter 6 has been published in the Journal of the International Neuropsychological Society: 
Kudlicka, A., Clare, L., & Hindle, J. V. (2013). Awareness of executive deficits in 
people with Parkinson's disease. Journal of the International Neuropsychological Society, 
19(5), 559–570. doi:10.1017/S1355617713000064 
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Several conference presentations have been made to date based on findings from this 
thesis: 
Kudlicka, A., Clare, L., & Hindle, J. V. (2012, November). Quality of life, health status 
and caregiver burden in Parkinson’s disease: Relationship to executive functioning. Paper 
presented at The NEURODEM Cymru Annual Conference, Cardiff. 
Kudlicka, A., Clare, L., & Hindle, J. V. (2011, March). Executive functions in Parkinson's 
disease: Systematic review and meta-analysis. Poster presented at The Welsh Branch of the 
British Geriatric Society Spring Meeting, St Asaph. 
Kudlicka, A., Clare, L., & Hindle, J. V. (2010, December). Executive functions in 
Parkinson's disease: Systematic review and meta-analysis. Poster presented at The 7th 
International Congress on Mental Dysfunctions and Other Non-Motor Features in PD, 
Barcelona. 
Kudlicka, A., Clare, L., & Hindle, J. V. (2010, October). Executive functions in 
Parkinson's disease: Systematic review and meta-analysis. Poster presented at The 
NEURODEM Cymru Annual Conference, Cardiff 
Kudlicka, A., Clare, L., & Hindle, J. V. (2010, July). Executive functions in Parkinson's 
disease: Systematic review and meta-analysis. Poster presented at The International 
Neuropsychological Society Midyear Meeting, Kraków. 
1.8 Conclusions 
Despite considerable evidence of impaired performance on neuropsychological tests among 
people with PD, there is no agreement about the exact prevalence of particular executive 
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deficits, or about whether there is any pattern in what abilities are impaired and what 
abilities are preserved. Only limited information is available about how people with PD 
appraise their own executive functioning and how executive deficits influence their 
everyday lives. Addressing these questions is important in order to provide adequate 
support for PwPD and their families. The aim of this thesis is to extend our understanding of 
EF in early stage PD and provide information to assist in the development of adequate 
person-centred support for people diagnosed with PD and their family members. While it 
might not be possible to address underlying cognitive impairment directly, it may 
nonetheless be possible to reduce activity limitation (functional disability) and restrictions 
on social participation (handicap) through a rehabilitative approach. 
  
 
 
 
2 Method 
 
 
Chapter 2 
Method
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This chapter describes the methodology employed in the systematic literature review and in 
the empirical studies. It summarises and complements information reported in the method 
sections of chapters 3, 4, 5, and 6.  
I Systematic literature review and meta-analysis 
The first research question posed in this thesis aimed to clarify what pattern of executive 
impairment emerges from the existing literature (see section 1.5 Aims of the thesis, research 
questions, and research methodology in Chapter 1). The extensive body of  research on 
executive functions (EF) in Parkinson’s disease (PD) is complex and combines a variety of 
disciplines and research methods. For example, cognitive change is investigated in the 
context of the neuronal and neurochemical basis of PD (Lewis, Dove, Robbins, Barker, & 
Owen, 2003; Monchi, Petrides, Mejia-Constain, & Strafella, 2007), effects of medication and 
medical treatments (Cools, Barker, Sahakian, & Robbins, 2003; Jahanshahi et al., 2000), 
genetic predisposition (Williams-Gray, Hampshire, Robbins, Owen, & Barker, 2007),  
economic impact on  society (Huse et al., 2005), and relevance for well-being of PwPD 
(Klepac, Trkulja, Relja, & Babic, 2008). A range of research methods are employed, such as 
brain imaging, experimental paradigms, neuropsychological assessment, animal models or 
questionnaire surveys. It was decided that to allow a meaningfully synthesis of this complex 
literature the review should focus on a clearly defined aspect of the research into EF in PD. 
The neuropsychological perspective was chosen as it is closely linked to the everyday 
functioning of PwPD and seems most appropriate in the context of the research questions 
posed in this thesis. 
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It is recommended that systematic reviews base literature searches on MeSH terms. 
However, at the time of the literature search, the term ‘executive’ was not included as a 
MeSH term. The term ‘executive’ was added as a MeSH term in 2010 and suggests the 
following entry terms: ‘Executive Functions’, ‘Function, Executive’, ‘Functions, Executive’, 
‘Executive Control’, ‘Executive Controls’. The scope note acknowledges the modular nature 
of EF, but lists only some examples of EF-related abilities, without formally providing 
narrower terms for literature searches. Some of the included EF-related abilities are not 
listed as MeSH terms and the abilities that are listed as MESH terms are indexed in the 
MeSH hierarchies without being linked to the term ‘executive’ (e.g. inhibition is indexed in 
‘behavior’, ‘learning’, and 'psychoanalytic theory’). There is no widely accepted and 
sufficiently detailed definition of EF and EF-related abilities that could guide selection of the 
search terms (see section Definitions and historical background of executive functions in 
Chapter 1). 
In the review presented in this thesis the following two-stage strategy was 
implemented to capture studies investigating a broad range of EF-related abilities. In the 
first stage the following broad EF-related terms were used: ‘cognitive impairment’, 
‘dysexecutive’ or ‘executive’. Based on the initial analysis of the articles retrieved in the first 
search 11 subcomponent functions were identified as commonly investigated in relation to 
or as a part of EF. These terms, used in the second stage search, were:  ‘frontal’, ‘working’, 
‘set-shifting’, ‘switching’, ‘fluency’, ‘inhibition’, ‘decision making’, ‘planning’, ‘flexib*’, 
‘processing speed’, ‘cognitive speed’. Terms used in both searches were combined with the 
term ‘Parkinson’s disease’.  
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Studies on cognition and EF in PD report varying prevalence rates and severity of 
cognitive deficits (Costa, Peppe, Caltagirone, & Carlesimo, 2008; Foltynie, Brayne, Robbins, 
& Barker, 2004; McKinlay et al., 2009; Muslimovic et al., 2005), and several PD 
characteristics have been identified as impacting on cognition in PD and possibly 
contributing to the observed differences (Colman et al., 2009; Cools et al., 2010; 
Kobayakawa, Koyama, Mimura, & Kawamura, 2008; Leh, Petrides, & Strafella, 2010). To 
improve clarity in synthesising the existing evidence, the review focused on the studies with 
PwPD groups that were similar in terms of the PD stage (H&Y stage I-III), depression level 
(no significant depression) and general cognition (no dementia). In addition a number of 
sample characteristics, such as age, PD duration, side of PD onset, medication, and whether 
participants were tested ‘on’ or ‘off’ medication, were monitored in the reviewed papers 
(see a structured form to summarise articles in Appendix F). A list of the selection criteria 
applied in the review is presented in Table 3.1 in Chapter 3.  
A systematic literature search was performed in the following databases: PsycInfo 
(CSA), MEDLINE (Web of Knowledge), PubMed, CINAHL, and the Cochrane Library. This 
yielded 3,264 unique hits. Following the screening of titles and abstracts, 393 articles were 
retrieved for more detailed inspection. This included 22 articles that were received either 
following requests sent to authors (8 articles) or ordered via inter-library loan (14 articles). 
There were 189 articles that unambiguously failed to meet the eligibility criteria and were 
excluded at this stage. The key reasons for excluding papers at this stage were as follows:  
1. Cognition, EF or a relevant executive ability was mentioned in the abstract, but not 
investigated in the study (e.g. Nobukatsu Sawamoto, Honda, Hanakawa, Fukuyama, 
& Shibasaki, 2002). 
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2. The study focused on cognition in a clinical group other than PD (e.g. Hanes, 
Andrewes, & Pantelis, 1995). 
3. EF was investigated from the neurochemical or neuroanatomical perspective (e.g. 
Beste, Dziobek, Hielscher, Willemssen, & Falkenstein, 2009). 
The full text of the remaining 204 articles were examined, and 134 articles were excluded. 
The main reasons for excluding the studies at this stage were as follows:  
1. The article retrieved was a theoretical study or a literature review (e.g. Leh et al., 
2010). 
2. The cognitive abilities studied were not from the EF spectrum (Taylor, Saint-Cyr, & 
Lang, 1990). 
3. Cognition was assessed in a general manner without distinguishing EF (Ryder et al., 
2002). 
4. The study specified that the sample included PwPD with dementia or people in the 
more advanced stages of PD (H&Y > III) (e.g. O'Brien et al., 2009).  
The remaining 70 studies were carefully analyzed using a structured form (see Appendix F), 
and summarized in a table (see Appendix G). Thirty-seven studies were excluded at this 
stage; the reason for the exclusion of each article is specified in Appendix G. The main 
reasons for exclusions at this stage were:  
1. No depression, dementia, and/or H&Y PD severity rating was provided.  
2. No control data were provided.  
3. EF was assessed with an experimental paradigm and not with standardized 
measures.  
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The remaining 33 studies were included in the review (see Appendix G and Table 3.2 in 
Chapter 3).  
A meta-analytic approach (Borenstein, Hedges, Higgins, & Rothstein, 2009) was 
employed to quantitatively synthesize the results of studies identified in the literature 
review. The results were compared using a random-effects model, which provides a 
statistical parameter representing the inter-study variation and allows for better control of 
heterogeneity. Further details of the literature search and meta-analysis are presented in 
the method section of Chapter 3. 
II Empirical studies  
2.1 Design 
The empirical studies presented in chapters 4, 5, and 6 present the results of quantitative 
analyses based on cross-sectional data from a sample of PwPD and their caregivers, and 
from healthy controls of a  similar age:  
I. Chapter 4 presents analyses based on cross-sectional data from a subgroup of the 
sample of PwPD who were identified as having EF deficits. 
II. Chapter 5 presents analyses based on cross-sectional data from PwPD and their 
caregivers. 
III. Chapter 6 presents analyses based on cross-sectional data from PwPD, their 
caregivers, and healthy controls. 
Ethical approval was obtained from the Research Ethics Committee of the School of 
Psychology, Bangor University, and from the National Health Service (NHS) North Wales 
(West) Research Ethics Committee (Appendix A). All participants provided written informed 
consent (see Participant Information Sheets and Consent Forms in appendices B – D). 
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2.1.1 Participants  
To address the research questions posed in this thesis (see section 1.5 Aims of the thesis, 
research questions, and research methodology in Chapter 1) data were collected from a 
group of PwPD and their caregivers, and healthy older people.  
Potential participants for the PwPD group were identified from Movement Disorders 
clinics in North-West Wales by the consultant physician Dr John Hindle, and invited to 
participate in the study by the author or by staff members of the National Institute for Social 
Care and Health Research Clinical Research Collaboration (NISCHR CRC); these are NHS staff 
with a specific remit to support identification and recruitment of research participants. In 
addition, some participants were invited to take part upon completion of their involvement 
in another research project.  
People with Parkinson’s disease 
The eligibility criteria for the PwPD group were chosen to control a number of factors that 
may impact on performance in EF tests (Colman et al., 2009; Cools et al., 2010; Kobayakawa 
et al., 2008; Leh et al., 2010). It was expected that collecting data from a well-defined group 
of PwPD, similar in terms of PD stage, depression level and general cognition will facilitate 
better clarity in the performed analyses. 
Inclusion criteria for the PwPD group were mild to moderate PD (Hoehn and Yahr 
stage I-III; Hoehn & Yahr, 1967) diagnosed according to the UKPDS Brain Bank criteria 
(Daniel & Lees, 1993), stable antiparkinsonian medication, normal general cognition, as 
indicated by an Addenbrooke’s Cognitive Examination – Revised (ACE-R) score ≥ 82 (Mioshi, 
Dawson, Mitchell, Arnold, & Hodges, 2006) and a MMSE score ≥ 24 (Folstein, Folstein, & 
McHugh, 1975), and no clinically significant depression, as indicated by a Hospital Anxiety 
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and Depression Scale (HADS) score ≤ 11 (Snaith & Zigmond, 1994). Exclusion criteria were 
presence of a serious neurological condition other than PD, severe hearing or eyesight loss, 
and lack of proficiency in English.  
Over the 18 month recruitment period, 75 PwPD agreed to take part in the study. 
Sixty-five of them met the above-mentioned eligibility criteria and completed an assessment 
of EF, awareness, QoL, and subjective health status.  
PwPD with probable executive deficits 
The prevalence rates of executive deficits in PwPD without dementia vary, with some 
studies reporting the impairment as affecting less than 20% of PwPD (Muslimovic et al., 
2005) and other studies reporting a 50% impairment rate (McKinlay et al., 2009). However, 
it is evident that executive impairment affects only some of PwPD, while a large proportion 
of PwPD seem to have intact EF. In order to determine  what are the most problematic 
areas of EF in early stage PD (Chapter 4) it was therefore decided to identify a subgroup of 
PwPD with probable EF deficits. It was expected that excluding PwPD with no evidence of 
executive impairment would allow for the pattern of executive impairment to emerge more 
prominently in the analyses. EF were assessed with the Frontal Assessment Battery (FAB; 
Dubois, Slachevsky, Litvan, & Pillon, 2000; see description of the FAB in section 2.4.1 
Screening measures in this chapter) and the study adopted a cut-off score of 15 for probable 
frontal-type deficits, which is 2 SD below the mean reported for healthy controls (M = 17.3, 
SD = 0.8) (Dubois et al., 2000). Some studies report lower mean FAB scores for healthy older 
people (Appollonio et al., 2005), but in this study a less conservative cut-off score was 
adopted as higher sensitivity of the screening assessment (a correct classification of PwPD 
with EF deficits as ‘impaired’) was considered more relevant for the purpose of this study.  
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Forty (61.1%) of the 65 participants meeting the general inclusion criteria for the 
PwPD group had a FAB score ≤ 15, indicating possible frontal type cognitive deficits (Dubois 
et al., 2000), and were thus eligible for the in-depth EF assessment. Three of these 
participants did not complete the in-depth EF assessment due to elective withdrawal and 
three due to fatigue, leaving a sample of 34 who completed the assessment.   
Caregivers of PwPD 
To obtain a more comprehensive picture of how executive impairment may impact on PwPD 
(chapters 5 and 6), in each case people who support and know the PwPD very well (n = 50; 
referred to in this thesis as caregivers, carers or informants) provided information about the 
executive functioning of PwPD and their own perception of burden associated with 
supporting a PwPD. A proportion of PwPD lived alone and did not specify a suitable 
informant, and some family members who lived with PwPD and were invited to participate 
did not return the questionnaires. In one case the caregiver opted not to take part in the 
study.  
Control group 
To examine whether PwPD can accurately appraise their executive functioning (Chapter 6) it 
was necessary to compare ratings made by  PwPD with ratings from a control group. Forty-
three healthy older people were recruited and assessed by MSc students as part of their 
master’s research.  They were recruited from various community sources (e.g. over-50s 
clubs, University of the Third Age branches, church groups). Inclusion criteria for healthy 
older people were no dementia, as indicated by an ACE-R score ≥ 82 (Mioshi et al., 2006) 
and an MMSE score ≥ 24 (Folstein et al., 1975), and no significant depression, as indicated 
by a Geriatric Depression Scale (GDS-15) score ≤ 5 (Burke, Roccaforte, & Wengel, 1991; 
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Sheikh & Yesavage, 1986). The master’s project included additional measures not presented 
in this thesis. I helped to devise the assessment for the master’s project, and contributed to 
training and supervision of the students.  
2.1.2 Sample size calculations 
Sample size calculations were based on the analyses planned for exploring the relationship 
between executive functioning and other variables of interest in the subgroup of PwPD 
showing executive deficits (RQ 2, see section 1.5 Aims of the thesis, research questions, and 
research methodology in Chapter 1). To demonstrate that a correlation coefficient of 0.46, 
an average value reported in previous studies (Siegert, Weatherall, Taylor, & Abernethy, 
2008), is different from zero in a test with 80% power for a 5% significance level, a sample of 
34 PwPD is needed. McKinlay et al. (2009) reported that 50% of PwPD may have deficits 
specifically in the EF domain. Therefore, it was anticipated that approximately 70 PwPD 
would need to be assessed in order to identify the required sample of individuals with EF 
deficits for Research Question 2. The sample size of 70 was considered appropriate for the 
analyses planned for Research Questions 3 and 4.  
2.2 Measures 
In this section all measures used in the empirical studies will be introduced and the rationale 
for their selection will be presented. All measures were administered according to the 
procedures described in the relevant manuals and publications. 
2.2.1 Screening measures 
The following screening measures were used in the empirical studies to screen for cognitive 
and executive deficits and depression. 
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Screening for deficits in general cognition 
There are a number of generic tools designed to screen for cognitive deficits and many of 
them, for example the Mini-Mental State Examination (MMSE; Folstein et al., 1975), the 
Mattis Dementia Rating Scale (MDRS; Mattis, 1988), the Addenbrooke’s Cognitive 
Examination – Revised (ACE-R; Mioshi et al., 2006), and the Cambridge Cognitive 
Assessment (CAMCOG; Athey, Porter, & Walker, 2005) are validated for use in PD. There are 
also several PD-specific dementia screening tools, for example the Scales for Outcomes of 
Parkinson's disease—Cognition (SCOPA-COG; Marinus, Visser, Verwey, et al., 2003), the 
Parkinson's Disease—Cognitive Rating Scale (PD-CRS; Pagonabarraga et al., 2008), and the 
Mini-Mental Parkinson (MMP; Mahieux et al., 1995). These screening measures differ with 
regard to what cognitive abilities they assess and the extensiveness of their psychometric 
evaluation. There is also a trade-off between the feasibility of measure administration and 
the comprehensiveness of the assessment (Barone et al., 2011; Chou et al., 2010; Kulisevsky 
& Pagonabarraga, 2009).  
In this thesis general cognition was assessed with the Addenbrooke’s Cognitive 
Examination Revised (ACE-R; Mioshi et al., 2006), which is a well-established tool for 
screening cognitive abilities and which has been  validated in PD studies (McColgan et al., 
2012; Reyes et al., 2009; Rittman et al., 2013). The ACE-R takes longer to complete than 
some other screening measures, but it provides a relatively comprehensive assessment of 
the key cognitive domains: attention and orientation, memory, verbal fluency, language and 
visuospatial abilities. The ACE-R has been reported to have very good reliability (α = .80), 
and the validity was demonstrated by significant correlation with the Clinical Dementia Scale 
(r = -0.32, p < 0.001) (Mioshi et al., 2006). The maximum total score of 100 indicates 
errorless performance and an MMSE score can also be calculated (Folstein et al., 1975). 
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Screening for executive deficits 
The screening tools designed to capture overall cognitive decline aim to assess various 
cognitive domains, and do not focus specifically on EF (e.g. PD-CRS , SCOPA-COG); executive 
functioning may be assessed with a single item or not assessed at all (Folstein & Folstein, 
2010). While these tools are useful in screening for global cognitive decline, they are less 
able when screening specifically for EF deficits as required for the purpose of this thesis. The 
Frontal Assessment Battery (FAB, Dubois et al., 2000) was used in the empirical studies as it 
appears to be the only screening tool developed specifically to capture frontal-type 
cognitive deficits. The FAB assesses six aspects of frontal-type abilities: conceptualization, 
mental flexibility, motor programming, sensitivity to interference, inhibitory control, and 
environmental autonomy, and includes some well-known tasks sensitive to frontal lobe 
damage (e.g. verbal fluency, Go/NoGo).  
The psychometric properties are well-described and indicate strong concurrent 
validity (correlation with MDRS, r = .82, p < .001), and good internal consistency (α = .78) 
and inter-rater reliability (K =.87, p < .001) (Dubois et al., 2000). The FAB is time-efficient and 
has been validated for use in conditions involving frontal-lobe dysfunction (Lima, Meireles, 
Fonseca, Castro, & Garrett, 2008).  
Screening for depression 
Depression is common in PwPD (Brown et al., 2011) and may impact on cognitive test 
performance (Stefanova et al., 2006; Uekermann et al., 2003). It was therefore decided to 
exclude PwPD who had significant depressive symptoms. The available depression screening 
tools were carefully considered as they often include a proportion of questions about 
somatic symptoms that overlap with PD symptoms and may inflate depression scores. For 
  Chapter 2. Method  38 
 
example, in the Hamilton Depression Rating Scale (Ham-D, Hamilton, 1960) and the Beck 
Depression Inventory (BDI, Beck, Ward, Mendelson, Mock, & Erbaugh, 1961) over 50% of 
the questions refer to symptoms that may be normally experienced by PwPD who are not 
depressed.  
In the present study depression levels in PwPD were assessed with the Hospital 
Anxiety and Depression Scale (HADS; Snaith & Zigmond, 1994). The HADS is a self-rating 
questionnaire consisting of two 7-item subscales:  HADS – Anxiety and HADS – Depression. 
Scores for each of the scales range from 0 to 21, with higher scores indicating higher levels 
of self-rated anxiety/depression. The HADS includes a limited number of questions about 
somatic symptoms and is recommended for use in PD (Schrag et al., 2007). It is reported to 
have good internal consistency (Cronbach α = .88) and test-retest reliability (r = .84) in PwPD 
(Marinus, Leentjens, Visser, Stiggelbout, & van Hilten, 2002), and is widely used in PD 
studies (Schrag et al., 2007). The empirical studies adopted the cut-off of 11 suggested for 
depression screening purposes (Crawford, Henry, Crombie, & Taylor, 2001).  
In healthy older people depression levels were assessed using the Geriatric 
Depression Scale (GDS-15; Sheikh & Yesavage, 1986) (Appendix J), which is a short and 
convenient screening tool with good psychometric characteristics that is widely used for 
assessing depression in older people. It consists of 15 yes-no questions, scored 1 or 0, with 
higher scores indicating higher levels of self-rated depression. The study adopted the cut-off 
of ≤ 5 recommended for depression screening (Burke et al., 1991).  
2.2.2 Executive functions (EF) 
The modular nature of the EF concept means that a single measure of EF does not suffice 
and to comprehensively assess executive abilities a set of measures needs to be employed. 
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However, as there is no clear definition of EF there is little guidance to inform measure 
selection for a comprehensive assessment of EF (Strauss et al., 2006).  
There are numerous tests and procedures used to assess various EF-related abilities 
(Strauss et al., 2006) and choosing the appropriate test and version requires careful 
consideration. Some of the most popular tests of EF include the Stroop test (Jensen & 
Rohwer Jr, 1966), the Trail Making test (Reitan, 1971), the Tower of London (Shallice, 1982), 
the Wisconsin Card Sorting Test (WCST; Milner, 1963), and verbal fluency tasks (Bechtoldt, 
Benton, & Fogel, 1962). The Stroop test assesses the ability to inhibit unwanted automatic 
reactions; the Trail Making test evaluates the ability to switch between mental sets; the 
Tower of London test requires planning abilities; the WCST involves the ability to form 
abstract concepts; and the verbal fluency test is used to assess initiation and cognitive 
flexibility (see also Table 3.4 in Chapter 3).  
The best-known tests of EF are often available in several versions based on the same 
paradigm (Strauss et al., 2006). For example, there are several commercially-available 
versions of the Stroop test: the Golden version (Golden, 1978), the Victoria version (Spreen 
& Strauss, 1998), and the Color-Word Interference test (Delis et al., 2001). There are also 
groups of EF tests that differ significantly in terms of administration procedures and 
materials, but are based on the same underlying paradigm. One example is provided by the 
Tower of London test (Shallice, 1982) and the Stockings of Cambridge test (Robbins et al., 
1994); another is provided by the WCST (Milner, 1963), the Intra/Extradimensional Shift test 
(Robbins et al., 1994), the Rule Shift Cards Test (B. A. Wilson, Evans, Alderman, Burgess, & 
Emslie, 1997), and the Sorting test (Delis et al., 2001). Some of the best-known EF tests are 
part of large batteries of tests, such the Cambridge Neuropsychological Test Automated 
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Batteries (CANTAB; Robbins et al., 1994), which is a multi-domain battery of tests, or the 
Delis-Kaplan Executive Functions System (D-KEFS ), which consists solely of EF tests. 
Several tests of EF were derived from a non-clinical basis; for example the 20 
Questions test (Delis et al., 2001) is based on a spoken game, and the Tower of London 
(Shallice, 1982) is based on a mathematical puzzle. There are also a number of EF tests and 
test batteries that were developed specifically as neuropsychological tools, such as the 
Behavioural Assessment of the Dysexecutive Syndrome (BADS; B. A. Wilson et al., 1997), and 
the Hayling and Brixton Tests (Burgess & Shallice, 1997).  
When choosing tests of EF for this study a number of factors were considered. The 
key aim was to ensure that a broad range of executive abilities could be assessed, and that 
the chosen tests have good psychometric properties. Priority was given to measures 
offering reliable normative data, as the study objectives included classification of test 
performance in terms of impairment (Chapter 4). It was important that the tests should 
have minimal motor skills involvement or offer a way to control the impact that motor 
symptoms of PD might have on test performance. Finally, the assessment had to be time-
efficient and portable to permit administration in participants’ homes.  
The Delis-Kaplan Executive Function System (D-KEFS; Delis et al., 2001) was chosen 
for the empirical studies as it meets the above criteria, and having normative data from the 
same large sample allows for a direct comparison of the scaled scores from different 
subtests (Homack, Lee, & Riccio, 2005). The D-KEFS includes nine standard tests of EF: Trail 
Making, Verbal Fluency, Design Fluency, Colour Word Interference, Sorting, 20 Questions, 
Word Context, Tower, and Proverb. Most of them are the variations of well-known tests of 
EF (e.g. Tower or Verbal fluency), but the D-KEFS versions address some of the limitations 
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reported for original versions; for example, the length of lines drawn to connect numbers 
and letters in various conditions of the Trail Making test is always the same.  
All PwPD completed the Trail Making and Colour Word Interference tests, and PwPD 
who were identified as having probable EF deficits completed all nine tests. Healthy older 
people completed the Trail Making test. Detailed descriptions of the tests and 
interpretations of the relevant performance indices are given at the appropriate points in 
subsequent chapters (see section 4.3.4. Assessment of EF, and Table 4.1 in Chapter 4; 
section 5.3.3. Measures in Chapter 5; and section 6.3.3. Measures in Chapter 6). 
2.2.3 EF-related behavioural problems 
Executive deficits may be manifested in various ways, including inappropriate social 
behaviour, difficulties in planning and organising daily responsibilities, making unwise 
decisions and carelessness (Strauss et al., 2006). These aspects of EF are known to be poorly 
addressed in standard performance-based tests of EF. It is therefore important to 
complement standard tests of EF with behavioural ratings of everyday functioning 
(Manchester et al., 2004).  
Several generic behaviour rating scales have been developed to assess behavioural 
disturbances in dementias and brain injury (Malloy & Grace, 2005), but there seems to be 
no PD-specific scales. The rating scales designed for people with dementia include the 
Neuropsychiatric Inventory (NPI; Cummings et al., 1994), and the Frontal Behavior Inventory 
(FBI; Kertesz, Davidson, & Fox, 1997), and the rating scales designed for people with brain 
injury include the Dysexecutive Questionnaire (DEX; B. A. Wilson et al., 1997), the Frontal 
Systems Behavior Scale (FrSBe; Grace & Malloy, 2001), the Iowa Rating Scales of Personality 
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Change (IRSPC; Barrash & Anderson, 1993), and the Behavior Rating Inventory of Executive 
Functions – adult version (BRIEF-A; Roth et al., 2005). 
The rating scales listed above are designed to gather information about relevant 
behavioural difficulties, but the majority provide no standardized norms or offer norms that 
based only on a small sample (DEX, FBI, IRSPC, and NPI) (Malloy & Grace, 2005). Some of the 
ratings were considered inappropriate for the purpose of this thesis as they require a 
comparison of the behaviour before and after brain injury (FrSBe, IRSPC), and the ratings 
developed for people with dementia were considered less practical as they require an 
expert interviewer to administer the measure. Not all scales provide for parallel ratings as a 
means of assessing the accuracy of self-appraisal in PD (Chapter 6). 
In this thesis EF-related behavioural disturbances were assessed with the Behavior 
Rating Inventory of Executive Functions-Adult (BRIEF-A; Roth et al., 2005), as it provides the 
two parallel versions (self-rating and informant-rating) needed for evaluation of awareness 
levels in PD (Chapter 6), and the interpretation of the results is supported by normative data 
from a large sample. Internal consistency is reported as high for the summary index (Global 
Executive Composite, GEC), with Cronbach α =  .96 for the self-rating, and Cronbach α = .98 
for the informant rating (Roth et al., 2005). The test–retest reliability was also reported as 
high, with correlation r = .94 in self-rating, and r = .96 in informant rating (Roth et al., 2005). 
The validity of the BRIEF-A was confirmed by demonstrating strong correlations of the GEC 
with other behavioural ratings of EF, the DEX and FrSBe. The BRIEF-A has been used in 
various clinical groups, including Alzheimer’s, MCI and TBI (Roth et al., 2005; Waid-Ebbs, 
Wen, Heaton, Donovan, & Velozo, 2012), and has been reported as sensitive to subtle 
executive changes in MCI (Rabin et al., 2006). 
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The BRIEF-A assesses the ability to efficiently regulate behaviour and emotional 
responses, and to appropriately distribute attention to sustain task-completion efforts and 
systematically solve problems. The BRIEF-A provides a list of 75 behaviours to be rated on a 
3-point scale (never, sometimes, often; scored 1, 2, 3 respectively). Participants and their 
informants indicate on two parallel versions which of the described behaviours has been a 
problem for the participant during the past month. A higher GEC summary score (range 70-
210) indicates more EF-related difficulties in the everyday environment. The GEC scores are 
converted to age-scaled T scores (M = 50, SD = 10), which indicate whether the reported 
degree of difficulty suggests a clinically-significant level of EF-related behavioural problems 
(T ≥ 65, 1.5 SD above the mean). 
2.2.4 Quality of life and subjective health status 
The importance of acknowledging PwPD subjective perception of the illness is widely 
recognised, and there are several measures developed to examine the subjectively 
perceived impact of the illness on PwPD lives. The terms that are used in this context 
include quality of life, health-related quality of life, and subjective health status. It is argued 
that while these concepts might be related, the subjective perception of the severity or 
magnitude of symptoms (subjective health status) should not be treated as equivalent to 
how satisfied people feel with their health or life in general (quality of life) (Den Oudsten, 
Van Heck, & De Vries, 2007b; Hunt, 1997; Sprangers & Schwartz, 1999; The WHOQOL 
Group, 1995). This distinction is often missing in research studies, and in some cases the 
questionnaires reported as measures of QoL consist of questions about health status. In this 
study both subjective health status and QoL were investigated and in both cases a 
questionnaire developed specifically to capture that particular aspect of well-being was 
carefully selected. To identify relationships between EF deficits and QoL and health status 
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specific to PD, as well as to allow a meaningful comparison of the two concepts, it was 
considered more appropriate to use PD-specific measures for both concepts.  
As far as could be determined, only one questionnaire has been developed 
specifically to assess QoL in movement disorders, the Questions on Life Satisfaction Scale 
(Henrich & Herschbach, 2000; Kuehler et al., 2003) (Appendix G), and it was chosen for this 
study. The scale has been validated for use in PD and includes PD-specific items (Henrich & 
Herschbach, 2000; Kuehler et al., 2003). The questionnaire examines subjective quality of 
life in three dimensions: general life satisfaction (QoL-Life, 8 items), satisfaction with health 
(QoL-Health, 8 items), and satisfaction with health in relation to movement disorders (QoL-
MD, 12 items). On two separate 5-point scales participants indicate the subjective 
importance of specific areas of life and health (importance rating), and the degree of 
satisfaction in these areas (satisfaction rating). The two ratings for each item are converted 
into a weighted satisfaction score (WS) with a formula: WS = [importance rating - 1] x [(2 x 
satisfaction rating) - 5]. The WS scores are summed to provide global ratings for each of the 
three dimensions. For QoL-Life and QoL-Health the possible values range from -96 to 160, 
and for QoL-MD the possible values range from -144 to 240. Negative values indicate a 
predominance of “dissatisfaction”. Internal consistency is reported as high, with α = . 82 for 
QoL-Life, α = .89 for QoL-Health (Henrich & Herschbach, 2000), and α = .87 for QoL-MD 
(Kuehler et al., 2003). The test–retest reliability was satisfactory and the validity of the scale 
was confirmed by demonstrating adequate correlations with other ratings of well-being 
(Henrich & Herschbach, 2000; Kuehler et al., 2003). 
There is a wide range of PD-specific questionnaires assessing subjective health status 
(Martinez‐Martin et al., 2011), such as the Parkinson’s Disease Questionnaire (PDQ-39; 
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Jenkinson, Fitzpatrick, & Peto, 1998), Scales for Outcomes in Parkinson’s Disease – 
Psychosocial (SCOPA-PS  Marinus,  isser, Mart  nez-Mart  n, van Hilten,   Stiggelbout, 2003), 
and Parkinson’s Impact Scale (PIMS; Calne et al., 1996). They differe with regard to 
comprehensiveness of assessment, for example how many questions relate directly to 
physical health, and what aspects of health and well-being are considered.   
In this thesis, subjective health status was assessed with the PDQ-39 (Jenkinson et 
al., 1998) (Appendix H), which consists of 39 questions about the subjectively-perceived 
severity of various PD symptoms that are of particular relevance to PwPD. The 
questionnaire covers a broad range of health-related topics and is widely used in PD studies 
(Martinez‐Martin et al., 2011). It appears to be the only PD-specific health status 
questionnaire that includes items on social support and one of the few that includes 
questions about cognition (Den Oudsten et al., 2007b). It assesses the following eight 
dimensions: mobility, activities of daily living, emotional well-being, stigma, social support, 
cognition, communication and bodily discomfort. Participants indicate on a 5-point scale 
how often they have been affected by each of the 39 problems listed. The total score for 
each dimension is calculated on a scale from 0 to 100 using the following formula: [sum of 
scores in a dimension/(the maximum score per question x number of questions in 
dimension)] x 100, with higher scores indicating a higher level of problems. The mean value 
for all eight dimensions provides a summary index. The questionnaire has high internal 
consistency, with α = .84 for the summary score (Jenkinson, Fitzpatrick, Peto, Greenhall, & 
Hyman, 1997), and between α =.69  (Social support) and α = .94 (Mobility) for the individual 
scales (Peto, Jenkinson, Fitzpatrick, & Greenhall, 1995). The test–retest reliability has been 
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reported as adequate to good, with correlation values between r = .68 (Social support) and r 
= .94 (Mobility)(Peto et al., 1995).  
2.2.5 Caregiver Burden 
A number of generic questionnaires have been developed to assess burden associated with 
providing informal care for a family member (Deeken, Taylor, Mangan, Yabroff, & Ingham, 
2003; Vitaliano, Young, & Russo, 1991). These questionnaires differ with regard to the 
number of questions and comprehensiveness of assessment, as well as the  extent to which 
their psychometric properties have been established (Deeken et al., 2003). For example, the 
Caregiving Stress Inventory (Pearlin, Mullan, Semple, & Skaff, 1990) provides a 
comprehensive assessment of burden in caregivers as it yields 15 different subscales, but 
the internal consistency of some of the scale is low (α = .48) and as there are 89 questions, 
administration is time-consuming. The Zarit Caregiver Burden Interview (Zarit, Reever, & 
Bach-Peterson, 1980) is relatively brief as it consists of 29 questions, but it provides only one 
summary score. It was originally validated in a group of 29 caregivers of people with 
dementia, and the analyses showed no correlations with other established measures. As far 
as can be determined, the only PD-specific questionnaire assessing specific needs of people 
caring for PwPD is the Belastungsfragebogen Parkinson Angehörigen questionnaire 
(Spliethoff-Kamminga, Zwinderman, Springer, & Roos, 2003). It was considered less 
appropriate for the purpose of this thesis, as it was developed to identify caregivers in need 
of additional support, rather than to provide a detailed picture of the overall impact of 
caregiving in PD, and it was validated only on a relatively small group of PwPD. A generic 
tool, the Caregiver Burden Inventory (CBI; Novak & Guest, 1989) (Appendix I) was chosen, as 
it provides a comprehensive evaluation of the caregiver’s feelings and responses to the 
burden of care, while remaining relatively brief. It consists of 24 questions related to five 
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areas that might be affected by caregiving: flexibility with time, physical health, social 
relationships, emotional well-being, and life in general. Responses are rated on a 4-point 
scale, with the maximum score of 96 indicating the highest level of burden. Internal 
consistency was reported as good, with α = .85 for the flexibility with time subscale, α = .86 
for the physical health subscale, α = .73 for the social relationships subscale, α = .77 for the 
emotional well-being subscale, and α = .85 for the life in general subscale. The CBI is a 
generic tool, but it has been used previously in PD studies (D’Amelio et al., 2009; Happe & 
Berger, 2002; Schrag et al., 2006). 
2.3 Procedure and data collection 
Sixty-five PwPD who met the inclusion criteria for the study completed the assessment of 
executive functions, awareness, QoL, and subjective health status.  A sub-group of 34 PwPD 
identified as having possible EF deficits completed a more extensive neuropsychological 
assessment of executive abilities.  
PwPD were assessed during their ‘on’ phase and the majority of them were visited at 
home. Six PwPD chose to meet at the University. The initial assessment (screening, EF, 
awareness, QoL, and health status) took between 1.5 and 3 hours, with some participants 
completing the assessment over two shorter visits and some opting to send the self-
completion questionnaires by post. In-depth assessment of EF took another 4 to 6 hours 
over two to three visits, and included measures not reported in this thesis. 
Fifty people who lived with PwPD and/or knew the participants very well (e.g. 
spouses or adult children) provided informant ratings of the executive functioning of PwPD 
and their own level of burden associated with caring for a PwPD. The majority of caregivers 
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completed the questionnaires during the home visit by the researcher and some opted to 
send the questionnaires by post. 
Healthy older people completed the assessment of EF and awareness. The majority 
of them were visited at home, with nine choosing to meet at the University. The assessment 
took 1.5 to 2.5 hours and included measures not reported in this thesis.  
2.4 Data handling and statistical analyses 
2.4.1 Data entry and cleaning 
Participants’ responses were recorded on the relevant score sheets and summary indices 
were calculated according to the procedure outlined in the test manuals or relevant 
publications. The performance scores for the D-KEFS were calculated using the D-KEFS 
Scoring Assistant software, which has built-in minimum and maximum values, reducing the 
risk of erroneous data entry, and automatically calculates the summary scores, eliminating 
possible calculation errors. It also generates the scaled scores without the need for checking 
the complex normative data tables, again reducing the risk of inaccuracy in the final dataset. 
The Scoring Assistant produces test reports detailing the chosen performance indices (raw 
and scaled scores) for individual participants. These reports were printed out, cross-checked 
for accuracy with the scoring sheets, and used for entering data into SPSS. 
The relevant performance indices from the D-KEFS and the other measures and 
questionnaires were entered into a study-specific spreadsheet in SPSS v.19.0 (IBM SPSS 
Statistics for Windows, Version 19.0. Armonk, NY: IBM Corp.). The study-specific 
spreadsheet for data entry contained all variables of interest, with built-in validity checks for 
each variable: pre-specified entry format, possible range of scores and coding (where 
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feasible), and codes for missing data. The accuracy of the final data set was checked visually 
and the descriptive statistics for individual variables were explored to identify unlikely 
values. For example, the summary scores were checked against the possible maximum 
values. Additionally, the total scores were recalculated in SPSS where feasible and cross-
checked with the values calculated manually. Finally, the accuracy of data entry was 
validated by comparing data in the SPSS spread sheet against the actual questionnaires and 
scoring sheets from a random sample of 10 participants (15%).  
One of the questionnaires, the BRIEF-A, provides an additional validity check. It has 
three validity scales (Negativity, Infrequency, and Inconsistency), which highlight abnormal 
patterns of responses (Roth et al., 2005, pp. 16-19). The validity scales were inspected for 
both self- and informant ratings for all participants and the recommended procedure for 
elevated scores was followed when necessary (see details in Table 6.3 in Chapter 6).  
2.4.2 Dealing with missing data 
Missing data were identified in the SPSS spreadsheet with an appropriate code (999, 9999 
or 99999). For one of the questionnaires (BRIEF-A) the test manual specifies a detailed 
procedure for dealing with missing responses (Roth et al., 2005, p. 8), and the 
recommended procedure was observed in this study. In all other measures missing data 
were not imputed and cases were excluded pairwise in the analyses. The only exception 
related to the hierarchical cluster analysis examining associations between cases 
(participants) in EF test performance, where missing values were excluded listwise (see 
Figure 4.3 in Chapter 4). See also Table 2.1 below for information about the completeness of 
the data set and descriptive statistics for the study measures.  
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Table 2.1. Completeness of the data set and descriptive statistics for the study measures. 
Note. See Table 4.1 in Chapter 4 for details of which indices of performance were used for 
particular tests. 
M – Mean; SD – Standard deviation; ACE-R – The Addenbrooke’s Cognitive Examination - 
Revised; HADS – Hospital Anxiety and Depression Scale; FAB – Frontal Assessment Battery; 
TM – Trail Making; CWI – Color Word Interference; GDS-15 – Geriatric Depression Scale; 
BRIEF-A Self – BRIEF-A Global Executive Composite Self-rating (raw score); BRIEF-A Caregiver 
– BRIEF-A Global Executive Composite Caregiver rating (raw score); QoL – Quality of Life; 
PDQ-39 – Parkinson’s Disease Questionnaire – 39; CBI – Caregiver Burden Inventory 
Measures administered to the full 
sample of PwPD 
N  M (SD) Range Min. and Max. 
ACE-R 65 93.83 (4.41) 82 – 100 0 – 100 
HADS-Depression 65 4.43 (2.51) 0 – 10 0 – 21 
HADS-Anxiety 65 5.42 (3.52) 1 – 16 0 – 21 
FAB 65 14.86 (1.85)  11 – 18 0 – 18 
TM 64 136.84 (67.80)  45 – 240 – 240s 
CWI  64 84.61(29.69) 39–180 – 180s 
QoL-General Life 57 83.88 (28.83) 30 – 141 -96 – 160 
QoL-General Health 58 62.10 (43.23) -59 – 134 -96 – 160 
QoL-Movement Disorders 55 96.96 (52.27) -49 – 216 -144 – 240 
PDQ-39 54 20.13 (11.57) 0.52 – 53.75 0 – 100 
BRIEF-A Self 61 107.26 (19.62) 71 – 177 70 –210 
Measures administered to the 
sub-group of PwPD with EF 
deficits 
N  M (SD) Range Min. and Max. 
D-KEFS Verbal Fluency  34 11.85 (3.47) 3 – 20 0 – 
D-KEFS Design Fluency 34 85.00 (11.88) 42 – 100 0 – 100% 
D-KEFS Sorting 30 28.43 (12.22) 6 – 53 0 – 64 
D-KEFS 20 Questions 33 26.70 (11.44) 4 – 53 0 – 60 
D-KEFS Word Context 33 24.55 (6.28) 9 – 36 0 – 50 
D-KEFS Tower 33 15.39 (4.85) 4 – 24 0 – 30 
D-KEFS Proverb 30 8.73 (2.79) 3 – 12 0 – 12 
Measures administered to carers N  M (SD) Range Min. and Max. 
BRIEF-A Caregiver 47 97.87 (23.26) 70 – 166 70 – 210 
CBI 42 12.45 (10.55) 0 – 46 0 – 96 
Healthy older people n M (SD) Range Min. and Max. 
ACE-R  43 92.86 (3.87) 82 – 99 0 –100 
GDS-15 43 1.51 (1.59) 0 – 5 0 – 15 
D-KEFS TM 42 110.60 (52.15) 42 – 240 – 240s 
BRIEF-A Self 39 101.59 (18.91) 71 – 142 70 – 210 
BRIEF-A Caregiver 39 97.87 (20.98) 70 – 151 70 – 210 
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2.4.3 Data transformation and dealing with outliers 
Before conducting statistical analyses, all variables were inspected to identify potential 
outliers. The variables were converted into z-scores and the frequency of the absolute z-
scores above the relevant cut-off values (1.96, 2.58, and 3.29; Field, 2005) was calculated for 
each variable of interest. Test performance scores were within the expected range of scores 
and there were no outliers impacting significantly on the analyses.  
In order to decide on the most appropriate statistical methods for the planned 
inferential analyses, the properties of the variables were checked against the statistical 
assumptions relating to particular parametric tests. The variables were checked against 
assumptions of normality and homogeneity of variance, and more specific checks were 
performed for the regression analyses and the principal components analysis. The details of 
the specific assumption checks are presented at the appropriate points in the subsequent 
chapters. Where assumptions were violated, non-parametric equivalents were used (Field, 
2005). One set of variables (performance ratios; see section 6.4.3. Performance monitoring 
in chapter 6) was logarithmically transformed to ensure a more symmetrical distribution for 
the statistical analysis (Trosset & Kaszniak, 1996).  
2.4.4 Planned analyses 
A range of statistical tests was used to address the research questions posed in the 
empirical studies. To investigate the pattern of performance on EF tests (Chapter 4) the 
results were analysed using data-driven approaches: cluster analysis and principal 
component analysis (PCA). Data-driven approaches are useful in exploring potential 
relationships in complex data sets where there is  limited a priori knowledge of the data 
structure (Morris, Blashfield, & Satz, 1981; Ward, 1963). The associations between the study 
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variables of interest, as indicated in the specific research questions, were examined with the 
appropriate correlational analyses (chapters 4, 5, and 6). To establish the predictors of QoL, 
health status and caregiver burden (Chapter 5), multiple regression analyses were 
conducted. For the group comparisons in Chapter 6, one-way ANOVA were conducted with 
Bonferroni or Games-Howell post-hoc analyses as appropriate, depending on the results of 
the homogeneity of variance test. The rationale for selecting particular statistical tests and 
the details of the analyses are given at the appropriate points in the subsequent chapters. 
All analyses were performed in IBM SPSS Statistics 19. 
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3.1 Abstract 
Background: Impairment of executive function (EF) is commonly reported as a feature of 
PD. However, the exact pattern of executive impairment remains unclear. Also, there is an 
ongoing discussion surrounding the definition and conceptualization of EF, which might 
affect the clarity of research evidence on cognition in PD. The aim of this systematic review 
was to describe the pattern of executive impairment in early stage PD emerging from the 
research literature and to identify critical issues for improving consistency in this field.  
Methods: The PsychInfo, Medline, Science Direct, CINAHL and Cochrane Library databases 
were searched using the term ‘Parkinson’s disease’ combined with each of 14 cognitive 
abilities defined as representing aspects of executive function. The review was limited to 
studies that investigated EF as the central variable in early stage non-demented people with 
PD (PwPD). 
Results: The review identified 33 studies of EF that were operationalised in terms of 30 
abilities tested by 60 measures and variously interpreted. Many measures were used only 
once, so only a small part of the available research evidence could be synthesized in the 
meta-analysis. Meta-analysis was undertaken using data from 5 commonly-used tests of 
executive function drawn from 18 studies. This revealed consistent evidence for cognitive 
difficulties across all 5 EF tests. 
Conclusions: Research on EF in PD is characterized by a considerable lack of clarity with 
regard to measure selection and interpretation. The findings support the view that EF 
impairments are evident in PD. However, the clinical significance of the cognitive 
abnormalities reported has yet to be clarified. 
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3.2 Introduction 
Although motor impairment is the most profound feature of PD, cognitive deficits are also 
common and may add a considerable burden to the lives of people with PD (PwPD) and 
carers (Klepac et al., 2008; Schrag et al., 2000). Dopaminergic depletion leads to the 
disruption of frontostriatal circuits, which in turn may affect cognitive abilities (Zgaljardic et 
al., 2003). The severity of cognitive impairment ranges from difficulties in a single domain, 
through global decline, to dementia (Mindham & Hughes, 2000; Royall et al., 2002; 
Zgaljardic et al., 2003). Research on cognition in PD indicates that the disease may affect 
every cognitive domain: memory, language, attention, visuospatial and visuoconstructive 
abilities, and executive functions (Zgaljardic et al., 2003). However, executive dysfunction 
seems to be the most profound impairment. Some studies suggest that a proportion of 
broader cognitive deficits reported in the literature may actually be the manifestation of 
underlying executive impairment (Stuss & Alexander, 2000). The exact pattern of executive 
impairment in PD is still debated (Muslimovic, Schmand, Speelman, & De Haan, 2007), as 
numerous reports on executive dysfunction (Barnes & Boubert, 2008; Muslimovic et al., 
2005) are accompanied by studies reporting normal performance on EF tests. For example, 
Zgaljardic et al. (2006), Uekermann et al. (2004), Dujardin et al. (2001), and  Bouquet, 
Bonnaud, and Gil (2003) reported impaired performance in phonemic fluency, while Farina 
et al. (2000), Colman et al. (2009), Auriacombe et al. (1993), and Cools et al. (2001) found no 
significant differences between PwPD and controls. Dalrymple-Alford, Kalders, Jones, and 
Watson (1994) report central executive deficits, while Nathalie Fournet, Moreaud, Roulin, 
and Naegele (1996) claim that the central executive seem to be intact. Moreover, there are 
reports indicating the superior performance of PwPD in some tasks requiring executive 
control (Bialystok, Craik, & Stefurak, 2008; Cools et al., 2010). This inconsistency in results 
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may be influenced by a number of factors presumably related to the complex pathology of 
PD, including age of onset, severity and type of disease (Uekermann et al., 2004). Another 
reason for the inconsistency, however, may be the complexity of the EF construct itself. To 
provide the context for our review, we first present a brief overview of EF definitions and 
related concepts, and discuss the implications of the non-unitary character of EF for 
research. 
3.2.1 Definitions of EF and related concepts 
Researchers concur that the key elements of EF are successful coping with novelty and 
managing personal goals. Lezak (2004) describes EF in terms of capacities that enable 
successful, “independent, purposive, self-serving behavior” (p. 34) and responding in an 
“adaptive manner to novel situations” (p. 611), involving appropriate, socially responsible 
behavior. Burgess and Alderman (Burgess & Alderman, 2004) define EF as the abilities 
required for setting goals, determining strategies to achieve them and monitoring 
progression, as well as adjusting plans to changing circumstances. Other definitions 
accentuate the supervisory role of EF in coordinating ‘lower-level’ cognitive processes, and 
the significance of dealing with novelty in the non-automatic processing mode (Alvarez & 
Emory, 2006; Aron, 2008; Rabbitt, 1997). EF can also be explained as “a collection of 
anatomically and functionally independent but interrelated attentional control processes” 
(Stuss & Alexander, 2007, p. 901). Although expressing the essential concept of EF is 
relatively unproblematic, definitions remain rather broad and vague (see Salthouse 
(Salthouse, 2005) for a comprehensive list of definitions). One account aptly describes the 
issue by characterising EF as “a shorthand description of a complex set of processes that 
have been broadly and variously defined” (Strauss et al., 2006, p. 401). 
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Although executive function is frequently referred to as reflecting a homogenous ability 
(Costa et al., 2008; Edelstyn, Mayes, Condon, Tunnicliffe, & Ellis, 2007; Fama & Sullivan, 
2002), most researchers acknowledge that EF serves as an umbrella term, and does not 
necessarily reflect a single, discrete cognitive function (2007). It is suggested that EF may be 
constituted by a number of abilities that are “separable but moderately correlated” (Miyake 
et al., 2000, p. 87). Lezak (2004) lists four components of EF: volition; planning; purposive 
action; and effective performance. She does not include concept formation and reasoning, 
which she considers as separate processes, although these abilities are included in other 
classifications of EF (Delis et al., 2001; Lafleche & Albert, 1995). Another frequently cited 
classification by Smith and Jonides (1999) proposes five components: attention and 
inhibition; task management (including switching attention between tasks); planning; 
monitoring; and coding. Stuss and Alexander (2000) note that although the great majority of 
recent studies seem to concentrate on ‘cognitive’ aspects of behavioral control (e.g. 
attention, set-shifting, inhibition), there are also other concepts at least equally important 
for successful behavior, such as personality, emotions, motivation, and awareness. 
A concept commonly linked to EF is the multicomponent model of working memory 
(WM) introduced by Baddeley and Hitch (1974). This model distinguishes four components 
of WM: the visuospatial sketchpad; the phonological loop; the episodic buffer; and a central 
executive that controls attention and enables manipulation of information (Baddeley & 
Hitch, 1994). The central executive is closely related to the Supervisory Attentional System 
(SAS) described by Norman and Shallice (1986). Impairment of the SAS is linked to the 
‘frontal lobe syndrome’. The debate over the role of the central executive/SAS has 
contributed greatly to defining executive functions. The SAS framework (Norman & Shallice, 
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1986) divides cognitive functioning into routine activity and a non-routine, executive 
multicomponent system, labeled the Supervisory System (Stuss et al., 1995). In the context 
of Baddeley and Hitch’s mode (1974), EF forms a component of working memory (the 
central executive). However, WM is also considered as an EF subcomponent or as a separate 
but related function (Alvarez & Emory, 2006; Royall et al., 2002). Another concept closely 
related to managing behavior (and to EF) is attention, as it plays a crucial role in managing 
behavior by regulating the appropriate distribution of cognitive resources (Stuss & 
Alexander, 2007). 
3.2.2 Challenges in researching EF 
The complex character of the EF construct creates challenges for EF research (Chan et al., 
2008). Stuss and Alexander (2000) point out that problems may arise as a consequence of 
interchangeable and inconsistent use of terms and definitions of executive versus frontal 
functions. Moreover, terms such as EF (or ‘executive control’, ‘supervisory system’) are 
difficult to operationalize and ‘executive’ tests are characterized by low validity and 
reliability. EF are also multifactorial in nature, and thus impaired executive performance 
may be caused by dysfunctions in other cognitive domains (Stuss & Alexander, 2000). There 
are a number of tools described as “classic frontal” tests, developed to capture EF as a 
whole or selected components of it (e.g. tower tasks, Wisconsin Card Sorting Test, verbal 
fluency tasks, dual-task paradigms) and these are widely used in research and clinical 
practice (Bell-McGinty, Podell, Franzen, Baird, & Williams, 2002; Delis et al., 2001). However, 
there is an ongoing debate on approaches to measuring EF and no “gold standard” for tool 
selection has been agreed (Norman & Shallice, 1986; Royall et al., 2002).  
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3.2.3 Executive impairment in PwPD 
Motor symptoms of PD are naturally the central concern in the care of PwPD. However, the 
effects of executive impairment may also have a significant impact on everyday life. PwPD 
with executive impairment have been compared to people with frontal lobe damage (Owen 
et al., 1993; Rogers et al., 1998), who may perform well in many cognitive tests and show no 
obvious signs of cognitive difficulties in structured settings, but fail in everyday situations 
(Lezak, 2004). It is important to investigate whether this is true for PwPD. Research in 
healthy older adults indicates a relationship between activities of daily living and 
performance on measures of executive functioning (Bell-McGinty et al., 2002; Jefferson, 
Paula, Ozonoffc, & Cohen, 2006). There is also evidence of a relationship between cognitive 
abilities and everyday functioning among PwPD in later stages of the disease (Bronnick et 
al., 2006; Cahn et al., 1998). Poliakoff and Smith-Spark (2008) found that PwPD without 
dementia do report being distractible and forgetting important information from the 
previous day more often than healthy controls. However, the impact of cognitive difficulties 
on PwPD’ independence and well-being in the early stages of PD still needs to be better 
understood to facilitate appropriate support for PwPD and carers.  
3.2.4 Rationale for the systematic review 
In this review we aimed to describe the pattern of executive impairment in early PD by 
synthesizing existing research in a meta-analysis. In addition, we intended to explore which 
neuropsychological models, theories or conceptualizations of EF underlie research in PD, 
and to identify and clarify some of the possible factors contributing to the inconsistency in 
existing research findings. To control for the influence of complex disease characteristics as 
well as other methodological issues we aimed for a homogenous group of studies.  
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3.3 Method 
A systematic literature search was performed in October 2009 and updated in May 2010 
using the following databases: PsycInfo (CSA), Medline (Web of Knowledge), PubMed, 
CINAHL, and the Cochrane Library. 
The search was performed in two stages: firstly using broad EF-related terms and 
then using specific EF subcomponents. Key words used were: ‘Parkinson’s disease’ (in 
title/key words) combined with ‘cognitive impairment’, ‘dysexecutive’ or ‘executive’ (in 
title/abstract). The initial analysis identified 11 subcomponent functions commonly 
investigated in relation to or as a part of EF, and these were used in the second search: 
‘frontal’, ‘working’, ‘set-shifting’, ‘switching’, ‘fluency’, ‘inhibition’, ‘decision making’, 
‘planning’, ‘flexib*’, ‘processing speed’, ‘cognitive speed’ (in title/abstract/keywords) 
combined with ‘Parkinson’s disease’ (in title). Only articles from peer-reviewed journals, 
written in English and published after 1990, were included. 
The inclusion and exclusion criteria used in study selection are summarized in Table 
3.1. In questionable cases, co-authors independently read the article and a joint decision 
was reached.  
To narrow down the search only articles focusing specifically on EF in PD were 
included. We were interested in exploring the neuropsychological perspective which seems 
to link more directly to the everyday functioning of PwPD  and their carers, rather than brain 
imaging or neuropharmacological studies. Working memory was considered to be related to 
EF only if the central executive component was directly investigated; otherwise the study 
was excluded. In making decisions in regard to the above criteria we referred to the theories 
and concepts of EF discussed in the introduction. Additionally, the review included only 
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those studies that clearly reported that all participating PwPD were in the early stages of the 
disease (Hoehn and Yahr stages I-III). Studies that included a broader range of PwPD, or did 
not specify the range, were not taken into consideration. 
Table 3.1. Selection criteria for the literature search. 
Inclusion criteria 
Studies were included if: 
1. The main aim of the study, as directly stated, was to investigate executive 
impairment in Parkinson’s disease (overall, or its component(s), or EF distinguished 
as part of a general cognitive assessment) 
2. The study was based on a neuropsychological perspective 
3. Directly investigated abilities included executive functions, frontal lobe functions or 
at least one of the core subcomponents of EF 
4. The severity of PD was stage I-III Hoehn & Yahr (as directly stated) 
5. PwPD included in the study were not severely depressed and did not have a 
diagnosis of dementia (as directly stated) 
6. The study was written in English, and published after 1990 
Exclusion criteria 
Studies were excluded if: 
1. The study investigated only the neuronal or neurochemical basis of EF in PD 
2. The study investigated the effect of a particular medical treatment 
3. The study’s aim was to verify the suitability of a particular EF measure for PD PwPD 
4. The study investigated apathy (apathy may be interpreted as impairment of 
motivation or volition and may therefore be considered as an impairment of EF, but 
most studies consider apathy as a separate symptom) 
5. The main interest of the study was not EF in PD 
6. The study investigated general cognition in PD without distinguishing EF and/or no 
direct EF measure was used 
7. The study concentrated on cognitive abilities without linking them directly to EF 
8. A PwPD group served as a comparison group for another condition  
9. The study presented results from a PD group without a control group or normative 
data (or did not provide full details of such a comparison) 
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In total, from 3264 hits, 393 articles were retrieved for detailed inspection and 33 
fulfilled all inclusion criteria. See Figure 3.1 for a detailed flow chart of study selection for 
both searches. Key information was extracted from the articles considered at the final stage 
of the literature search and entered into a structured form for analysis (see appendix F, G, 
and H).  
 
Figure 3.1. Study selection process. 
 
To synthesize the results of the review articles, meta-analyses were performed for 
scores derived from five commonly-used tests (see Table 3.2). Analyses were carried out 
using Comprehensive Meta-Analysis software (Borenstein, Hedges, Higgins, & Rothstein, 
2005). Results were compared using a random-effects model. First, the Standardised Mean 
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Difference (d) was computed and then the correction factor was applied to compute 
Hedges’ g. Between-study heterogeneity for each cognitive measure was assessed by the Q 
statistic as well as an Index of Inconsistency (I2). The Q statistic refers to the weighted 
squared deviation and provides a ratio of the total observed variation between studies to 
the variation that is a consequence of within-study errors. The I2 statistic is the ratio of true 
heterogeneity to total observed variation (Borenstein et al., 2009). 
3.4 Results 
3.4.1 Executive functions and measures 
Thirty-three articles met the inclusion criteria for the study, and these are briefly 
summarized in Table 3.2 (see also Appendix H for a more detailed summary). A detailed 
summary of studies examined at the final stage of the literature search and excluded from 
the review after in-depth analysis of content is presented in Appendix G. Amongst the 
studies included to the review there were three main approaches to investigating EF: 
exploring overall executive (or frontal) function; focusing on a single dimension of EF, 
frequently without discussing the EF concept; and exploring general cognition with EF 
distinguished as one of the abilities of interest. Several studies met inclusion criteria but had 
more than one of the following limitations: 1) background theories of executive/frontal 
domains were not discussed; 2) subcomponents of EF/frontal functions were not 
distinguished; 3) it was not specified which tests measure which subcomponents. 
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(Table 3.2 continues) 
Table 3.2. Summary of articles included in the review. 
First author Participants 
n (men), mean age, years (SD or range, 
as reported), mean PD duration 
EF components and measures 
List of EF components (as specified by authors) and measures of EF (also if it was not 
clear whether authors considered a test as an EF measure, if clearly EF related) *PD 
significantly lower than controls 
Studies focused on executive or frontal functions as a whole, selectively or in relation to other factors. 
Zgaljardic et al. 
(2006) 
32 PwPD (19 men), 66.9 (8.1 ) 
29 controls (15 men), 66.7 (5.7) 
Anterior cingulate cortex* (response monitoring, inhibition, initiation, apathy) Apathy Scale, 
Initial Fluency, Stroop test (Interference Index); 
Dorsolateral prefrontal cortex* (set-shifting, working memory, intrinsic response generation, 
and conditional associate learning) VF Category, DS, Executive Scale (Frontal Systems Behavior 
Scale), Phonemic Fluency, Odd Man Out, Petrides Conditional Associate Learning – Criterion (no. 
trials), Petrides Conditional Associate Learning – Errors, Spatial Span, VF Switching Accuracy;  
Orbitofrontal cortex (disinhibition, decision-making, impulsivity, and perseveration, depression) 
Beck Depression Inventory, Disinhibition Scale, Alternating Loops (no. errors), Twenty Questions 
Test – Abstraction Score, Total Questions, Weighted Score. 
Farina et al. 
(2000) 
20 PwPD (13 men), 57.9 (8.3) 
18 controls (10 men), 56.6 (6.4) 
MPD duration=28 months (3-96) 
Abstract behavior and shifting ability: WCTS (2*of 4 variables); Concept formation and free recall: 
Test of categorization and recall (2*of 5 variables); Abstract non-verbal reasoning: Ravens 
Progressive Matrices*; Short-term verbal memory and attention: DS; Short-term visuo-spatial 
memory and attention: Corsi’s block-tapping; Visuospatial long-term memory: Corsi’s Supra span 
tapping*; Verbal long-term memory: Paired associated learning test; Measures not discussed: 
(Odd Man Out (1*of 2 variables), VF phonemic) 
Uekermann et al. 
(2004) 
20 PwPD (8 men), 55.9; 
20 controls (9 men), 53.2  
MPD duration= 4.6 years (3.0) 
Initiation: VF (phonemic*, semantic, alternating); Planning and problem solving: Key Search, Six 
Elements* and  Zoo Map test (BADS, Behavioral Assessment of the Dysexecutive Syndrome); 
Reasoning: Temporal Judgment* and Cognitive Estimation task (BADS); Inhibition: Rule shift 
cards* of BADS, Hayling test*; Self-reported behavioral problems: Dysexecutive questionnaire of 
BADS) 
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Dujardin et al. 
(2001) 
#12 sporadic PD (7 men), 65.92 (51-74) 
12 familial PD (5 men), 63.42 (44-76)  
12 controls (6 men), 59.25 (47-73)  
MPD duration= 103/74 months 
Planning: VF, spatial sequences generation* 
Resistance to interference: Brown-Peterson paradigm* 
Set shifting: WCST, VF alternate*, motor sequences*; 
Memory: immediate (DS forward and backward, spatial span, word span); working memory 
Farina et al. 
(1994) 
22 PwPD (11 men), 52.86 (39-72) 
19 controls (6 men), 53.42 (33-66)  
MPD duration=57.7 months  
Organization, planning and memory:  
Classification* and recall of pictures 
Price and Shin 
(2009) 
12 mild PD (H&Y: I) 71.9 (2.0) 
 #10 moderate PD (H&Y: II-III) 71.4 (1.4) 
10 controls 70.5 (3.2)  
MPD duration=4.0 (0.9)/9.7 (1.1) years 
Mental set-shifting: mWCTS perseverative errors; Concept formation: number of categories on 
the Modified WCST; Spontaneous cognitive flexibility: VF semantic, COWAT (Controlled Oral 
Word Association Test)*; Working memory: CSpan test 
Price (2010) 15 PwPD (10 men), 67.67 (1.42) 
12 controls (8 men), 64.2 (1.67)  
MPD duration= 6.47 (1.2) 
Problem solving: Anagram task (baseline* and cued), Executive functions: Set shifting: WCST-64 
(perseverative errors), Inhibitory control: Stroop interference (response time) Semantic verbal 
fluency: COWAT*, Working memory: CSpan (total correctly recalled)  
Colman et al. 
(2009) 
28 PwPD (16 men), 61.39 (8.8) 
28 controls(16 men), 62.93 (9.04)  
MPD duration=6.04 years (4.55) 
Attention: 3 subtests of Testbatterie zur Aufmerksamkeitsprufung (sustained visual*, sustained 
auditory and divided attention); Working memory: DS forward and backward; Cognitive set-
switching: TMT A and B + Odd Man Out (composite*); Inhibititory control: Stroop test; VF: 
phonemic, semantic, action; Abstract structure processing: experimental paradigm 
Bondi, Kaszniak, 
Bayles, and 
Vance (1993) 
19 PwPD (16 men), 67.32 (6.85) 
19 controls (7 men), 69.26 (5.36)  
Median PD duration=8 years (1-17) 
Frontal system tasks (composite*):  VF * (phonemic, semantic), Modified WCST *, California 
Sorting Test*, Verbal Temporal Ordering*. 
Studies investigating subcomponents of executive (or frontal) functions, selectively or in relation to other factors. 
Altgassen, 
Phillips, Kopp, 
and Kliegel 
(2007) 
16 PwPD (11men), 61.1 (6.9) 
16 controls (8 men), 62.6 (9.1)  
MPD duration = 4.81 (3.0) 
Planning: ToL*; Working memory: Phonological loop (VF forward), Visuospatial sketchpad (block 
span forward), Episodic buffer (logical memory*), Central executive processes (n-back task*) 
Bouquet et al. 20 PwPD (12 men), 66.1(7.6) Internal strategy generation and inhibition of unwanted response:  
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(2003) 20 controls (13 men), 63.5 (10.1)  
MPD duration =10.25 years (5.83) 
Hayling test*, VF * (phonemic, semantic, alternating), TMT 
Bublak, Müller, 
Grön, Reuter, 
and von Cramon 
(2002) 
14 PwPD (5 men), 55.1 (14.7) 
14 controls 55.2 (14.7)  
MPD duration=47.3 months (50.0) 
Working memory: experimental paradigm 
Working memory resources seem to diminish excessively with the increasing complexity of the 
task. 
Gilbert, Belleville, 
Bherer, and 
Chouinard (2005) 
14 PwPD (5 men), 66.29 (11.08) 
14 controls 65.79 (10.33)  
MPD duration= 7.29 years (4.53) 
Executive tasks: Alphabetical recall* and updating memory tasks 
Storage Task: DS 
McKinlay, Kaller, 
et al. (2008) 
30 PwPD 65.77 (6.6) 
30 controls 66.43 (5.3)  
MPD duration= 7.3 (4.6) 
Planning: ToL (computerised version) There was no evidence for general planning difficulties in 
the PD group when compared to controls. When the ambiguity of goal hierarchy increased 
(subgoals sequence was less predictable) the PD group performed worse than controls. 
Cronin-Golomb, 
Corkin, and 
Growdon (1994) 
15 non-medicated PwPD (14 men), 62.5 
(44-73) 
15 medicated PwPD (11 men) ,63.9 (44-
79) 
15 controls (10 men), 63.9 (42-77)  
MPD duration=1.9 years (1-4) 
Problem solving: Poisoned Food Problems*  (set-shifting component), Hukok Logical Thinking 
Matrices Test, Mental Calculation; 
Concept formation and comprehension: Wechsler Adult Intelligence Scale - Revised Similarities, 
the Concept Comprehension Test, Proverb Interpretation 
Downes, Sharp, 
Costall, Sagar, 
and Howe (1993) 
20 PwPD (11 men), 60.05 (10.23) 
14 controls (7 men), 60.0 (10.53)  
Median PD duration= 30 months (15-156) 
Set shifting and attention: VF: 2x  single semantic/letter, 2x alternating semantic, 2x alternating 
letter, 2x alternating semantic/letter* (cued and uncued conditions for alternating conditions) 
Kehagia et al. 
(2009) 
13 PwPD (H&Y stage I) (10 men), 62.2 
(9.1)  
#11 H&Y stage II (7 men), 66.6 (8.5) 
16 control (10 men), 63.6 (8.3) 
Background neuropsychological profile: VF phonemic, Spatial and Pattern (H&Y stage II group*) 
Recognition Memory 
Switching: task set switching procedure (H&Y stage II group*) 
Euteneuer et al. 21 PwPD (7 men), 67.60 (7.31) EF and working memory: Modified Cart Sorting Test, VF * (FAS and category (animal)), working 
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(2009) 23 controls (12 men), 64.4 (8.56)  
MPD duration=85.7 months (72.70) 
memory (DS reverse, DEMTect subtest (2* of 5 variables)); Reasoning: subtest of 
Leistungsprufsystem (German intelligence scale); Decision-making under risk: Game of Dice 
Task* (Rules of gains and losses are explicit) 
Decision making under ambiguity:  Iowa Gambling Test; ToM: Reading the mind in the Eyes 
Cools et al. 
(2001) 
43 PwPD (31 men), 62.1 (1.2) 
27 controls (18 men), 59.4 (1.8)  
MPD duration= 6.9 years (7.2) 
Set-shifting: task-set switching procedure  
Background assessment: The one-touch ToL Planning*, VF, Intra/Extra-Dimensional Set-Shifting 
task* (CANTAB), pattern* and spatial recognition memory (CANTAB). 
Gabrieli, Singh, 
Stebbins, and 
Goetz (1996) 
10 PwPD (6 men), 60.1 (7.5)  
10 controls (2 men), 55.5 (9.7)  
MPD duration= 2.9 years (1.6) 
Working memory: Verbal span*, arithmetic span* 
Strategic memory: self-ordering pointing*, temporal ordering*, word recall*  
Kliegel et al. 
(2005) 
16 PwPD (11 men), 61.2 (6.9) 
16 controls (11 men), 62.6 (9.1)  
MPD duration=4.81 (3.00) 
Prospective memory (formation, retention, initiation and execution of intention): experimental 
paradigm (planning phase*); Cognitive resources: divided attention (test battery of attention), 
short-term memory span (DS forward), working memory* (operation span measure), inhibition 
(Stroop task*) 
Kobayakawa et 
al. (2008) 
34 PwPD (12 men), 69.9 (8.9) 
22 controls (13 men), 67.6 (6.9)  
MPD duration=6.4 (3.4) 
Decision making: Iowa Gambling Task* ; EF: WCTS; Short-term memory and attentional ability: 
DS; Emotional arousal: Skin Conductance Responses* 
Mimura, Oeda, 
and Kawamura 
(2006) 
13 PwPD (5 men), 68.9 (7)  Set-shifting:  WCTS (2* of 3 variables); Planning: Maze-tracing of WISC-R*, Inhibition: Stroop 
test*, VF phonemic* and semantic; Decision making: Iowa Gambling Test *; Mind-reading: 
Reading the mind in the eyes test* 
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Witt et al. (2006) 20 PwPD (14 men), 59.25 (8.58) 
 20 older controls (12 men), 59.00 
(5.70) 
20 young controls (12 men), 25.90 
(2.57)  
MPD duration=3.25 years (4.40) 
EF: Stroop test* (reading time and reading error only), VF* (semantic, phonemic), WCTS* 
Switching abilities in the predictable (cued) and unpredictable conditions*: task-switching 
paradigm 
R. Tomer et al. 
(2002) 
28 PwPD (18 men), 66.4 (9.5) 
19 controls (10 men), 67.1 (9.1) 
Reactive flexibility (set-shifting): WCST (3* of 4 variables) 
Spontaneous flexibility (ideas generation):  Alternate uses* 
S. Hsieh, Lee, and 
Tai (1995) 
12 PwPD (8 men), 64.8 (7.1)  
12 controls (5 men), 61.1 (8.6) 
Set-shifting: Odd Man Out * 
Studies focused on overall cognition with executive or frontal functions clearly distinguished. 
Muslimovic et al. 
(2005) 
115 PwPD (61 men), 66.2 (10.1)  
70 controls (37 men), 63.7 (7.30) 
MPD duration:  18.8 (10.7 ) months 
EF*: Modified WCST (number of categories achieved, errors, perseverative errors); VF (animals 
and supermarket items), WAIS-III Similarities; ToL-Drexel test (problems solved in  minimum 
number of moves) 
Attention: DS forward and backward*; TMT-B*, Stroop test (interference condition) 
Studies investigating executive/frontal functioning, but with two or more of the following weaknesses: 1) background theories of executive/frontal 
domains were not discussed; 2) subcomponents of EF/frontal functions were not distinguished; 3) It was not clear which tests measurde which 
subcomponents. 
Saltzman et al. 
(2000) 
11 PwPD (6 men), 70.98 (13.43) 
8 older controls (3 men), 71.61 (9.42) 
9 young controls (3 men), 20.87 (2.53) 
EF: California Card Sorting Task* (correct sorts), VF* (phonemic), Five-Point Fluency task* 
(figural fluency); 
Theory of mind tasks (composite*)  
Costa et al. 
(2008) 
23 PwPD (12 men), 63.5 (10.0) 
25 controls (12 men), 65.0 (7.7)  
MPD duration=7.69 (8.5) years 
EF: Modified card sorting test, VF phonological; Short-term and working memory: DS forward 
and backward, Corsi test forward and backward; Prospective memory: experimental task 
*Almost 50% of PwPD were impaired in digit span tasks and almost 40% showed impairment in 
card sorting task. No formal group comparison for particular tests. 
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Edelstyn et al. 
(2007) 
17 PwPD (11 men), 65.4 (8.9) 
17 controls (9 men), 64.5 (7.4)  
MPD duration = 7.7 years (8.6) 
EF (fluid intelligence): matrix reasoning*, the Hayling* and Brixton* Tests 
Pagonabarraga et 
al. (2007) 
35 PwPD (22 men), 67.2 (8.0)  
(19 stable and 16 fluctuating) 
31 controls (16 men), 70.2 (10)  
MPD duration= 8.4 years (5) 
Attention and executive prefrontal function: digit span (forward, backward, WAIS-III), Stroop; 
Limbic function: Iowa Gambling Test*; Global cognition: MMSE, Mattis Dementia Rating Scale, 
VF phonemic, semantic. No group comparison for particular tests. 
Cooper, Sagar, 
Jordan, Harvey, 
and Sullivan 
(1991) 
60 PwPD (31 men) 59.8 (37.3-77.6) 
37 controls (20 men), 59.6 (40.2-76.1)  
MPD duration= 15.75 months (3-48) 
Frontal tasks: WCST (1*/9), Picture Arrangement (WAIS); Cognitive sequencing and working 
memory: digit ordering*; Memory: DS forward and backward*, Rey-Osterreith and Taylor 
figures, Brown-Peterson paradigm; Language: VF* semantic, alternating 
Woods and 
Tröster (2003) 
18 PwPD without dementia (12 men), 
69.39 (5.80)  
18 PwPD with dementia (12 men), 
69.67 (6.78) 
18 controls (12 men), 68.76 (6.44)  
MPD duration = 5.50 (3.35) 
EF: WCST (number of categories) Mattis Dementia Rating Scale (Conceptualization subtest) 
Language: COWAT, Boston Naming test  
*No comparison between non-demented PwPD and controls. 
DS – digit span; H&Y – Hoehn and Yahr; WCST – Wisconsin Card Sorting Test; VF – verbal fluency; TMT AB – Trail Making Test A, B; ToL – Tower 
of London Test; UKPDSBB – UK PD Society Brain Bank 
# PD group included in the meta-analyses.
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In the 33 included studies over 30 abilities were identified and measured as EF 
components or abilities related to EF, and these abilities were measured by over 60 tests 
and procedures. The most commonly investigated abilities were: executive functions as a 
whole (16 studies), set shifting (12 studies), working memory (11 studies), attention (8 
studies), inhibition (6 studies), decision making (5 studies), and planning (4 studies). In many 
cases, however, there was no indication of which abilities were considered to represent EF 
and some abilities thought to be executive (Cools et al., 2001; Kehagia et al., 2009) were 
measured and interpreted along with others that did not come under that definition (e.g. 
both concept formation and the non-EF function of comprehension were measured by 
WAIS-R Similarities, the Concept Comprehension Test and Proverb Interpretation (Cronin-
Golomb et al., 1994).  
A broad selection of tests was used to measure EF-related functions. The majority of 
the studies used verbal fluency tasks (22 studies). Other frequently-used types of task 
included digit span (as well as spatial, verbal and arithmetic spans, 17 studies), card sorting 
tests (mostly the Wisconsin Card Sorting Test, used in 16 studies), Stroop tests (8 studies), 
tower tests (3 studies), and the Trail Making Test (5 studies). Apart from these, over 50 
measures and experimental paradigms were each used only once. Some of these measures 
were variations on well-known ‘executive tests’ (e.g. different versions of a tower task), 
while others concentrated on a specific aspect of EF (e.g. experimental paradigms).  
It is noteworthy that the interpretation of measures was inconsistent. The same 
tests were described as measuring different functions in different studies. For example, 
verbal fluency was variously described as measuring EF, as measuring a sub-component of 
EF (e.g. set-shifting, planning), as measuring a discrete function of verbal fluency, as 
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measuring language ability, or as measuring global cognition (Downes et al., 1993; Dujardin 
et al., 2001; Farina et al., 2000). 
3.4.2 Meta-analysis of studies  
It was not possible to undertake a meta-analysis of all the identified studies, as nearly 60 
tests assessing 30 abilities were reported and the majority of tests were used only once. To 
synthesize the results, five commonly used tests were identified. See Table 3.3 for a 
summary of these tests and the associated abilities that are assessed. Where different 
variants or indices were used, these were treated individually. Meta-analysis was therefore 
performed for each of 11 separate measures. 
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Table 3.3. Demographic and clinical characteristics of PwPD in the study samples. 
Measure k N Age 
Disease 
duration 
(months) 
Heterogeneity 
Q p(Q) I2 
Phonemic fluency (Bouquet et al., 2003; Colman et al., 2009; Cools et al., 2001; Downes et al., 1993; Dujardin et al., 
2001; Euteneuer et al., 2009; Farina et al., 2000; Kehagia et al., 2009; Mimura et al., 2006; Muslimovic et al., 2005; Saltzman et al., 
2000; Uekermann et al., 2004; Witt et al., 2006; Zgaljardic et al., 2006) 
14 388 63.99 60.90 33.82 0.00 61.56 
Semantic fluency (Bouquet et al., 2003; Colman et al., 2009; Cooper et al., 1991; Downes et al., 1993; Dujardin et al., 
2001; Euteneuer et al., 2009; Mimura et al., 2006; Muslimovic et al., 2005; Price, 2010; Price & Shin, 2009; Uekermann et al., 2004; 
Witt et al., 2006; Zgaljardic et al., 2006) 
13 393 64.17 66.11 48.16 0.00 75.08 
Alternating fluency(Bouquet et al., 2003; Cooper et al., 1991; Downes et al., 1993; Dujardin et al., 2001; Uekermann et 
al., 2004; Zgaljardic et al., 2006) 
6 164 63.88 59.59 45.19 0.00 88.94 
Digit span backward(Colman et al., 2009; Cooper et al., 1991; Dujardin et al., 2001; Euteneuer et al., 2009; Muslimovic 
et al., 2005; Uekermann et al., 2004; Zgaljardic et al., 2006) 
7 288 63.44 49.59 7.29 0.29 17.71 
WCST categories achieved(Muslimovic et al., 2005) (Cooper et al., 1991; Mimura et al., 2006; Price & Shin, 2009; 
Witt et al., 2006) 
5 223 63.96 24.52 6.80 0.15 41.22 
WCST total errors(Cooper et al., 1991; Dujardin et al., 2001; Euteneuer et al., 2009; Muslimovic et al., 2005; Witt et al., 
2006) 
5 228 63.89 46.65 5.70 0.22 29.83 
WCST perseverative errors(Cooper et al., 1991; Dujardin et al., 2001; Farina et al., 2000; Mimura et al., 2006; 
Muslimovic et al., 2005; Price, 2010; Price & Shin, 2009; Witt et al., 2006) 
8 270 64.14 58.97 16.96 0.02 58.72 
WCST cards to 1st category(Cooper et al., 1991; Farina et al., 2000) 2 80 63.74 21.88 0.03 0.86 0.00 
Stroop interference time(Muslimovic et al., 2005; Price, 2010; Witt et al., 2006; Zgaljardic et al., 2006) 4 182 65.01 45.15 1.85 0.60 0.00 
Stroop interference minus baseline(Kliegel et al., 2005; Mimura et al., 2006) 2 34 65.02 57.72 0.03 0.86 0.00 
TMT B(Bouquet et al., 2003; Muslimovic et al., 2005) 2 135 63.54 70.90 0.30 0.58 0.00 
k – number of studies; N – number of PwPD; Q – within domain heterogeneity; p(Q) – p value for heterogeneity; I2 – percentage of 
heterogeneity due to study differences 
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Figure 3.2 presents numerical values and visual representation of the effect sizes and 
confidence intervals for each meta-analysis. The analyses showed that PwPD scored 
significantly lower than controls on all five tests (including all 11 separate indices), with 
differences reflecting medium to large effect sizes (Howell, 2007).  
 
Figure 3.2. Numerical values and visual representation of the effect sizes and confidence 
intervals for each meta-analysis.  
Hedges’ g – corrected mean weighted effect size; CI – confidence interval; WCST – 
Wisconsin Card Sorting Test; TMT – Trail Making Test 
* Test of null hypothesis (2-Tailed). 
 
Descriptive statistics for PwPD and control groups (sample size, mean and standard 
deviations) were extracted from 18 studies. In four cases the effect sizes were calculated 
from t values as other data were not reported. Results from three studies were excluded as 
Chapter 3. EF in PD: Systematic review and meta-analysis 74 
 
there was no suitable group comparison reported despite the inclusion of a control group in 
the study. All variables included in the analysis were continuous data.  
Participants were all in the early stages of the disease (I-III Hoehn and Yahr), without 
dementia and also without depression (unless this was controlled for in the analysis and 
found to have no influence on the results).  
As presented in Table 3.3, the mean age of PwPD groups ranged from 63 to 66 years 
with an average PD duration of 5 years or less. Sample sizes for the meta-analyses were 
based on between 2 and 14 studies, with 34 to 388 PwPD in each analysis. For the three 
verbal fluency tasks, and WCST perseverative errors, variability was high, which means that 
effect sizes were substantially different between studies and the true effect size may differ 
from the one calculated. For alternating fluency in particular, the I2 index indicates that a 
large proportion of the variance is not explained by random within-study error (see Table 
3.3). 
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Table 3.4. Abilities tested by the measures included in the meta-analysis. 
Measures and their indices  Abilities tested 
Verbal fluency 
(3 variants: phonemic, 
semantic or alternating); 17 
studies 
Words named in 60 seconds Initiation, simultaneous processing, rapid retrieval of 
lexical items, recalling of words, search strategy, attention, 
cognitive flexibility, organizing thinking. An alternating 
condition (switching between categories) additionally 
measures an ability to switch between cognitive sets. 
Digit span backward;  
seven studies 
Number of digits correctly repeated  Working memory, selective attention. 
WCST; eight studies 
 
Categories achieved – number of categories 
correctly identified, as indicated by 10 
consecutive correct responses 
Total errors – total number of incorrect responses 
Perseverative errors – number of incorrect 
perseverative responses 
Cards to 1st category – number of cards presented 
before achieving 1st category 
Abstraction ability, shifting, strategic planning, organized 
searching, using feedback, goal oriented behavior, 
modulating impulsive responses. Total number of errors 
and categories achieved refer to overall performance, and 
cards to achieve first category estimates concept 
formation. 
Stroop Test; six studies Interference time – time taken in the interference 
condition (seconds)  
Interference minus baseline – baseline time 
subtracted from time taken in the interference 
condition (seconds) 
Concentration effectiveness, selective processing, 
selective attention, resistance to distractions, inhibition of 
unwanted responses. The baseline minus interference 
index gives a correction for the baseline speed. 
TMT B; two studies Time taken to complete Part B – Switching 
(seconds) 
Complex visual scanning, conceptual tracking, cognitive 
flexibility, divided attention, speed. 
Based on: Delis et al. (2001) Lezak (2004), and Strauss et al. (2006). See also Royall et al. (2002). 
WCST – Wisconsin Card Sorting Test; TMT – Trail Making Test 
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3.5 Discussion 
3.5.1 Meta-analysis of studies 
The results provide consistent evidence for cognitive difficulties in PwPD in comparison to 
controls across all the EF tests included in the meta-analysis. These tests assess a broad 
range of executive functions, including abnormalities in cognitive flexibility (verbal fluency), 
and more specifically in set-switching (TMT B, WCST) and inhibition (Stroop), as well as in 
selective attention/working memory (digit span backward) and concept formation (WCST). 
The tests included in the meta-analysis cover a number of EF abilities. However, there is no 
rationale for assuming that they constitute a comprehensive assessment of EF. Therefore 
we can conclude only that performance on these particular tasks was impaired, and not that 
there is impairment across the whole spectrum of executive abilities.   
3.5.2 Methodological challenges in researching EF in PD  
The clinical heterogeneity of PwPD groups may be one reason for contradictory reports in 
the literature, as complex pathology in PD may influence cognition in various ways (Colman 
et al., 2009; Kobayakawa et al., 2008). As the reviewed studies had PwPD groups that were 
similar in terms of general cognition, depression level and disease stage, this may account 
for the consistent findings from the meta-analyses. Aiming for homogenous groups of PwPD 
may facilitate more consistent results and better understanding of cognitive deficits. 
It was noteworthy that only a proportion of the available research evidence could be 
synthesized in the meta-analysis. The limited potential for summarizing findings across 
studies seems to be related to the methodological challenges inherent in measuring EF 
(Miyake et al., 2000; Salthouse, 2005). The systematic review demonstrated that only a few 
studies based their methods on a formal theory of EF that could serve as a framework for 
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distinguishing EF subcomponents and selecting appropriate measures. The most commonly 
discussed theory was working memory (Baddeley, 1986), which was referred to in four 
studies (Altgassen et al., 2007; Bublak et al., 2002; Gilbert et al., 2005). In most studies, 
either a definition of EF was presented or one of the frequently-used shorthand terms was 
adopted, such as ‘frontal-like abilities’, or dysfunction similar to that “found in patients with 
frontal lobe damage” (Farina et al., 1994, p. 34). The definitions were usually followed by a 
list of functions that constitute EF. However, these lists tended to be left open by ubiquitous 
phrases: ‘such as’, ‘like’ or ‘for example’ (Altgassen et al., 2007; Euteneuer et al., 2009). As a 
consequence, it is not possible to be certain precisely what was meant by executive or 
‘frontal’ functions, or what subcomponents of EF were investigated. 
Additionally, the interpretation of EF measures was inconsistent. The same tests 
were used to measure various functions depending on the study. Some studies explicitly 
specified which test is supposed to measure which particular ability (Colman et al., 2009; 
Farina et al., 2000; Uekermann et al., 2004; Zgaljardic et al., 2006), but others did not. In 
many cases there were comprehensive lists of abilities tested (e.g. working memory, set-
shifting, verbal fluency, inhibition, short-term memory) as well as an outline of measures 
supposed to tap these abilities, but it often remained unclear which of these were regarded 
as ‘executive’. 
A large proportion of studies was excluded in the early stages of the search, as study 
reports lacked basic information such as details of disease severity and presence of 
dementia. At the same time, we attempted to include a broad spectrum of studies referring 
to EF, which affected the number of studies available for meta-analysis of particular tests. 
However, the range of EF measures reflects the complexity of executive control and 
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highlights a key challenge of research on EF in PD. Given the variability in the way that 
different measures are interpreted, and the frequent absence of a clearly-articulated 
theoretical framework, it is difficult to synthesize the results of these studies. However, it is 
important to acknowledge that many of these studies do indicate some abnormalities in 
PwPD performance and may be useful in understanding cognitive functioning of PwPD. 
In the included studies there was little consideration of how impaired performance 
on neuropsychological tests impacts on the quality of life of PwPD and their carers (Siegert 
et al., 2008). There is an urgent need to understand the everyday impact of cognitive 
impairment to provide appropriate support for PwPD and their families (Clare, 2008). The 
meta-analysis showed consistent differences in all EF measures. However, the differences 
were small and their impact on everyday life may or may not be significant. It might be 
helpful for future research to focus more on the subjective experience of cognitive decline 
and the impact of cognitive impairment on everyday functioning. 
3.5.3 Conclusions 
A meta-analytic approach has the potential to synthesize and clarify evidence regarding 
executive deficits in PD. This review provides consistent evidence for the presence of 
executive deficits in PD. Increased precision in reporting PD characteristics of PwPD groups 
and defining executive abilities in future studies will facilitate better understanding of 
observed cognitive changes. An important question that has yet to be addressed is how 
observed deficits translate into everyday functioning and affects PwPD well-being, and 
whether there is a need for specific support for those people with PD who demonstrate EF 
impairment. 
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4.1 Abstract 
Background: The exact pattern of impairment in executive functions (EF) among people 
with Parkinson’s disease (PD) is still debated. Using a data-driven approach we investigated 
which areas of EF are particularly problematic in mild to moderate PD.  
Methods: Thirty-four people with mild to moderate PD, who scored in the normal range on 
general cognition screening tests, but displayed frontal-type deficits indicated by Frontal 
Assessment Battery (FAB) screening, completed the nine tests that comprise the Delis-
Kaplan Executive Function System. Patterns of performance were explored using cluster 
analysis and Principal Component Analysis (PCA), and the frequency of impairments was 
established using normative data.   
Results: Both cluster analysis and PCA identified two distinct groups of EF tests. The first 
group included tests requiring time-efficient attentional control (e.g. the Trail Making test). 
The second group included tests measuring abstract reasoning and concept formation 
abilities (e.g. the 20 Questions test). Impairment was more frequent on the attentional 
control tests than on the abstract thinking tests.  
Conclusions: PD pathology in the mild to moderate PD appears to affect the attentional 
control aspect of EF to a greater extent than abstract reasoning. Understanding the nature 
of executive deficits in PD is important for the development of targeted pharmacological 
and cognitive interventions for cognitive disturbances.   
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4.2 Introduction 
Parkinson’s disease (PD) is a heterogeneous neurodegenerative movement disorder 
associated with a number of non-motor difficulties, including neuropsychiatric, autonomic 
and gastrointestinal symptoms, sleep disturbance, and fatigue. There are three commonly 
identified subtypes of PD, based on the main motor symptoms: tremor dominant, postural 
instability gait disorder (PIGD) and akinetic-rigid (Jankovic et al., 1990; Marras & Lang, 2013). 
Cognitive decline is frequently observed in people diagnosed with PD (PwPD) even at the 
onset of the disease, with over 80% having some cognitive impairment or dementia within 
15 years of onset (Hely et al., 2005). The impairment ranges from single domain difficulties 
(e.g. in memory, language, attention, or executive functions), through global decline, to 
dementia (Janvin, Aarsland, Larsen, & Hugdahl, 2003; Mindham & Hughes, 2000; Owen, 
2004; Zgaljardic et al., 2003), and is particularly evident in the executive function (EF) 
domain (McKinlay et al., 2009; Muslimovic et al., 2005). EF is an umbrella term for complex 
attentional processes and cognitive abilities regulating independent goal-oriented behaviour 
(Burgess & Alderman, 2004; Lezak, 2004; Strauss et al., 2006). Reports indicate that many 
aspects of EF are impaired in PD, including planning, concept formation, decision making, 
cognitive flexibility, set-switching, inhibition and selective attention (Altgassen et al., 2007; 
Bouquet et al., 2003; Cools et al., 2001; Dujardin et al., 2001; Kobayakawa et al., 2008; 
Muslimovic et al., 2005; Zgaljardic et al., 2006). However, the research evidence is not 
consistent with regard to the reported level of impairment. There have been varying reports 
of performance on verbal fluency, a task commonly employed to estimate abilities related 
to frontal lobe function, with some studies reporting impaired performance (Bouquet et al., 
2003; Dujardin et al., 2001; Uekermann et al., 2004; Zgaljardic et al., 2006), and other 
studies reporting no difference between PwPD and controls (Colman et al., 2009; Cools et 
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al., 2001; Farina et al., 2000). The verbal fluency task has been variously reported to 
measure EF, set-shifting, planning, language ability, or global cognition (Auriacombe et al., 
1993; Downes et al., 1993; Dujardin et al., 2001; Farina et al., 2000). As similar 
inconsistencies exist in the evidence relating to other executive abilities, it is difficult to 
determine how prevalent particular EF deficits are, and whether there is any consistent 
pattern in the way in which PD pathology affects EF.  
The inconsistency in reports of executive functioning in PwPD may reflect the 
complex pathology of PD, which includes not only profound dopaminergic deficiency in the 
striatum (Dauer & Przedborski, 2003), but also widespread Lewy body pathology and cell 
loss in many brain regions, and abnormalities in noradrenergic, cholinergic, and serotonergic 
systems. EF deficits observed in PD may result from the multifaceted influences of these 
abnormalities on frontostriatal circuitry. Alexander, DeLong and Strick (1986) proposed that 
specific aspects of motor, cognitive and behavioural control are mediated by five 
frontostriatal circuits that interconnect specific areas of the prefrontal cortex (PFC) with 
separate, well-defined areas of the striatum (Dubois & Pillon, 1997). The disruption of PFC 
circuits may result in specific cognitive, emotional and motivational deficits. In particular, 
the dorsolateral prefrontal circuit (DLPFC) seems to be essential for some aspects of EF 
(Alexander et al., 1986; Dauer & Przedborski, 2003; Royall et al., 2002; Tekin & Cummings, 
2002; Zgaljardic et al., 2004). The impact that PD-related neurochemical imbalance has on 
cognition might change throughout the course of the disease as the neurodegeneration  of 
dopaminergic regions progresses, and might be complicated by the effects of dopaminergic 
medication (Cools et al., 2010; Leh et al., 2010). In addition it seems that the EF deficits 
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develop as a function of PD severity, while more posterior functions including memory have 
a different trajectory (Williams-Gray et al., 2009). 
The inconsistency in the research evidence may also reflect the complexity of the EF 
construct, as there is ongoing debate regarding both definitions of EF and the neuronal basis 
of EF, with a plethora of abilities described as ‘executive’, and no gold standard measure of 
EF available (Kudlicka, Clare, & Hindle, 2011; see previous chapter). The term ‘executive 
functions’ tends to be used interchangeably to describe either one of a range of specific 
cognitive abilities involved in behavioural control, or the whole group of such abilities and 
processes (Miyake et al., 2000). At the behavioural level EF may be defined in terms of 
successfully coping with novelty and managing personal goals in a socially appropriate 
manner, and this is linked to non-cognitive capacities like personality, motivation and 
emotions (Ardila, 2008; Stuss & Alexander, 2000). More frequently, EF is considered in the 
context of attentional control, for instance in terms of attentional processes controlling 
‘lower level’ cognitive functions (Alvarez & Emory, 2006; Aron, 2008; Krpan et al., 2007), or 
as a concept closely related to the central executive component of the multicomponent 
model of working memory and the supervisory attentional system (SAS) (Baddeley & Hitch, 
1974; Norman & Shallice, 1986). It has been suggested that to improve the consistency of 
reports of EF deficits in PD, there is a need for careful consideration of EF test selection, as 
well as meticulous precision in reporting and interpreting tests results (Kudlicka et al., 2011; 
see previous chapter).  
In summary, there is good evidence for EF deficits in PwPD, but some inconsistency 
remains, possibly related to multifaceted PD pathology and the complexity of the EF 
concept. More in-depth understanding of executive functioning in PD comes from studies 
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that have examined how the results of various EF tests relate to each other. For example, in 
one study (Zgaljardic et al., 2006), researchers analysed the performance of non-demented 
PwPD on 20 measures of frontal-type abilities classified as relating to the function of one of 
the three non-motor frontostriatal circuits (Alexander et al., 1986), and reported the DLPFC 
to be affected more than other circuits. However, the classification of measures was based 
on a literature review, rather than being data-driven, and included standard tests of EF as 
well as measures of mood and self-reported behavioural problems, which might have 
implications for interpretation of the findings. In another study (Weintraub et al., 2005), 
factor analysis identified two factors relating to EF in non-demented PwPD. The Planning 
factor included three indices of the Tower of London test, with lower scores associated with 
higher apathy. The Inhibitory Control factor included three measures (TM errors, Stroop 
errors and rule violations in the Tower of London test), with lower scores associated with 
lower education and greater motor impairment. There was little consideration of how PwPD 
differed across the two dimensions, and there was no measure of behavioural control or 
abstract thinking included. Cluster analysis has previously been employed to explore the 
heterogeneity of PD symptoms and patterns of cognitive functioning in PD, but has not been 
applied specifically to the investigation of EF in PD (Lewis, Foltynie, et al., 2005; McKinlay et 
al., 2009; van Rooden et al., 2010). 
In the present study we aimed to address some of the limitations in the existing 
evidence by examining EF with a broad range of standard EF measures, and focusing 
exclusively on people with mild to moderate PD, without dementia, but with frontal-type 
deficits indicated by screening using the Frontal Assessment Battery (Dubois et al., 2000). To 
establish the clinical significance of EF deficits we compared performance on EF tests to 
Chapter 4. Pattern of executive impairment in early stage PD 85 
 
 
normative data. We used Cluster Analysis and Principal Component Analysis to investigate 
which areas of executive functioning are particularly problematic in PD, and whether there 
is any consistent pattern of performance on EF tests. A good understanding of the nature of 
executive deficits in PD is important for tailoring treatment plans to the specific needs of 
PwPD, as different aetiology of cognitive impairment in PD may require different medication 
(Wurtman, 2012). It might also provide a basis for developing cognitive interventions that 
would support PwPD and their families in coping with the deficits. This is particularly 
important in the context of growing evidence that particular EF deficits may help to 
distinguish those PwPD who are at risk of developing dementia (Janvin et al., 2006; 
Williams-Gray et al., 2009; Woods & Tröster, 2003).  
4.3 Method 
4.3.1 Design 
The study employed a cross-sectional design to examine the pattern of EF in PwPD shown 
during screening to have frontal-type deficits. As reported in Chapter 1, the assessment 
presented here was part of a wider study of PwPD and included some measures not 
reported here. Ethical approval was obtained from the relevant University and National 
Health Service (NHS) ethics committees. All participants provided written informed consent. 
4.3.2 Participants 
As described in Chapter 1, a sample of PwPD in the mild to moderate stages of PD (Hoehn 
and Yahr stage I-III; Hoehn & Yahr, 1967), diagnosed according to the UKPDS Brain Bank 
criteria (Daniel & Lees, 1993) was identified by the consultant physician (JVH) from 
Movement Disorders clinics in North-West Wales. Over 18 months of recruitment, 75 PwPD 
agreed to take part in the study. Sixty-five of them met the inclusion criteria of normal 
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general cognition, indicated by an Addenbrooke’s Cognitive Examination – Revised (ACE-R) 
score ≥ 82 (Mioshi et al., 2006) and a MMSE score ≥ 24 (Folstein et al., 1975), and no 
clinically significant depression, indicated by a Hospital Anxiety and Depression Scale (HADS) 
score ≤ 11 (Snaith & Zigmond, 1994). Forty (61.1%) of the 65 participants screened had a 
Frontal Assessment Battery (FAB) score ≤ 15, indicating possible frontal type cognitive 
deficits (Dubois et al., 2000), and were thus eligible for the in-depth EF assessment. Six of 
these participants did not complete the EF assessment, three due to elective withdrawal 
and three due to fatigue, leaving a sample of 34 who completed the assessment. All 
participants had adequate eyesight and hearing, and were fluent in English.  
The following measures from the wide database were used in this analysis. 
4.3.3 Screening measures 
The Addenbrooke’s Cognitive Examination - Revised (ACE-R; Mioshi et al., 2006) 
validated for use in PD (Reyes et al., 2009) was employed to screen general cognition in five 
domains: attention and orientation, memory, verbal fluency, language and visuospatial 
abilities. The maximum total score of 100 indicates accurate performance. The study 
adopted a conservative cut-off of ≥ 82 suggested for screening purposes, with 84% 
sensitivity and 100% specificity for dementia diagnosis (Mioshi et al., 2006).The ACE-R also 
provides an MMSE score (Folstein et al., 1975). 
The Frontal Assessment Battery (FAB; Dubois et al., 2000) was used for screening 
purposes to identify PwPD with frontal-type deficits. The scale consists of six components 
measuring different aspects of frontal-type abilities. The maximum score of 18 indicates 
accurate performance. The study adopted a cut-off of 15 for probable frontal-type deficits, 
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which is 2 SD below the mean reported for healthy controls (M = 17.3, SD = 0.8) (Dubois et 
al., 2000). 
Mood was assessed with the Hospital Anxiety and Depression Scale (HADS; Snaith & 
Zigmond, 1994) (Appendix F), a self-rating questionnaire consisting of two 7-item subscales, 
HADS-Depression and HADS-Anxiety. Scores for each subscale range from 0 to 21, with 
higher scores indicating higher levels of self-rated anxiety/depression. The study adopted 
the cut-off of 11 suggested for depression screening purposes (Crawford et al., 2001).  
In addition, an estimate of pre-morbid IQ was obtained for each participant. The 
National Adult Reading Test (NART; Nelson & Willison, 1991) estimates lifelong intellectual 
ability by assessing the ability to correctly pronounce 50 phonetically irregular words. The 
number of words pronounced incorrectly is converted into an estimated IQ score. More 
errors produce a lower estimated IQ score. 
4.3.4 Assessment of EF 
Executive functions were assessed with the Delis-Kaplan Executive Function System (D-KEFS; 
Delis et al., 2001), which is a set of nine tests assessing important aspects of EF with some 
well-known tests of EF (Trail Making, Verbal Fluency, Tower) as well as more novel tasks (20 
Questions, Proverb). The test administration procedure and clinical interpretation of the 
indices used in the study are described in Table 4.1. The results of standard EF tests from 
the D-KEFS were converted to scaled scores derived from a large normative sample. Using 
scaled scores allows for both evaluation of performance in terms of impairment and direct 
comparison of the results across the different tests (Homack et al., 2005; Strauss et al., 
2006).
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Table 4.1. Description of EF tests and indices. 
Test Index Task description and interpretation of performance index 
Trail Making 
Test (TM): 
Switching  
Time to 
complete 
 
TM consists of four conditions assessing lower-level cognitive 
abilities, and a higher-level switching condition, in which 
participants draw a line connecting numbers and letters in 
ascending order, while alternating between numbers and 
letters. A low scaled contrast score (composite score of two 
baseline conditions vs. switching condition) indicates that poor 
lower-level cognitive abilities may account for poor 
performance in the higher-level condition. Shorter time to 
complete indicates better flexibility in thinking and switching 
between mental sets. 
Verbal 
Fluency 
(VF): 
Switching  
Number of 
correct 
words  
Participants produce words from phonemic and semantic 
categories, according to given rules and within the time limit. 
In the switching condition they alternate between two 
semantic categories. A higher score indicates better initiation, 
systematic retrieval, simultaneous processing, and flexibility in 
shifting. 
Design 
Fluency (DF) 
 
Percentage 
accuracy 
 
Participants draw different designs according to given rules 
and within a time limit. They are presented with pages 
containing a number of boxes with identical arrays of dots 
(different arrays in each of the 3 conditions) and asked to 
connect the dots with four straight lines. The ratio between 
correct vs. attempted designs was chosen rather than a score 
based on the number of designs drawn, as the former is less 
affected by hand dexterity. Higher percentage accuracy 
indicates better initiation of problem solving, and better 
performance in establishing and maintaining cognitive set. 
Colour Word 
Interference 
(CWI): 
Switching 
Time to 
complete  
CWI consists of four parts, with two baseline and two higher-
level conditions. In the switching condition participants need to 
either name the dissonant ink colour (traditional Stroop task) 
or read the word, according to the given rules. A shorter time 
indicates better inhibition of unwanted reactions and greater 
cognitive flexibility. 
(Table 4.1 continues) 
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(Table 4.1 continued) 
Sorting: 
Recognition  
Description 
score  
Participants are presented with six cards of various colours, 
shapes and inscriptions, and asked to either sort the cards 
into two groups of 3 cards that are similar in some respect 
(Free Sorting) or recognise and describe such sorts when 
these are presented by the examiner (Recognition). Higher 
description scores reflect better flexibility in thinking and 
ability to perceive and express abstract concepts and 
conceptual relationships. 
Test Index Task description and interpretation of performance index 
20 
Questions  
Initial 
abstraction 
score 
Participants ask yes-no questions to identify which object, 
out of 30 presented, has been chosen by the examiner. The 
initial abstraction score indicates how many objects are 
eliminated with the first question. A higher score indicates 
more efficient categorical clustering and abstract thinking. 
Word 
Context  
Total 
consecutively 
correct score 
Participants guess the meaning of made-up words from the 
context of the consecutively presented sentences. A higher 
number of consecutively correct answers is indicative of 
better deductive reasoning, hypothesis testing, and 
flexibility in thinking. 
Tower  Total 
achievement 
score 
Participants need to move discs between 3 pegs in order to 
build target towers. They need to follow a set of rules and 
complete the task with as few moves as possible. One point 
is assigned for a correct tower and up to 3 extra points for 
minimum-moves solutions. A higher score indicates better 
spatial planning, rule learning, performance in establishing 
and maintaining instructional set, and inhibition. 
Proverb: 
Uncommon  
Achievement 
score 
Participants explain the meaning of proverbs. Achievement 
score in uncommon proverbs was used rather than the total 
achievement score that includes common proverbs, as with 
uncommon proverbs participants rely on abstract thinking 
more than on learnt descriptions, which might be the case 
in common proverbs. This is therefore a more sensitive 
measure of verbal abstract thinking, semantic integration, 
and generalisation. Higher scores assigned for abstraction 
and accuracy reflect better performance.  
Note. Description based on the D-KEFS manual (Delis et al., 2001). 
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4.3.5 Procedure and data collection 
Participants were assessed during their ‘on’ medication phase, usually in their own homes 
(four participants preferred to come to the University). After completing a screening session 
lasting 2 to 3 hours, participants who scored below the cut-off for frontal-type deficits on 
the FAB and otherwise met inclusion criteria were invited to complete the further in-depth 
assessment of EF, consisting of two to three visits, each lasting approximately 2 hours.  
4.3.6 Planned analysis 
The frequency of clinically significant deficits was established using D-KEFS normative data. 
Correlational analysis (Spearman’s Rho) was used to explore the extent of any association 
between EF tests. The pattern of performance on EF tests was examined using cluster 
analysis, a data-driven approach that is useful in exploring potential relationships within 
complex data sets, when there is little a priori knowledge of the data structure (Morris et al., 
1981; Ward, 1963). In the cluster analysis similar participants or variables are grouped 
together to form clusters of variables or cases that are most similar to each other. The 
identified clusters can then be further examined to reveal characteristics that discriminate 
between the groups (Morris et al., 1981; Ward, 1963). The approach offers various methods 
of assessing similarity and establishing number of clusters and several of them were 
explored to ensure that the method presented in the study (Ward hierarchical grouping, 
based on squared Euclidean distance) provided results that were generally representative 
across the range of methods. Two cluster analyses were run, the first examining associations 
between tests (variables) and the second examining associations between participants 
(cases). In the cluster analysis of variables, scaled scores were used to minimise the impact 
of age on the observed relationships between EF tests. However, in the cluster analysis of 
cases, raw scores were used, as age might be an important characteristic that would 
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differentiate between groups. To verify the results of the cluster analysis, an exploratory 
principal component analysis (PCA) was conducted on the EF tests. Oblimin rotation was 
employed as it was expected that various aspects of EF might be correlated (Miyake et al., 
2000). Associations between EF tests and other group characteristics were explored with 
correlational analysis (Spearman’s Rho). All analyses were performed in IBM SPSS statistics 
19. 
4.4 Results 
Thirty-four PwPD (15 men, 44.1%) with frontal-type deficits indicated by FAB screening 
completed the assessment. According to the Hoehn and Yahr classification (Hoehn & Yahr, 
1967), the majority of PwPD (n=19; 55.9%) were in stage I of the disease, 11 participants 
were in stage II (32.4%), and 1 person (2.9%) was in stage III. Information was unavailable 
for 3 participants (8.8%). Symptoms started on the left side in 12 participants, on the right 
side in 16, and bilaterally in 6. Demographic information and details of disease 
characteristics and medication use are presented in Table 4.2. Raw scores and scaled scores 
achieved on EF tests are presented in Table 4.3. 
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Table 4.2. Demographic information, disease characteristics, and medication use in PwPD 
(n=34). 
 M (SD) Range 
Age  72.62 (8.27) 48 – 89 
Education (years) 13.04 (3.04) 5 – 19 
NART-estimated IQ 114.56 (7.70) 100 – 128 
Socio-Economic Status1 2.41 (1.02) 1 – 4 
MMSE 29.41 (1.10) 25 – 30 
ACE-R 94.18 (4.65) 82 – 100 
FAB 13.74 (0.96) 12 – 15 
HADS-Depression 4.18 (2.04) 1 – 9 
HADS-Anxiety 5.29 (3.16) 1 – 12 
Hoehn and Yahr stage n = 31 1.42 (0.56) 1 – 3 
PD duration (months)2 68.21 (52.39) 10 – 204 
LED n = 33 596.21 (626.55) 100 – 3125 
Medication n (%) 
Levodopa 21 (61.8) 
Dopamine agonists 20 (58.8) 
Rasagiline 20 (58.8) 
Entecapone 6 (17.6) 
Amantadine 3 (8.8) 
Apomorphine 1 (2.9) 
M – Mean; SD – Standard deviation; NART – National Adult Reading Test; ACE-R – The 
Addenbrooke’s Cognitive Examination - Revised; HADS – Hospital Anxiety and Depression 
Scale; FAB – Frontal Assessment Battery; LED – Total Daily Levodopa Equivalent Dose, based 
on Tomlinson et al. (2010); Dopamine agonists – Non ergot-derived dopamine-receptor 
agonists 
 11 – Professional; 2 – Managerial/technical; 3 – Skilled, non-manual; 4 – Skilled, manual; 5 – 
Partly skilled; 6 – Unskilled.  
2Time since the diagnosis, as reported by PwPD. 
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Table 4.3. Mean raw and scaled scores on EF tests. 
Test 
 Raw Scaled 
n M (SD) Range M (SD) Range 
TM  33 151.88 (69.45) 50 – 240 7.94 (4.83) 1 – 15 
Verbal Fluency  34 11.85 (3.47) 3 – 20 10.00 (4.08) 1 – 19 
Design Fluency 34 85.00 (11.88) 42 – 100 9.91 (2.23) 4 – 14 
CWI  34 88.03 (29.52) 48 – 180 9.32 (3.22) 1 – 14 
Sorting 30 28.43 (12.22) 6 – 53 10.53 (3.58) 3 – 18 
20 Questions 33 26.70 (11.44) 4 – 53 10.70 (2.73) 5 – 17 
Word Context 33 24.55 (6.28) 9 – 36 10.85 (2.61) 4 – 16 
Tower 33 15.39 (4.85) 4 – 24 10.36 (3.30) 2 – 16 
Proverb 30 8.73 (2.79) 3 – 12 12.53 (2.40) 8 – 16 
Note. See Table 4.1 for details of which index was used for each test. The range of possible 
scaled scores is 1 – 19. 
M – Mean; SD – Standard deviation; TM – Trail Making; CWI – Color Word Interference   
 
Table 4.4 presents a comparison of the two PwPD groups identified on the basis of 
their performance on the Frontal Assessment Battery (FAB) screening tool. One group 
consists of PwPD who scored 15 or below on the FAB (FAB-poor, n = 40), and the second 
group consists of PwPD who scored above 15 on the FAB (FAB-normal, n = 25). Independent 
samples t-tests indicated that PwPD with poor performance on the FAB were older on 
average than PwPD with normal FAB scores, and performed significantly worse on the 
switching condition of the Trail Making test. There was also a trend toward a difference in 
PD severity; PwPD with lower FAB scores tended to be at more advanced Hoehn and Yahr 
stages, but this was not significant.  
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Table 4.4. Comparison of PwPD who scored 15 or below and PwPD who scored above 15 on 
the FAB. 
 PwPD FAB-poor (n=40)5 PwPD FAB-normal (n=25) Independent 
sample t-test  
p 
 M (SD) Range M (SD) Range 
Age  72.35 (8.34) 48–89 66.52 (8.79) 49–82 t(63) = 2.69 .009 
Education (years) 12.81 (3.03) 5–19 13.22 (2.94) 8–20 t(63) = -0.53 .596 
NART-estimated IQ1  113.64 (8.39) 95–128 113.96 (7.64) 92–127 t(62) = -0.15 .878 
MMSE 29.38 (1.06) 25–30 29.64 (0.64) 28–30 t(63) = -1.13 .262 
ACE-R 93.25 (4.74) 82–100 94.76 (3.72) 88–100 t(63) = -1.35 .181 
PD duration 
(months)2 
69.68 (56.81)  10–216 60.04 (45.70) 1–192 t(63) = 0.72 .477 
Hoehn and Yahr 
stage3 
1.49 (0.59) 1–3 1.24 (0.50) 1–3 t(52.70) = 1.73 .090 
LED4 
574.62 
(599.85) 
0–3125 
586.32 
(492.64) 
0–
2145.75 
t(62) = -0.08 .935 
HADS-Depression 4.53 (2.45) 1–10 4.28 (2.64) 0–9 t(63) = 0.38 .705 
HADS-Anxiety 5.50 (3.49) 1–14 5.28 (3.64) 1–16 t(63) = 0.24 .808 
TM switching 
(seconds) 
154.31 
(68.31) 
50–240 
109.60 
(58.38) 
45–240 t(62) = 2.70 .009 
TM switching 
(scaled) 
7.74 (4.84) 1–15 10.36 (3.81) 2–15 t(59.32) = -2.41 .019 
CWI inhibition 
(seconds) 
76.60 (24.81) 46–147 66.13 (31.21) 39–180 t(62) = 1.48 .143 
CWI inhibition 
(scaled) 
9.58 (3.57) 1–14 11.08 (3.90) 1–15 t(62) = -1.58 .119 
CWI inhibition/ 
switching (seconds) 
88.50 (28.44) 48–180 78.13 (31.19) 39–180 t(62) = 1.36 .178 
CWI inhibition/ 
switching (scaled) 
9.20 (3.26) 1–14 10.13 (3.79) 1–15 t(62) = -1.03 .305 
M – Mean; SD – Standard deviation; NART – National Adult Reading Test; ACE-R – The 
Addenbrooke’s Cognitive Examination - Revised; HADS – Hospital Anxiety and Depression 
Scale; FAB – Frontal Assessment Battery; LED – Total Daily Levodopa Equivalent Dose; HADS 
– Hospital Anxiety and Depression; TM – Trail Making; CWI – Color Word Interference  Scale 
1Pre-morbid IQ of PwPD (n=64) was estimated with the National Adult Reading Test (NART; 
Nelson & Willison, 1991).  
2Time since the diagnosis, as reported by PwPD. 
3PwPD FAB poor (n=36), PwPD FAB normal (n=23).  
4Based on Tomlinson et al. (2010), n=64. 
5Includes 6 PwD who did not complete in-depth assessment of EF, 3 due to fatigue and 3 
due to elective withdrawal 
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Scaled scores for the EF tests were calculated using normative data published in the 
D-KEFS manual. Scaled scores ≤ 5 (comparable to ≤ the 5th percentile and ≤ 1.5 SD below 
the mean) were classified as impaired. Scaled scores of 6 and 7 (comparable to the 9–24 
percentile the percentile and 1.3-0.7 SD below the mean) are traditionally interpreted as 
potentially indicative of clinically significant deficit or as borderline in the context of a 
comprehensive evaluation (Delis et al., 2001; Strauss et al., 2006), and were here labelled as 
‘poor’. The percentage of clinically significant deficits on the various EF tests is presented in 
Figure 4.1. The mean percentage of scaled scores ≤ 5 across all EF tests was 7.4%. 
Examination of performance on all tests for individual participants shows that 55.8% of 
PwPD performed within the normal range on all of the tests, 29.4% had impaired 
performance in one of the nine tests, and 14.7% had impaired performance on 2 to 5 of the 
tests (overall 44.2%). Impairment was most frequent in TM, with 18.2% of PwPD exhibiting 
impaired performance (after excluding the 15.2% of PwPD whose impaired performance in 
the switching condition could be explained by poor performance in the baseline conditions). 
In contrast, none of the participants scored below the cut-off for poor or impaired 
performance on the Proverb test. 
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Figure 4.1. Frequency of EF impairment on EF tests in PwPD who scored below the cut-off 
for frontal type cognitive deficits on the FAB. 
Note. See Table 4.1 for information about which index was used for each test. On all EF tests 
performance was classified as impaired for scaled scores ≤ 5, and as poor for scaled scores 
of 6 and 7.   
TM – Trail Making; CWI – Color Word Interference; 20 Quest – 20 Questions.  
* Low scores on TM seem to specifically reflect EF deficits rather than poor dexterity or 
other non-EF deficits in 18.2% of participants, according to the contrast measure analysis 
(Delis et al., 2001). 
 
Correlational analysis (Spearman’s Rho) was used to explore the extent of any 
association between EF tests. The CWI test was strongly correlated with TM and Verbal 
Fluency, and the Tower Test was strongly correlated with TM, Verbal Fluency and CWI. 
There were also moderate correlations between the TM and Verbal Fluency tests, between 
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the Sorting and 20 Questions tests, and between the Proverb and Verbal Fluency tests, but 
these were not statistically significant after Holm-Bonferroni correction. See Table 4.5 for 
details of the correlational analysis. 
Table 4.5. Spearman’s Rho correlation coefficients for associations between the EF tests. 
EF Tests 1 2 3 4 5 6 7 8 
1. TM         
2. Verbal Fluency  .459**        
3. Design Fluency  .261 .185       
4. CWI  .706** .654** .302      
5. Sorting .172 .316 -.075 .196     
6. 20 Questions  -.133 .033 -.016 -.080 .419*    
7. Word Context  .316 -.108 -.073 .017 -.009 .229   
8. Tower  .669** .608** .197 .684** .310 .007 .086  
9. Proverb  .085 .376* .252 .203 .245 .105 .212 .107 
Note. See Table 4.1 for information which index was used for each test. Bold typeface 
indicates significance after Holm-Bonferroni correction for multiple comparisons (p = .05/50 
= 0.001). 
TM – Trail Making; CWI – Color Word Interference  
 
Cluster analysis of variables, based on Ward hierarchical grouping using squared 
Euclidean distance (Morris et al., 1981; Ward, 1963), identified two groups of tests (see 
Figure 4.2). Cluster 1 consists of five tests: CWI, Tower, Verbal Fluency, Design Fluency and 
TM. Cluster 2 consists of the remaining four tests: Sorting, 20 Questions, Word Context and 
Proverb. Analysis of the test characteristics suggests that Cluster 1 tests primarily focus on 
attentional control, while Cluster 2 tests seem to require predominantly abstract reasoning 
abilities. Scaled scores for the tests included in each of the two clusters were averaged to 
provide two composite scores. A dependent t-test indicated that on average performance 
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was significantly better on the Cluster 2 tests (M = 11.33, SD = 1.81) than on the Cluster 1 
tests (M = 9.86, SD = 2.71), t(26) = -2.53, p = .018.  
 
Figure 4.2. Hierarchical cluster analysis examining associations between EF tests (variables). 
Note. See Table 4.1 for information on which index was used for each test.  
TM – Trail Making Test; CWI – Color Word Interference 
 
The Kaiser-Meyer-Olkin (KMO) measure of .609 indicated acceptable sampling 
adequacy for the PCA, and Bartlett’s test of sphericity (χ2 (36) = 89.41, p < .001) indicated a 
sufficient degree of correlation between the tests. A three-component solution was 
retained, based on the Kaiser’s eigenvalues > 1 criterion and the scree plot examination. The 
three components with eigenvalues > 1 together explained 66.76% of the variance. Table 
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4.6 shows the factor loading after rotation (pattern matrix). Component 1 includes all tests 
that were grouped in the Attentional Control cluster in the cluster analysis. Component 2 
includes Sorting, Twenty Questions and Proverb tests, reflecting abstract reasoning abilities. 
Component 3 includes only the Word Context test, which also requires abstract reasoning, 
but may rely more strongly on language abilities.  
Table 4.6. Summary of principal component analysis of EF test scores (factor loading after 
oblimin rotation). 
 Component 
1 2 3 
CWI  .901   
Tower  .868   
TM .812   
Verbal Fluency  .681   
Design Fluency  .478   
Sorting   .804  
20 Questions   .777  
Proverb   .558  
Word Context    .941 
Note. See Table 4.1 for information on which index was used for each test. Values below the 
suggested cut-off value of .40 were removed to increase clarity (Field, 2005). 
TM – Trail Making; CWI – Color Word Interference 
 
Cluster analysis of cases, based on Ward hierarchical grouping and squared Euclidean 
distance (Morris et al., 1981; Ward, 1963), identified three groups of PwPD (see Figure 4.3).  
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Figure 4.3. Hierarchical cluster analysis examining associations between participants (cases) 
in EF test performance. 
Note. Missing values excluded listwise, n = 28.  
Scaled scores on each test for all participants in each group are presented in Table 
4.7. The groups were compared with regard to the two composite scores for EF tests, and to 
demographic and PD characteristics. Kruskal-Wallis comparison of Cluster 1 composite 
scores across the three groups indicated a significant group effect, with Mann-Whitney 
post-hoc analysis showing that Group C performed significantly worse than Groups A and B. 
For the Cluster 2 composite scores, there was a trend towards a between-group difference, 
with Mann-Whitney post-hoc analysis indicating that Group A performed significantly worse 
than Group B. There was also a significant difference in ACE-R scores, with Group C 
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performing significantly worse than Groups A and B. There were no other significant 
differences between the groups. See Table 4.8 for details.  
Table 4.7. Comparison of the three groups identified by the cluster analysis of cases. 
 
Group A Group B Group C   
M (SD) M (SD) M (SD) Statistics1 Post-hoc2 
Cluster 1 (Attentional 
control) 
11.08 
(1.78) 
10.78 
(1.10) 
5.08 
(1.11) 
H(2) = 12.07, 
p = .002 
A, B > C 
Cluster  2  
(Abstract reasoning) 
10.44 
(1.49) 
12.40 
(1.83) 
10.88 
(1.81) 
H(2) = 4.74, 
p = .094 
A=C; B=C; A < B 
Age 
70.67 
(9.95) 
71.50 
(8.66) 
76.17 
(1.94) 
H(2) = 2.50, 
p = .287 
 
Education (years) 
13.33 
(3.75) 
13.20 
(3.02) 
12.58 
(3.07) 
H(2) = 0.78, 
p = .678 
 
NART-estimated IQ  
114.75 
(7.26) 
114.20 
(8.04) 
115.50 
(7.42) 
H(2) = 0.15, 
p = .927 
 
HADS Anxiety 
5.75 
(3.49) 
4.40 
(2.95) 
5.17 
(3.55) 
H(2) = 0.94, 
p = .626 
 
HADS Depression 
3.75 
(1.66) 
3.70 
(2.50) 
4.00 
(1.14) 
H(2) = 0.25, 
p = .881 
 
ACE-R 
96.00 
(2.86) 
96.50 
(2.88) 
90.50 
(5.82) 
H(2) = 6.07, 
p = .048 
A, B > C 
Hoehn and Yahr stage  
1.45 
(0.69) 
1.22 
(0.44) 
1.60 
(0.55) 
H(2) = 1.77, 
p = .414 
 
PD duration (months) 
52.66 
(45.04) 
70.30 
(51.16) 
79.00 
(53.45) 
H(2) = 1.79, 
p = .409 
 
LED 
604.33 
(826.48) 
350.44 
(279.45) 
770.58 
(524.19) 
H(2) = 3.47, 
p = .177 
 
M – Mean; SD – Standard deviation; NART – National Adult Reading Test; ACE-R – The 
Addenbrooke’s Cognitive Examination - Revised; HADS – Hospital Anxiety and Depression 
Scale; LED – Total Daily Levodopa Equivalent Dose (Tomlinson et al., 2010)  
1 Kruskal Wallis test; 2 Mann-Whitney; Group A: n=12; Group B: n=10; Group C: n=6. 
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Scaled scores on each test for all participants in each group are presented in Table 4.7. 
Table 4.8. Scaled scores of EF tests grouped by clusters identified in the cluster analyses of 
variables (EF tests) and cases. 
   Attentional Control Abstract Reasoning 
 Case CWI Tower 
Verbal 
Fluency 
Design  
Fluency TM 
Word 
Context Proverb Sorting 
20 
Quest 
Group A 5 12 11 11 13 14 13 11 7 10 
11 11 11 9 10 9 10 9 5 10 
8 10 12 11 10 12 10 11 9 8 
1 9 10 11 10 7 10 9 3 8 
4 12 16 14 11 15 15 15 6 10 
9 13 15 14 11 14 12 15 12 10 
12 13 13 11 12 13 13 14 10 6 
3 14 11 10 12 13 8 13 13 9 
2 10 12 11 5 11 11 12 8 9 
7 12 12 9 10 11 12 16 9 10 
6 8 6 5 10 8 10 15 8 7 
10 10 10 15 9 11 12 16 14 8 
Group B 24 8 10 12 12 9 8 15 10 13 
28 7 11 12 13 2 10 15 12 11 
19 12 12 19 11 1 9 15 13 13 
21 12 12 18 8 3 8 14 12 11 
26 12 10 14 10 13 12 13 18 16 
27 11 12 11 11 12 13 15 17 17 
20 7 12 9 8 10 16 13 17 11 
22 12 15 14 8 13 10 9 13 11 
23 11 15 11 9 12 11 10 14 11 
25 10 14 8 11 10 6 8 14 12 
Group C 15 7 7 6 9 2 12 13 10 14 
16 4 7 3 7 2 12 12 10 12 
13 4 8 5 8 2 14 12 7 13 
17 8 8 8 4 1 14 13 11 13 
18 8 6 9 1 2 8 9 7 10 
14 1 3 1 10 2 12 9 9 5 
 
Cases not classified due to missing data 
      
 29 1 2 7 7 1 4 13 - 10 
30 8 10 9 12 1 7 - 9 7 
31 8 7 1 12 - 13 - - 14 
32 11 - 11 14 8 12 - 9 14 
34 12 10 11 9 9 11 12 - 10 
34 9 12 10 11 9 - - - - 
 poor (scaled scores 6-7) impaired (scaled scores ≤ 5) 
TM – Trail Making; CWI – Color Word Interference; 20 Quest – 20 Questions 
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Spearman’s correlational analysis indicated only two moderate correlations, 
between Cluster 1 composite score and premorbid IQ estimated with NART, and between 
Cluster 2 composite score and Hoehn and Yahr stage, which were not significant after Holm-
Bonferroni correction for multiple comparisons (p = .05/19 = 0.0026). See details in Table 
4.9. 
Table 4.9. Bivariate correlations between disease-related and demographic characteristics 
and EF composite scores (Spearman’s Rho). 
 N 
Cluster 1 
(Attentional control) N 
Cluster 2 
(Abstract reasoning) 
Cluster 2  27 .099   
Age 28 .195 31 -.100 
Education (years) 28 .360 31 .219 
NART-estimated IQ  28 .435* 31 .056 
HADS Anxiety 28 .143 31 .298 
HADS Depression 28 .287 31 -.001 
ACE-R 28 .226 31 .270 
PD duration (months) 28 -.092 31 -.073 
Hoehn and Yahr stage1  25 -.088 29 -.411* 
LED 27 -.066 30 -.232 
NART – National Adult Reading Test; HADS – Hospital Anxiety and Depression Scale; ACE-R – 
The Addenbrooke’s Cognitive Examination - Revised; LED – Total Daily Levodopa Equivalent 
Dose (Tomlinson et al., 2010)  
1There was no rating available for 3 participants (8.8%).  
* significant at p  = .05. 
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4.5 Discussion 
In the present study we investigated patterns of performance on EF tests in people with 
mild to moderate PD without dementia, who screened positive for frontal-type deficits. The 
frequency of impaired performance (1.5 SD or more below the mean) ranged from 18.2% in 
the TM to none in the Proverb test. Almost 30% of PwPD had impaired performance in one 
of the nine tests and 15% had impaired performance in 2 to 5 tests, while over 55% of PwPD 
scored within the normal range on all tests. Cluster Analysis identified two groups of tests, 
which we interpreted as reflecting attentional control (Cluster 1) and abstract reasoning 
(Cluster 2). PwPD performed significantly worse on attentional control than on abstract 
reasoning tasks, suggesting that the two aspects of EF may be differentially affected in mild 
to moderate PD.  
4.5.1 Frequency of clinically significant EF deficits 
Nearly 45% of PwPD in our study performed below the normal range (1.5 SD or more below 
the mean) on at least one of the tests, while 14.7% had impaired scores on two or more 
tests. Similar rates have been reported previously; however, as studies employ different 
definitions of impairment, focus on various aspects of EF, and include PwPD at different PD 
stages and with differing cognitive status, some of the reports might not be directly 
comparable. The 45% rate of impairment (at least one test score at least 1.5 SD below the 
mean) is similar to the results of another study (McKinlay et al., 2009), where about 50% of 
non-demented PwPD exhibited impairment on executive and problem solving tests. In that 
study (McKinlay et al., 2009), impairment in the EF domain was defined as performance 1.5 
SD below the control group mean, presumably on at least one of the tests, but this criterion 
was not stated directly. EF impairment is frequently assumed on the basis of performance 
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on one test only. For example, approximately 9% of non-demented PwPD, who performed 
at least 1.5 SD below the mean on the Stroop test, were reported as having impaired EF 
(Caviness et al., 2007), and this was further interpreted as reflecting mild cognitive 
impairment. In another study (Foltynie et al., 2004) almost 30% of non-demented PwPD 
were described as having EF impairment on the basis of scores on the Tower of London test 
(ToL), but no rationale for the choice of the cut-off score for impaired performance was 
given. The authors suggested that, in 17% of the impaired group, impaired performance on 
the ToL might reflect underlying deficits in recognition memory. 
In the present study, the range of impaired performance varied from none in the 
Proverb test to 18.2% in the TM. Even greater variability in performance on tests assessing 
various aspects of EF has been reported previously (Costa et al., 2008), with impaired 
performance (below the lower limit of the 95% tolerance interval of the normative sample, 
approximately 2 SD below the mean) observed in 39% of PwPD on the Card Sorting test 
(categories achieved), but only in 4% on the Phonological Fluency test. In line with our 
findings, one other study (Muslimovic et al., 2005) reported that the TM had the highest 
level of impairment in comparison to other EF tests, with impaired performance (2 SD or 
more below the mean) seen in 16% of non-demented PwPD in early stages of PD.  
Cluster analysis of cases identified three groups of PwPD. Group C performed 
significantly worse than other groups on Cluster 1 tests and on a test of general cognition 
(ACE-R). One possibility is that this group differed from the other groups in terms of global 
cognitive impairment, rather than specifically in terms of EF. However, this is unlikely to be 
the case as all participants had normal general cognition. Hence it is more likely that for this 
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group the greater deficits in EF affected performance on the ACE-R. The relationship 
between general cognition and performance on EF tests needs to be further investigated.  
There are varying views on how to define cognitive impairment, what cut-off is 
appropriate for classifying a score as impaired, and how many scores in a set of tests need 
to be in the impaired range to indicate impairment in a given cognitive domain (Binder, 
Iverson, & Brooks, 2009; Ingraham & Aiken, 1996). It has been demonstrated (Liepelt-
Scarfone et al., 2011) that different criteria for diagnosing mild cognitive impairment in PD 
(performance 1 SD, 1.5 SD or 2 SD below the mean, in at least one test or at least two tests 
in a cognitive domain) result in the frequency rates ranging from 9.9% to 92.1% in the same 
group of PwPD. The more measures that are used, both in terms of the number of tests and 
the number of indices for each test, the higher the chances are of observing an abnormal 
score. A single abnormal score might not reflect genuine cognitive problems, as some 
abnormal scores are commonly observed in healthy people (Binder et al., 2009; Ingraham & 
Aiken, 1996). In the present study we aimed to minimise the risk of reporting a random 
abnormal score as impaired, while comprehensively assessing EF, by limiting the use of 
performance indices to one index per test only. Nevertheless, it remains debatable whether 
one impaired score is sufficient to classify a person as having impaired EF. Further studies in 
healthy older adults might offer some clarification. In clinical practice impairment is 
diagnosed on the basis of convergent evidence from elements of a comprehensive clinical 
evaluation, for example medical history, observation, and different measures involving 
similar cognitive processes (Strauss et al., 2006). As such an approach is not usually 
considered feasible in research projects, single impaired scores may be useful in indicating 
areas of possible difficulties, but the lower figure of 14.7% (at least two scores falling 1.5 SD 
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or more below the mean) might more reliably estimate the frequency of EF impairment in 
our group of PwPD. 
4.5.2 Pattern of EF performance 
Cluster analysis and PCA both identified similar groups of tests, which seem to reflect two 
distinctive aspects of EF: attentional control (Cluster 1) and abstract reasoning (Cluster 2). 
The interpretation of performance on EF tests is not straightforward, as it typically involves 
a number of EF as well as lower-level cognitive functions, but since EF tests are typically 
designed to elucidate some distinctive features of executive control, they enable more 
specific analysis. The majority of EF tests in both clusters are defined as measuring, among 
other executive abilities, cognitive flexibility. However, it seems that cognitive flexibility 
might be understood differently in the two aspects of EF.  
In Cluster 1 tests (CWI, Tower, Verbal Fluency, Design Fluency and TM) cognitive 
flexibility seems to reflect time-efficient distribution of attention between various aspects of 
a test (switching). Time-efficiency is an important aspect of performance in all these tests, 
with time to complete the test being a primary index of performance in the CWI and TM. 
The subtasks may be relatively simple (e.g. connecting numbers or letters in ascending 
order), while the key challenge of the test is associated with the switching itself (e.g. 
switching between numbers and letters). This is particularly evident in TM, CWI and Verbal 
Fluency (switching conditions), which specifically require switching, while other tests in 
Cluster 1 rely more strongly on abilities such as inhibition and simultaneous processing that 
are related to switching (Miyake et al., 2000).  
In the Cluster 2 tests (Sorting, 20 Questions, Word Context and Proverb), flexibility in 
thinking seems to be equivalent to the cognitive processes of abstract reasoning. All these 
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tests require the ability to perceive various aspects of abstract concepts, adopt different 
interpretations and understandings, and implement various strategies to approach the task. 
For example, in the Word Context test examinees deduce the meaning of a made-up word 
based on the context given by the clue sentences in which the word appears. The key 
challenge of these tests seems to be associated with the complexity of the particular 
cognitive processes involved, rather than the flexibility aspect. While the Cluster 1 tests rely 
on time-efficient distribution of attention, the majority of Cluster 2 tests have no time limit. 
Only the Sorting test in Cluster 2 is timed, and noticeably, it is the task with the highest 
impairment rate among the Cluster 2 tests. What seems to distinguish the Sorting test from 
the timed tests of Cluster 1 is the abstract reasoning aspect, involving perceiving conceptual 
relationships between various features of the cards in order to deduce the logic behind the 
presented grouping. 
The Cluster 2 tests seem to require more verbal abilities than the Cluster 1 tests. This 
might be interpreted as showing that the differences between the two clusters reflect 
verbal abilities in PD rather than EF. However, this interpretation seems unconvincing as 
some of the sorts in the Sorting test included in the mostly verbal Cluster 2 are purely visuo-
spatial, while the mostly non-verbal Cluster 1 includes the Verbal Fluency test, which 
assesses an essentially verbal ability of word production.  
Interestingly, PwPD performed significantly worse on the attentional control tests 
than on abstract reasoning tasks, suggesting that the two aspects of EF might be 
differentially affected in mild to moderate PD. The results seem to be in line with the 
current understanding of the neuronal basis of EF and the potential role of striatal 
dopaminergic depletion in EF (Goldman‐Rakic, 1992). As proposed by Miller and Cohen 
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(2001) the striatum and mesocortical dopaminergic modulation of PFC may be critical for 
the appropriate updating of goal representation in PFC, as it seems to modulate the balance 
between responsiveness to changing circumstances and the resistance to distraction (E. K. 
Miller & Cohen, 2001; Seamans & Yang, 2004). Therefore, the disruption of that system 
might result in disturbances in the inhibitory control and attentional shifting that seem to be 
important for the tests in the attentional control cluster. In contrast, the aspect of EF related 
to abstract reasoning and concept formation seem to have stronger associations with 
anterior and frontopolar regions of PFC and the interconnections of PFC with other cortical 
sensory systems (Badre, Kayser,   D’Esposito, 2010; Green, Fugelsang, Kraemer, Shamosh, 
& Dunbar, 2006; Kopp, 2012; Krawczyk, McClelland, & Donovan, 2011). The observed 
pattern of performance might therefore be interpreted as reflecting the progression of 
dopaminergic depletion in PD that spreads from the striatum toward the mesocorticolimbic 
dopaminergic system (Kish & Shannak, 1988; N. Sawamoto et al., 2008). The proposed 
interpretation could be further investigated by comparing the two aspects of EF in PwPD in 
more diverse stages of PD and in a prospective study. 
4.5.3 Limitations 
There are several limitations of the present study that need to be taken into account when 
interpreting the results. The study aimed to identify the aspects of EF that are particularly 
problematic in PD, rather than to provide comprehensive frequency rates. The frequency 
rates given here apply only to the subgroup of PwPD who underperformed in the screening 
test (FAB) and might not be the same for the whole group of non-demented PwPD in mild to 
moderate stages of PD. The FAB is a well-established screening tool with good psychometric 
properties (Lima et al., 2008), but may have distinguished PwPD with a specific profile of 
executive abilities. A proportion of PwPD who underperformed on FAB had normal scores 
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on all standard tests of EF and it is possible that some PwPD who have EF deficits not 
captured by this screening tool were not included in this study. There might be recruitment 
bias, as PwPD who felt less confident about their cognitive abilities might have chosen not 
to take part in a study that explicitly focused on cognition. The study employed a cross-
sectional design, and a longitudinal follow-up could demonstrate how executive functioning 
changes as the disease progresses. The analyses were performed on a relatively small 
sample of PwPD and the findings need to be further validated. However, the convergent 
evidence from two different analyses (Cluster Analysis and PCA) does increase the likelihood 
that the identified EF dimensions might generalise to other groups of PwPD. A larger sample 
would enable more detailed characterisation of factors associated with executive 
functioning in the subgroups of PwPD distinguished by cluster analysis, for example with 
regard to motor impairment, medication, age, genetic factors, or PD subtype. We have 
attempted to control for the impact that lower-level cognition and motor functioning might 
have on observed executive performance by including PwPD with normal general cognition 
and choosing measures less affected by motor speed, but some non-executive deficits may 
still have a potential impact on performance on EF tests. Finally, it should be noted that 
while the ability to cope with novelty is described as central for EF, this might not be 
effectively assessed in a firmly structured testing situation (Manchester et al., 2004).  
4.5.4 Conclusions 
In summary, more than half of PwPD in our sample performed within the normal range on 
all nine EF tests. The highest rate of impaired scores, 18.2%, was observed for TM, and the 
lowest for Proverb, with all PwPD performing within the normal range. Cluster analysis 
identified two groups of tests that seem to reflect two distinctive sets of abilities: 
attentional control and abstract reasoning. Both aspects of EF are typically included in broad 
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definitions of EF (Alvarez & Emory, 2006; Ardila, 2008; Aron, 2008; Krpan et al., 2007; Stuss 
& Alexander, 2000), but they seem to rely on fundamentally different cognitive processes, 
possibly reflecting regional specialisation within the PFC and frontostriatal circuits. It seems 
that PD pathology in the mild to moderate stages affects the attentional control aspect of EF 
to a greater extent than the abstract reasoning aspect. Better understanding of the nature 
of executive deficits may facilitate development of targeted pharmacological treatment and 
provision of the adequate support for PwPD and their families. 
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5.1 Abstract 
Background: High-quality person-centred care for people with Parkinson’s disease (PwPD) 
and their families relies on identifying and addressing factors that specifically impact on 
quality of life (QoL). Deficits in executive functions (EF) are common in Parkinson’s disease, 
but their impact on PwPD and their caregivers is not well understood. The present study 
evaluated how EF contributes to QoL and health status for the PwPD, and caregiver burden. 
Methods: Sixty-five PwPD completed measures of QoL, health status and EF, and 50 
caregivers rated the EF of the PwPD and their own burden. Multiple regression analyses 
examined predictors of QoL (General life, Health, and Movement disorders domains), health 
status and caregiver burden. 
Results: QoL in the Health and Movement disorders domains was best explained by 
caregiver-rated EF, while QoL in the General life domain was best explained by level of 
depression. Health status was predicted by self-rated EF, with an objective EF measure also 
included in the regression model. Caregiver burden was best explained by caregiver-rated 
EF and disease severity, with general cognition and other factors also included in the 
regression model. 
Conclusions: EF-related behavioural problems may contribute to QoL and health status in 
PwPD, and affect caregiver burden. The findings support the view that the concepts of 
subjective QoL and self-assessed health status are only partially related and should not be 
seen as identical. Adequate strategies to reduce the impact of EF deficits are needed as this 
may have the potential to improve QoL in PwPD. 
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5.2 Introduction 
People diagnosed with Parkinson’s disease (PwPD) are affected by the disease in numerous 
ways. The typically profound motor symptoms (tremor, rigidity and postural instability) are 
accompanied by a plethora of non-motor symptoms: neuropsychiatric problems  
(e.g. depression, apathy and cognitive deficits), sleep disturbances, and various autonomic 
symptoms (including gastrointestinal problems), as well as widespread slowness and fatigue 
(Chaudhuri et al., 2005; Poewe, 2008). Impairment in executive functions (EF) is one of the 
most commonly reported cognitive deficits in PD, observed even in the early stages of the 
disease (Muslimovic et al., 2005). EF is an umbrella term for a number of processes involved 
in regulating goal-oriented behaviour (Strauss et al., 2006). PwPD are reported to have 
deficits in cognitive flexibility, set-switching, inhibition and selective attention, as well as 
concept formation, planning, and decision making (Altgassen et al., 2007; Bouquet et al., 
2003; Cools et al., 2001; Dujardin et al., 2001; Kobayakawa et al., 2008; Kudlicka et al., 2011; 
Muslimovic et al., 2005; Zgaljardic et al., 2006). Executive deficits may affect functional 
abilities (Bronnick et al., 2006; Cahn et al., 1998; Hobson et al., 1999; Sabbagh et al., 2007; 
Schrag et al., 2000) and the use of coping strategies, with implications for the subjective 
health status of PwPD (Hurt et al., 2012). One-third of PwPD assessed in a large multi-centre 
study reported difficulties with maintaining concentration (Barone et al., 2009). Many PwPD 
complain about forgetfulness and slowness of thinking (Brod et al., 1998; Poliakoff & Smith-
Spark, 2008). Despite their ubiquity and possible implications for everyday life (Hely et al., 
2005; Leiknes, Tysnes, Aarsland, & Larsen, 2010), cognitive deficits and other non-motor 
symptoms have received attention only in recent decades and still tend to be under-
diagnosed (Chaudhuri & Schapira, 2009; Shulman, Taback, & Weiner, 2002). There is also 
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limited evidence regarding the specific impact that executive deficits may have on PwPD 
and their families.  
Studies evaluating the impact of PD on PwPD and their families frequently consider 
quality of life (QoL) or health-related QoL. QoL is defined as a subjective evaluation of 
various aspects of life, such as health, family, or occupation, in the context of the person’s 
needs and expectations (Den Oudsten et al., 2007a; Sprangers & Schwartz, 1999; WHOQOL 
group, 1998). However, the questionnaires used for assessing health-related QoL tend to 
ask about magnitude and/or frequency of symptoms, rather than about satisfaction with 
health (Den Oudsten et al., 2007a). It has been suggested that subjective perception of 
symptom severity might be more accurately referred to as subjective health status, and that 
this is only partially related to the QoL concept (Den Oudsten et al., 2007a). People can 
adjust and reconceptualise their internal standards and values, and their expectations, to 
incorporate the illness (Foley et al., 2006; Sodergren & Hyland, 2000; Sprangers & Schwartz, 
1999; Thornton, 2002). Therefore persons acknowledging similar levels of symptom severity 
(subjective health status) may express different levels of satisfaction with health and with 
life in general (QoL), depending on their expectations about health, after being diagnosed 
with PD.  
Only two of the 61 studies identified in a systematic literature review of studies on 
QoL in PD (Den Oudsten et al., 2007a) employed a measure assessing QoL specifically, rather 
than subjective health status, and these studies reported a possible role for depression (Lee 
et al., 2006) and PD duration and severity (Schestatsky et al., 2006). Subjective health status 
seems to be most strongly associated with depression and there is some evidence for the 
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influence of insomnia, medication use and surgery (Den Oudsten et al., 2007a; Soh, Morris, 
& McGinley, 2011).  
Only a small proportion of studies found cognition relevant to QoL or health status 
(Leroi et al., 2011; Leroi, McDonald, Pantula, & Harbishettar, 2012), but the limited number 
of significant findings may result from the fact that many studies assessed cognition only 
with the MMSE (Folstein et al., 1975) or other screening tools, which are not sensitive to the 
more subtle executive impairment observed in PD (Folstein & Folstein, 2010). 
When considering the impact of PD on a person’s life, it is important to acknowledge 
the role of family members, as particularly in the later stages PwPD depend on the care 
provided by family members in order to continue living at home. Given their critical role in 
supporting PwPD, caregivers’ specific needs should be well-understood and addressed 
alongside the needs of PwPD. Severity of motor symptoms is often reported as an important 
predictor of burden associated with caring for PwPD (Cifu et al., 2006; D’Amelio et al., 2009; 
Martínez-Martín et al., 2007; Schrag et al., 2006). Other studies highlight the importance of 
various non-motor symptoms, particularly depression (Aarsland et al., 1999; Martinez-
Martin et al., 2005; E. Miller et al., 1996). Some studies have found a relationship between 
caregiver burden and cognition (Aarsland et al., 1999; Leroi, Harbishettar, et al., 2012; 
Martinez-Martin et al., 2005; Thommessen et al., 2002), while other found no association 
(D’Amelio et al., 2009; E. Miller et al., 1996; Peters et al., 2011; Schrag et al., 2006). As in the 
studies of QoL and health status in PwPD, cognition was in many cases assessed using 
screening instruments only.  
In summary, the adequate support of PwPD and their families relies upon identifying 
and targeting factors that specifically impact on the QoL and health status of PwPD and on 
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the burden associated with caring for PwPD. Cognitive functioning, and more specifically EF, 
may influence the functioning of PwPD and the well-being of caregivers, but to evaluate this 
relationship, measures sensitive to EF need to be employed. In the present study we 
evaluated the extent to which executive impairment contributes to QoL, subjective health 
status and self-reported caregiver burden. 
5.3 Method 
5.3.1 Design 
As described in Chapter 1, the study employed a cross-sectional design, and the assessment 
presented here was part of a wider study, approved by the relevant University and National 
Health Service (NHS) ethics committees. 
5.3.2 Participants  
The same sample as that reported in Chapter 3 and the same inclusion/exclusion criteria 
were used. A sample of people with early stage PD (H&Y stage I-III, Hoehn & Yahr, 1967), 
diagnosed according to UKPDS Brain Bank criteria (Daniel & Lees, 1993), were identified by 
the consultant physician (JVH) from local Movement Disorders clinics in North-West Wales. 
Over 18 months of recruitment, 75 PwPD agreed to take part in the study and 65 of them 
met the inclusion criteria of normal general cognition, indicated by an Addenbrooke’s 
Cognitive Examination – Revised (ACE-R) score ≥ 82 (Mioshi et al., 2006) and a MMSE score 
≥ 24 (Folstein et al., 1975), and no clinically significant depression, as indicated by a Hospital 
Anxiety and Depression Scale (HADS) score ≤ 11 (Snaith & Zigmond, 1994). PwPD were on 
stable medication and had no serious comorbid neurological or psychiatric conditions, such 
as stroke, epilepsy or schizophrenia. Caregiver ratings were provided by people who lived 
with PwPD and/or knew the participants very well (e.g. spouses or adult children). Although 
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some of these people would not identify themselves as ‘caregivers’ the term has been used 
in this chapter to refer to individuals providing support to a PwPD as it is a widely-
understood and accepted construct. Caregiver data is not available in all cases as a 
proportion of PwPD lived alone and did not specify a suitable informant, and some family 
members who lived with PwPD and were invited to participate did not return the 
questionnaires. All participants had adequate eyesight and hearing, and were fluent in 
English.  
5.3.3 Measures 
The following measures from the wide database were used in this analysis. 
Quality of life (QoL) 
PwPD completed the Questions on Life Satisfaction scale (Henrich & Herschbach, 2000; 
Kuehler et al., 2003) (Appendix H), validated for use in PD, which examines subjective 
quality of life in three dimensions: general life satisfaction (QoL-Life, 8 items), satisfaction 
with health (QoL-Health, 8 items), and satisfaction with health in relation to movement 
disorders (QoL-MD, 12 items). This seems to be the only PD-specific measure of QoL rather 
than subjective health status (Den Oudsten et al., 2007b). On two separate 5-point scales 
participants indicate the subjective importance of a specific area of life or health 
(importance rating), and the degree of satisfaction in that area (satisfaction rating). The two 
ratings for each item are used to calculate a weighted satisfaction score and summed to 
provide global ratings for each of the three dimensions. Negative values indicate a 
predominance of “dissatisfaction”.  
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Health status 
PwPD completed the Parkinson’s Disease Questionnaire (PDQ-39; Jenkinson et al., 1998), a 
widely-used PD-specific questionnaire assessing subjectively perceived severity of various 
PD symptoms (health status). Participants indicate how often they have been affected by 
each of 39 problems listed. A summary index ranges from 0 to 100, with higher scores 
indicating higher levels of problems.  
Caregiver Burden 
Caregivers of PwPD completed the Caregiver Burden Inventory (CBI; Novak & Guest, 1989) 
(Appendix I), a 24-item self-rating questionnaire providing a detailed picture of the 
caregiver’s feelings and responses to the burden of care, used previously in PD studies 
(D’Amelio et al., 2009). A maximum score of 96 indicates the highest level of burden.  
Mood 
PwPD completed the Hospital Anxiety and Depression Scale (HADS; Snaith & Zigmond, 
1994), a self-rating questionnaire assessing levels of depression (HADS - Depression) and 
anxiety (HADS-Anxiety), widely used in PD studies (Schrag et al., 2007). Scores for each of 
the 7 item subscales range from 0 to 21, with higher scores indicating higher levels of self-
rated anxiety/depression. The study adopted the cut-off of 11 suggested for depression 
screening purposes (Crawford et al., 2001).  
Cognitive screening 
PwPD completed the Addenbrooke’s Cognitive Examination Revised (ACE-R; Mioshi et al., 
2006), which estimates general cognition in five cognitive domains: attention and 
orientation, memory, verbal fluency, language and visuospatial abilities. It also provides an 
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MMSE score (Folstein et al., 1975). The maximum total score of 100 indicates errorless 
performance.  
Executive functions (EF) 
PwPD completed two tests from the Delis-Kaplan Executive Function System (D-KEFS; Delis 
et al., 2001): the Trail Making Test (TMT) and the Color-Word Interference test (CWI), both 
known to be sensitive to EF deficits in PD (Kudlicka et al., 2011; see chapter 2). In TMT 
participants draw a line connecting numbers (TMT-Numbers) or numbers and letters in 
alternating sequence (TMT-Switching) in ascending order. A ratio score TMT-Switching 
/TMT-Numbers (comparable to the widely used TMTB /TMTA) has been identified as the 
most accurate estimation of EF, differentiating EF from visuospatial and motor abilities 
(Arbuthnott & Frank, 2000). CWI is based on the traditional Stroop task, where participants 
name the dissonant ink colour instead of reading the word (colour name). In CWI 
inhibition/switching condition participants switch between naming the dissonant ink colour 
(Stroop task) and reading the word, which tests the ability to inhibit unwanted reaction as 
well as cognitive flexibility. Longer completion times indicate poorer performance. 
EF-related behavioural problems 
PwPD and their caregivers completed parallel versions of the Behavior Rating Inventory of 
Executive Function – Adult Version (BRIEF-A; Roth et al., 2005), which estimates the ability 
to efficiently regulate behaviour and emotional responses, and to appropriately distribute 
attention to sustain task-completion efforts and systematically solve problems. On a 3-point 
scale participants indicate which of the 75 behaviours described has been a problem during 
the past month. Higher scores indicate more difficulties. 
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5.3.4 Procedure and data collection 
Participants were assessed at home, except for six participants who preferred to meet at 
the University. Some participants opted to send the self-completion questionnaires by post.  
The assessment reported here took 1.5-3 hours, split over two visits when needed. Visits 
were arranged during the ‘on’ medication phase. 
5.3.5 Planned analysis 
The associations between the variables were evaluated with bivariate correlational analyses 
(Pearson’s correlation). Predictors of QoL and health status in PwPD, and of caregiver 
burden, were identified with multiple regression analyses. Stepwise backward regression 
was selected as most suitable for addressing the exploratory aims of the study. The multiple 
regression analyses were performed in SPSS v.20 (IBM Corporation, NY, USA) with the 
default criterion probability of F-to-remove ≥.10.   
5.4 Results 
Sixty-five PwPD were included in the study, and 50 caregivers also contributed. Table 5.1 
presents demographic and disease characteristics, and Table 5.2 shows a summary of scores 
on all study measures.  
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Table 5.1. Descriptive statistics of the study measures in PwPD (n=65). 
a) Demographic characteristics 
 M (SD) Range 
Age  70.11 (8.92) 48–89 
Education (years) 12.97 (2.98) 5–20 
NART-estimated IQ* (n=64) 113.77 (8.04) 92–128 
MMSE 29.48 (0.92) 25–30 
 n (%) 
Gender (Male) 30 (46.2) 
Socio-economical status  
    I Professional 10 (15.4) 
    II Managerial/technical  28 (43.1) 
    III N Skilled, non-manual 13 (20.0) 
    III M Skilled, manual 11 (16.9) 
    IV Partly skilled 3 (4.6) 
    V Unskilled 0 
Relationship with caregiver**  
    Spouse/Partner 45 (69.2) 
    Parent/Child 3 (4.6) 
    Friend 2 (3.1) 
Caregiver did not participate 15 (23.1) 
 
b) Disease characteristics and medication use 
 M (SD) Range 
PD duration (months)1 71.97 (50.42) 7–216 
Hoehn and Yahr stage2 1.34 (0.57) 1–3 
LED3  579.19 (556.35) 0–3125 
 n (%) 
Hoehn and Yahr stage2  
Stage I 41 (63.1) 
Stage II 16 (24.6) 
Stage III 2 (3.1) 
Side of onset  
Left 24 (36.9) 
Right 31 (47.7) 
Bilateral 10 (15.4) 
Levodopa 39 (60.0) 
Dopamine agonists 40 (61.5) 
Rasagiline 33 (50.8) 
Entacapone 11 (16.9) 
Amantadine 4 (6.2) 
Apomorphine 1 (1.5) 
None 3 (4.6) 
M – Mean; SD – Standard deviation; LED – Total Daily Levodopa Equivalent Dose; Dopamine agonists – Non ergot-derived dopamine-receptor 
agonists  
1Mean value of the time since first symptoms and the diagnosis, as reported by PwPD.  
2There was no rating available for 6 participants (9.2%).  
3Based on Tomlinson et al. (2010), n=64.  
* Pre-morbid IQ of PwPD was estimated with the National Adult Reading Test (NART; Nelson & Willison, 1991). The number of phonetically 
irregular words pronounced incorrectly is converted into an estimated IQ score. Based on the NART, 31% of PwPD had an average IQ and 69% 
had an above average IQ. **92% of caregivers lived with PwPD.
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Table 5.2. PwPD and caregiver scores on all measures. 
 n M (SD) Range Min. and Max. 
QoL-General Life 57 83.88 (28.83) 30–141 -96–160 
QoL-General Health 58 62.10 (43.23) -59–134 -96–160 
QoL-Movement Disorders 55 96.96 (52.27) -49–216 -144–240 
PDQ-39 54 20.13 (11.57) 0.52–53.75 0–100 
Caregiver Burden Inventory 42 12.45 (10.55) 0–46 0–96 
ACE-R 65 93.83 (4.41) 82–100 0–100 
HADS-Depression 65 4.43 (2.51) 0–10 0–21 
HADS-Anxiety 65 5.42 (3.52) 1–16 0–21 
TMT ratio 64 2.25 (0.79) 0.71–4.14 n/a 
CWI inhibit/switch (seconds) 64 84.61 (29.68) 39–180 –180s 
CWI inhibit/switch (scaled) 64 9.55 (3.37) 1–15 1–19 
BRIEF-A Self 61 107.26 (19.62) 71–177 70–210 
BRIEF-A Caregiver 47 97.87 (23.26) 70–166 70–210 
M – Mean; SD – Standard deviation; QoL – Quality of Life; PDQ-39 – Parkinson’s disease 
Questionnaire - 39; ACE-R – The Addenbrooke’s Cognitive Examination - Revised; HADS – 
Hospital Anxiety and Depression Scale; TMT ratio– Trail Making Test (D-KEFS), TMT-
Switching/TMT- Numbers; CWI – Color Word Interference (D-KEFS); BRIEF-A Self – BRIEF-A 
Global Executive Composite Self-rating (raw score); BRIEF-A Caregiver – BRIEF-A Global 
Executive Composite Caregiver rating (raw score) 
 
The three QoL domains were strongly correlated with each other, and health status 
was related to QoL–Movement Disorders and QoL–Health but not to QoL-Life. Caregiver 
burden was not related to QoL domains or health status. Details of the bivariate correlations 
are presented in Table 5.3. 
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Table 5.3. Pearson’s correlation coefficients for quality of life, health status and caregiver 
burden, and other study variables. 
 
QoL-Life QoL-Health 
QoL-
Movement 
Disorders 
Health status 
(PDQ-39) 
Caregiver 
burden 
(CBI) 
QoL Health .693***     
QoL MD .441*** .709***    
Health status (PDQ-39) -.207 -.521*** -.625***   
Caregiver burden (CBI) .001 -.240 -.316 .398*  
Age -.076 .125 -.160 -.078 .036 
Hoehn and Yahr stage -.068 .062 .075 .014 .413* 
HADS-Depression -.453*** -.492*** -.377** .403** .453** 
ACE-R -.028 -.175 -.021 .156 -.314* 
NART-estimated IQ -.269* -.174 -.147 .092 -.205 
TMT ratio .026 .144 .158 -.174 -.144 
CWI inhibit/switch (scaled) .108 .105 .034 -.055 -.416** 
BRIEF-A Self -.254 -.351** -.441*** .586*** .282 
BRIEF-A Caregiver -.163 -.447** -.466** .368* .723*** 
Note. Bold indicates significance after Holm-Bonferroni correction for multiple comparison p 
= .05/65 = 0.00077. 
QoL – Quality of Life; PDQ-39 – Parkinson’s disease Questionnaire - 39; HADS – Hospital 
Anxiety and Depression Scale; ACE-R – The Addenbrooke’s Cognitive Examination - Revised; 
TMT ratio– Trail Making Test (D-KEFS), TMT-Switching /TMT-Numbers; CWI – Color Word 
Interference (D-KEFS); BRIEF-A Self – BRIEF-A Global Executive Composite Self-rating (raw 
score); BRIEF-A Caregiver – BRIEF-A Global Executive Composite Caregiver rating (raw score) 
* Correlation is significant at the 0.05 level (2-tailed).  
** Correlation is significant at the 0.01 level (2-tailed).  
*** Correlation is significant at the 0.001 level (2-tailed).  
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Prior to the multiple regression analyses the data were checked against assumptions 
for multilinear regression (Field, 2005). To control for collinearity problems, scales that were 
highly correlated with others were removed when possible. Decisions were made as follows. 
The H&Y score was included, as a more direct indication of PD severity than LED and PD 
duration. The HADS Depression scale was included rather than HADS Anxiety as the variable 
of primary interest, based on previous studies (Den Oudsten et al., 2007a). To control for a 
strong age effect in CWI inhibition/switching, the scaled score was used.  
Multiple regression analyses were performed for the following dependent variables: 
QoL–Life, QoL–Health, QoL–Movement Disorders, PDQ-39 (health status) and the Caregiver 
Burden Inventory. The following independent variables were included: HADS-Depression; 
ACE-R (general cognition); CWI inhibition/switching scaled score and TMT ratio (executive 
functions); self- and caregiver ratings of BRIEF-A (EF-related behavioural difficulties); and 
H&Y stage (PD severity). The models that were statistically significant and accounted for the 
greatest variance (adjusted R2) were selected in each case, and these are summarised in 
Table 5.4.  
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Table 5.4. Results summary for the backward regression analyses. 
R2 adj – R2 adjusted  β – standardized coefficient; QoL – Quality of Life; PDQ-39 – Parkinson’s 
disease Questionnaire - 39; HADS – Hospital Anxiety and Depression Scale; ACE-R – The 
Addenbrooke’s Cognitive Examination - Revised; TMT ratio – Trail Making Test (D-KEFS), 
TMT-Switching /TMT-Numbers; CWI – Color Word Interference (D-KEFS); BRIEF-A Self – 
BRIEF-A Global Executive Composite Self-rating (raw score); BRIEF-A Caregiver – BRIEF-A 
Global Executive Composite Caregiver rating (raw score) 
 
The depression rating was the strongest and the only individually significant 
predictor of QoL-Life. The model explained 23% of the variance in QoL-Life. 
The BRIEF-A caregiver rating was the strongest and the only individually significant 
predictor of QoL-Health, while the depression rating only approached significance. The 
model explained 32% of the variance in QoL-Health. 
 
QoL–Life QoL–Health 
QoL–
Movement 
Disorders 
Health 
status 
(PDQ-39) 
Caregiver 
burden 
R2 .279 .393 .364 .388 .736 
R2 adj .225 .323 .262 .343 .661 
F 5.22 5.61 3.57 8.55 9.76 
p .012 .004 .019 .001 .000 
Predictors β p β p β p β p β p 
Age     -.173 .290     
H&Y         .377 .008 
HADS-D -.454 .010 -.330 .061 -.203 .262   .204 .151 
ACE-R         -.168 .188 
NART IQ -.271 .109 -.294 .080 -.282 .107   .224 .113 
TMT ratio       -.211 .172   
CWI inhibit/ 
switch (scaled) 
          
BRIEF-A Self       .599 .000 -.230 .148 
BRIEF-A 
Caregiver 
  -.400 .032 -.468 .018   .754 .000 
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The BRIEF-A caregiver rating was the strongest and the only individually significant 
predictor of QoL-Movement Disorders. The model explained 26% of the variance in QoL-
Movement Disorders. 
The BRIEF-A self-rating was the strongest and the only individually significant 
predictor of health status. The model explained 34% of the variance in health status. 
The BRIEF-A caregiver rating and PD-stage were the strongest and the only two 
individually significant predictors of caregiver burden. The model explained 66% of the 
variance in caregiver burden. 
5.5 Discussion 
The present study has addressed the complex variety of factors influencing quality of life 
and health status in PwPD, and the burden associated with caring for PwPD. The findings 
show that behavioural problems related to executive functioning, as indicated by the BRIEF-
A rating, contribute to QoL and health status in PwPD and to burden in caregivers of PwPD.  
Depression was the only individually significant predictor of QoL in the General Life 
domain in PwPD. This is in line with the study by Lee et al. (2006), where depression was the 
only predictor of subjective QoL in PwPD, while disease severity was not included in the 
model. That suggests that there is no straightforward relationship between general QoL and 
health, as has been reported in other conditions, particularly in cancer research (Foley et al., 
2006; Sodergren & Hyland, 2000; Thornton, 2002).  
The best predictor of QoL in both the general health and the movement disorders 
domains was executive functioning, as rated by the caregiver on the BRIEF-A questionnaire. 
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As far as can be determined, this is the first study suggesting that EF-related behavioural 
problems may impact on QoL related to health in PD.  
Consistent with other studies reporting a close relationship between health status 
and depression in PD (Den Oudsten et al., 2007a; Soh et al., 2011), we observed a strong 
relationship between depression and health status in the correlational analysis. However, 
depression was not included in the regression model. The only individually significant 
predictor included in the regression model of health status was BRIEF-A self-rating, which 
indicates EF-related behavioural problems, as perceived by PwPD themselves.  
Standard tests of EF were not included in any of the regression models, which might 
reflect the generally low ecological validity of such tests and the limited relationship 
between EF test scores and everyday functioning (Goldberg & Podell, 2000). The BRIEF-A 
questionnaire was developed specifically to address this limitation of standard EF tests, and 
it is therefore not surprising to see BRIEF-A ratings and not standard EF tests emerging as 
relevant for QoL and subjective health status (Koerts et al., 2012; Manchester et al., 2004). 
There are several possible explanations for the observed relationship between QoL, 
health status and executive functioning. One explanation might be that QoL in health 
domains is affected by the caregiver’s critical perception of the PwPD (illustrated by a low 
BRIEF-A rating) rather than executive deficits. However, the lack of such relationship in the 
general life domain, and the non-significant relationships between QoL and health status, 
and caregiver burden, make this explanation less plausible.  
Another possible explanation for the relationship between QoL, health status and EF 
is that particular EF-related difficulties (e.g. poor planning or problems with prioritising 
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activities) and behavioural disturbances hinder everyday functioning and impact directly on 
QoL (Leroi et al., 2011). Alternatively, difficulties in regulating behaviour and emotions, and 
solving problems, as indicated by low BRIEF-A ratings, may influence QoL indirectly, 
resulting in less effective use of strategies to overcome PD-related limitations or less 
effective coping with the psychological consequences of the illness (Frazier, 2000; Montel, 
Bonnet, & Bungener, 2009; Sanders-Dewy, Mullins, & Chaney, 2001). Adequate behavioural, 
cognitive, and affective processes (e.g. positive reappraisal, reordering goals or adjusting 
expectations) may help in adjusting to the illness and sustaining good QoL despite physical 
problems (Sprangers & Schwartz, 1999). These mechanisms can be seen as coping or self-
regulation strategies, and might rely on EF (Baumeister & Vohs, 2003). The role of EF in 
coping has not been specifically assessed in PD, but there is some evidence that the use of 
specific coping strategies may be related to general cognition in PwPD (Hurt et al., 2012). 
Moreover, coping styles are related to EF in other patient groups, for example in people 
with traumatic brain injury (Krpan et al., 2007), multiple sclerosis (Goretti et al., 2010), and 
schizophrenia (Wilder-Willis, Shear, Steffen, & Borkin, 2002). 
Interestingly, the regression model for caregiver burden explained a large proportion 
of the variance, despite including only patient-related variables. In line with other studies 
investigating caregiver burden in PD, the regression model included disease severity (Cifu et 
al., 2006; D’Amelio et al., 2009; Martínez-Martín et al., 2007; Schrag et al., 2006). However, 
the strongest individually significant predictor of caregiver burden in our study was 
caregiver-rated behavioural problems related to EF. As far as can be determined, this is the 
first study to demonstrate such a relationship in PD. EF deficits have been reported to 
specifically impact on caregiver burden in dementia (Davis & Tremont, 2007; Rymer et al., 
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2002). It is particularly interesting to observe such a relationship in people in mild to 
moderate stages of PD, where only a limited amount of care would be required with regard 
to physical symptoms.  
Health status was not related to general QoL, and was predicted by variables 
different to those included in the models for QoL domains. These findings support the view 
that the concepts of subjective QoL and self-assessed health status are only partially related 
and should not be seen as identical (Foley et al., 2006; Sodergren & Hyland, 2000; Sprangers 
& Schwartz, 1999; Thornton, 2002). 
5.5.1 Limitations 
Some limitations need to be taken into account when interpreting these results. Our 
study employed a relatively small sample and the results of our analyses need to be 
validated in a larger study. The BRIEF-A has been used in many clinical groups, including 
Alzheimer’s and MCI (Roth et al., 2005), but as far as can be determined it has not been 
employed in PD studies. Models of QoL domains and health status accounted for a modest 
proportion of the variance, and a broader range of variables may need to be considered, for 
example apathy, quality of relationship and activities of daily living, alongside a more 
comprehensive assessment of EF. Including more caregiver-related variables may also help 
to produce a more comprehensive model. In the present sample the average level of 
depression was relatively low and this might account for a less extensive impact of 
depression on the constructs we evaluated. The Hoehn and Yahr classification of PD severity 
is widely used, but a more detailed disease characterisation might give a better insight into 
how physical difficulties influence QoL and health status in PD.  
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5.5.2 Conclusions 
In summary, the study suggests that EF-related difficulties may influence QoL and health 
status in PwPD, as well as the burden associated with caring for PwPD. The results support 
the view that assessing QoL and health status separately is relevant to understanding how 
PwPD perceive the impact of PD on their life. Further research is needed to clarify the 
mechanisms whereby executive deficits affect QoL and health status in PD, and to inform 
development of adequate strategies to reduce the impact of EF deficits on PwPD and 
caregivers. Addressing difficulties related to EF offers the potential to improve QoL in PwPD 
(National Collaborating Centre for Chronic Conditions, 2006; Van der Eijk, Faber, Al Shamma, 
Munneke, & Bloem, 2011), which should be the overall aim of high-quality person-centred 
healthcare. 
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6.1 Abstract 
Background: Executive functioning is frequently impaired among people with Parkinson’s 
disease (PD). Little is known about awareness of executive functioning, in the sense of being 
able to accurately appraise functioning or performance, in people with PD, or about 
whether awareness is particularly affected in those who have impaired executive 
functioning.  
Method: This study explored awareness of executive functioning at the levels of evaluative 
judgment (comparison of self- and informant ratings of executive functioning), and 
performance monitoring (comparison of performance on cognitive tests and self-ratings of 
that performance). Awareness levels were assessed in people with PD with and without 
executive deficits, and in healthy controls.  
Results: When the level of agreement between self- and informant ratings was considered, 
people with PD in both groups appeared as accurate in evaluating their overall executive 
functioning as healthy controls. When appraising their performance as the specific tasks 
were completed, people with PD who had impairments in executive functioning appeared 
less accurate than controls and people with PD without executive impairments.  
Conclusions: People with PD who have executive deficits may lack the ability to recognise 
their limitations while performing specific tasks, which may have implications for their 
functional abilities. 
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6.2 Introduction 
Inaccurate appraisal of one’s condition and its consequences, which may be referred to in 
terms of reduced awareness, insight, metacognition, anosognosia or denial, is frequently 
reported in conditions involving cognitive impairment, such as dementia, or following brain 
injury or stroke, where it may interfere with treatment, add to carer burden and lead to 
problem escalation (Aalten, van Valen, Clare, Kenny, & Verhey, 2005; Nelis et al., 2011). 
Inaccurate self-appraisal may be observed in healthy people, and may be related to 
psychosocial factors (Clare et al., 2012), but is most commonly seen as a consequence of 
brain lesions (in particular where the prefrontal cortex is involved) and is often associated 
with impairment in executive functions (EF) (Bramham, Morris, Hornak, Bullock, & Polkey, 
2009; Stuss, Picton, & Alexander, 2001; Wheeler, Stuss, & Tulving, 1997). 
Frontal lobe functions involved in the performance of executive tasks are frequently 
compromised in Parkinson’s disease (PD) as dopamine depletion in the striatum causes a 
disruption of frontostriatal networks. This affects the motor loop (connecting the putamen 
and the supplementary motor area), as well as the cognitive loop (connecting the 
dorsolateral prefrontal cortex and the dorsal caudate nucleus, associated with executive 
deficits) (Cools, Stefanova, Barker, Robbins, & Owen, 2002; Leh et al., 2010). A significant 
proportion of people diagnosed with PD (PwPD) experience cognitive decline, particularly in 
EF, that may impact negatively upon quality of life (Klepac et al., 2008; Schrag et al., 2000) 
and activities of daily living (Cahn et al., 1998). Little is known about the extent of awareness 
of cognitive problems shown by PwPD. Lack of awareness might mean that impairments are 
unrecognised by PwPD and not reported to the clinician, with possible implications for 
treatment outcomes (Koerts et al., 2012). 
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Executive deficits and poor awareness of one’s own limitations may impact on various 
aspects of everyday life in PD, including driving (Devos et al., 2007; Rizzo et al., 2010; 
Stolwyk, Charlton, Triggs, Iansek, & Bradshaw, 2006; Uc et al., 2007) and adherence to 
medication regimes (Grosset, Bone, & Grosset, 2005; Grosset et al., 2006; Kulkarni et al., 
2008; Leopold, Polansky, & Hurka, 2004). Where the view of cognitive functioning held by 
the PwPD is discrepant from that held by the carer, there may be particular stresses in the 
caregiving relationship. Understanding how cognitive problems are perceived by both the 
PwPD and the carer is therefore crucial for providing appropriate support. 
The Levels of Awareness Framework proposed by Clare, Marková, Roth, and Morris 
(2011) describes awareness in terms of dynamic perceptual and appraisal processes 
operating at various levels: sensory registration, performance monitoring, evaluative 
judgment and meta-representation. Sensory registration relates to core consciousness and 
attentional processes; performance monitoring reflects an immediate judgement about 
performance on a specific task as it is completed; evaluative judgement refers to more 
general judgements about functioning in a particular area; and meta-representation is a 
complex reflection on the situation, which integrates individual knowledge, emotions and 
attitudes. The phenomena of awareness elicited at each level are different. They may be 
influenced by a number of internal (e.g. mood, personality) and external (e.g. social norms, 
carer responses) factors, and are additionally shaped by the object in relation to which 
awareness is assessed (e.g. cognitive deficits or the experience of illness and its 
implications); hence they are not directly comparable. To understand the implications of 
someone’s level of awareness for everyday functioning, it is useful to know how accurately 
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the individual perceives his/her overall cognitive functioning and appraises his/her 
performance in particular tasks. 
Studies of awareness in PD to date have focused exclusively on the evaluative 
judgement level, with informant ratings being used as a benchmark against which self-
ratings are compared, and less frequent comparisons to objective measures. Only a few 
studies have directly explored awareness of cognitive problems in PwPD; Seltzer et al. 
(2001) and Sitek, Soltan, et al. (2011) reported good agreement between self- and informant 
ratings of general cognition and of memory, respectively. Ivory et al. (1999) analysed the 
accuracy of evaluative judgments about memory and attention by correlating performance 
on three cognitive tests with responses on a metamemory questionnaire. Only one out of 11 
correlations was significant, suggesting limited accuracy of evaluative judgment in PwPD. 
While the above studies have investigated awareness of cognitive functions in PD, they did 
not focus specifically on EF. It would be particularly relevant to focus on awareness in 
relation to EF, as this is the cognitive domain commonly impaired in PwPD (Kudlicka et al., 
2011; Muslimovic et al., 2007). 
Three studies which did not refer directly to awareness have explored evaluative 
judgment of EF in PwPD by comparing self- and informant questionnaire-based ratings. In 
McKinlay, Grace, et al. (2008) PwPD reported more difficulties than their carers, while 
Koerts et al. (2012) and Mathias (2003) revealed good agreement between ratings. The 
inconsistency might be related to differences in cognitive status in the study samples. Poor 
awareness is commonly described in relation to executive deficits (Stuss et al., 2001), and 
studying awareness in PwPD without distinguishing those with actual executive deficits may 
produce mixed findings. The observed inaccuracies might be clarified by establishing how 
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the awareness level in PwPD compares to awareness in a similar but healthy population. 
There are two studies on executive and neurobehavioural functioning that examined self- 
and informant ratings in PwPD and controls (Koerts et al., 2012; Mathias, 2003), but without 
direct comparison of the actual level of agreement between participants and informants. 
In summary, studies on awareness in PD have only considered the level of evaluative 
judgement, have rarely investigated awareness in relation to well-specified EF impairment, 
and have not compared awareness levels in PD and healthy controls. The present study 
aimed to address these issues by distinguishing PwPD with and without EF impairments, and 
by comparing their performance to healthy controls. Awareness phenomena were 
examined in relation to the two levels of evaluative judgement and performance 
monitoring. The following research questions were addressed:  
1. How accurate are PwPD with and without EF impairments in assessing their overall 
executive functioning and performance in a given task, in comparison to controls?  
2.  What are the correlates of awareness in PwPD? 
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6.3 Method 
6.3.1 Design 
The study employed a cross-sectional design comparing PwPD with and without EF deficits, 
and healthy controls. Awareness of EF was assessed at the two levels of evaluative 
judgement and performance monitoring. In relation to evaluative judgment, awareness was 
assessed as follows: a) discrepancy between self- and informant ratings on a questionnaire 
evaluating executive functioning (BRIEF-A; Roth et al., 2005); b) relationship between BRIEF-
A ratings and EF test performance. In relation to performance monitoring, awareness was 
assessed through comparison of test performance on two EF tests (Trail Making Test and 
Colour Word Interference; Delis et al., 2001) with self-ratings of that performance, made 
immediately after the tasks had been completed. As described in Chapter 1, ethical approval 
was granted by the relevant University and National Health Service ethics committees and 
written informed consent was obtained from all participants. 
6.3.2 Participants  
The same sample as that reported in previous chapters and the same inclusion/exclusion 
criteria were used. People with Parkinson’s disease, recruited from local Movement 
Disorders clinics, were diagnosed according to the UKPDS Brain Bank criteria (Daniel & Lees, 
1993), and were in the mild to moderate stages of the disease (Hoehn & Yahr, 1967). They 
had normal general cognition, as indicated by an Addenbrooke’s Cognitive Examination – 
Revised (ACE-R) score ≥ 82 (Mioshi et al., 2006) and an MMSE score ≥ 24 (Folstein et al., 
1975), and no significant depression, as indicated by a Hospital Anxiety and Depression 
Scale depression score ≤ 11 (Snaith & Zigmond, 1994). Controls were recruited from various 
community sources (e.g. over-50s clubs, University of the Third Age branches, church 
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groups), had normal general cognition, as indicated by an ACE-R score ≥ 82 (Mioshi et al., 
2006) and an MMSE score ≥ 24 (Folstein et al., 1975), and no significant depression, as 
indicated by a Geriatric Depression Scale (GDS-15) score ≤ 5 (Burke et al., 1991; Sheikh & 
Yesavage, 1986). Informant ratings were provided by people who knew the participants very 
well (e.g. spouses, adult children or close friends). All participants were fluent in English and 
had adequate eyesight and hearing. 
6.3.3 Measures 
The following measures from the wide database were used in this analysis. 
Cognitive screening  
The Addenbrooke’s Cognitive Examination Revised (ACE-R; Mioshi et al., 2006) assesses five 
cognitive domains: attention and orientation, memory, verbal fluency, language and 
visuospatial abilities. The maximum total score of 100 indicates error-free performance. The 
ACE-R also provides an MMSE score (Folstein et al., 1975). 
Executive functions  
The Trail Making Test (TMT) of the Delis-Kaplan Executive Function System (D-KEFS; Delis et 
al., 2001) consists of five visual-motor tasks assessing basic visuospatial and motor skills 
(TMT 1, 2, 3, and 5), and flexibility in thinking (TMT 4), which is regarded as one of the core 
EF abilities (Royall et al., 2002). In TMT 1 participants cross out all instances of the number 3 
on a sheet of paper. In the following three conditions participants draw a line connecting 
numbers (TMT 2), letters (TMT 3) or numbers and letters in alternating sequence (TMT 4) in 
ascending order. In TMT 5 participants draw a line connecting circles in the indicated order. 
Greater time to complete each task indicates poorer performance. A ratio score TMT 4/TMT 
2 is suggested as the most accurate index of EF that differentiates EF from visuospatial and 
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motor abilities (equivalent to TMT B/TMT A in a widely used version of the TMT) 
(Arbuthnott & Frank, 2000; Delis et al., 2001). Raw scores for each condition (in seconds) are 
converted to age-scaled scores (M = 10, SD = 3).  For the purposes of this study, the age-
scaled scores were classified into five bands: impaired (≤ 5), below average (6-8), average 
range (9-11), above average (12-14) and superior (≥15). The five bands formed a five-point 
scale (1 to 5) with lower scores indicating worse test performance. The scale was used for 
comparing test performance with self-appraisal of that performance (as reported in Martyr 
et al., 2012). See details in the ‘Planned analyses’ section below. 
The Color-Word Interference test (CWI) of the D-KEFS (Delis et al., 2001) assesses 
inhibition and flexibility in thinking. There are two baseline conditions (naming the ink 
colour of colour patches – CWI 1, and reading a list of colour names in black ink – CWI 2), 
and two higher-level conditions, naming the dissonant ink colour instead of reading the 
colour name (CWI 3, inhibition; the traditional Stroop task), and switching between naming 
the dissonant ink colour and reading the word (CWI 4, inhibition and flexibility in thinking). 
As in the TMT, raw scores (time to complete the task) are converted to age-scaled scores. 
For the purposes of this study, scores were then classified into five bands. PwPD completed 
both the TMT and the CWI, and controls completed the TMT only. 
EF-related behavioural problems  
The Behavior Rating Inventory of Executive Function – Adult Version (BRIEF-A; Delis et al., 
2001) provides information about executive functioning (self-regulation skills) in the 
everyday environment, as rated by participants and informants in two parallel 
questionnaires (self and informant versions). Using a 3-point scale (never, sometimes, often; 
scored 1, 2, 3 respectively) participants indicate which of the 75 behaviours described have 
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been a problem during the past month. Higher Global Executive Composite scores (GEC, 
range 70-210) indicate more reported problems in regulating behaviour and emotional 
responses, distributing and sustaining attention, and solving problems. The GEC scores are 
converted to age-scaled T scores (M = 50, SD = 10), which indicate whether the reported 
level of difficulty suggests clinically significant problems in EF (T ≥ 65, 1.5 SD above the 
mean).  
Premorbid IQ 
The National Adult Reading Test (NART; Nelson & Willison, 1991) estimates lifelong 
intellectual ability. Participants read aloud 50 phonetically irregular words. The number of 
words pronounced incorrectly is converted into an estimated IQ score, with more errors 
producing a lower estimated IQ score.  
Mood 
PwPD completed the Hospital Anxiety and Depression Scale (HADS; Snaith & Zigmond, 
1994), a self-rating questionnaire assessing levels of depression and anxiety, validated for 
use in PD (Schrag et al., 2007). The 14 questions form two subscales: HADS-Anxiety and 
HADS-Depression. Higher scores indicate higher levels of self-rated anxiety/depression. This 
study adopted the cut-off of 11 that has been suggested for depression screening purposes 
(Crawford et al., 2001). Healthy controls completed the Geriatric Depression Scale (GDS-15; 
Sheikh & Yesavage, 1986) (Appendix J), a 15-item scale assessing levels of depression, with 
higher scores indicating higher levels of self-rated depression. The study adopted the cut-off 
of ≤ 5 recommended for depression screening (Burke et al., 1991). 
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Caregiver Burden 
Informants of the PwPD completed the Caregiver Burden Inventory (CBI; Novak & Guest, 
1989), a 24-item questionnaire describing caregivers’ feelings about and responses to the 
burden of care. The maximum score of 96 indicates the highest levels of caregiver stress. 
6.3.4 Procedure and data collection 
The majority of participants were visited at home; six PwPD and nine controls chose to meet 
at the University. PwPD were assessed during their ‘on’ phase. The assessment took 
between 1.5 and 3h and was part of a wider study, which included some measures not 
reported here. Some participants completed the assessment over two shorter visits and 
some opting to send the self-completion questionnaires by post. 
6.3.5 Planned analysis 
Prior to analysis the normality of distributions and the homogeneity of variance were 
assessed (using the Shapiro-Wilk test and a Q-Q plots, and the Leven test, respectively), and 
non-parametric statistics were employed where appropriate. 
Evaluative judgment analysis 
Self- versus informant rating of executive functioning. The level of agreement between 
self- and informant ratings was calculated for the BRIEF-A summary score (GEC) in the form 
of a Corrected Discrepancy score, which is a rigorous measure correcting for between-
subject differences in actual level of scoring (Clare, Whitaker, & Nelis, 2010). The corrected 
discrepancy score was calculated by subtracting the self-rating from the informant rating 
(BRIEF-A Informant raw score – BRIEF-A Self raw score) and dividing the difference by the 
mean value of the two ratings [(BRIEF-A Informant + BRIEF-A Self)/2]. The possible range of 
corrected discrepancy scores is -1 to 1, with positive values indicating that self-rating is 
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more positive than informant rating (taken to indicate an overestimation of executive 
functioning ability), and negative values indicating that self-rating is less positive than 
informant rating (taken to indicate an underestimation). Discrepancy scores close to 0 
indicate close agreement. The discrepancy scores in the three study groups were compared 
using one-way ANOVA and Bonferroni post-hoc analysis. BRIEF-A summary scores were 
compared using the Kruskal-Wallis test, and self- and informant ratings within each group 
were compared using the Wilcoxon Signed Ranks test. 
Evaluative judgment of executive functioning versus EF test performance. Correlational 
analyses (Spearman’s Rho) examined the relationship between performance on executive 
tests (TMT 4, CWI 3, and CWI 4; raw scores) and the overall judgment of executive 
functioning (BRIEF-A score), separately for PwPD with and without executive deficits. 
Performance monitoring analysis 
Awareness at the performance monitoring level was established by calculating Performance 
Ratios – the self-evaluation of test performance divided by the test performance band 
score, for each TMT and CWI condition. 
Participants evaluated their performance on TMT and CWI immediately after a task 
was completed, using a 5-point scale: very poor, poor, alright, good, or very good (scored 1 
to 5, respectively) (Appendix K). PwPD and controls rated their performance on each TMT 
condition and PwPD also rated their performance on CWI. Test performance on each 
condition was classified into one of five bands, based on the age-scaled scores: impaired, 
below average, average, above average and superior. This formed a five-point scale (1 to 5) 
with lower scores indicating worse test performance (as reported in Martyr et al., 2012). 
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A Performance Ratio score of 1 indicates perfect agreement between test 
performance and self-appraisal of that performance; values above 1 suggest overestimation 
of actual performance, and values below 1 indicate underestimation. As the interpretation 
of the scaled scores of EF tests in terms of the five self-appraisal categories is somewhat 
arbitrary, the actual values of the ratio need to be interpreted with caution. In contrast, the 
group comparison of the ratios provides an objective indication of whether PwPD are as 
accurate as healthy controls in self-appraising their task performance. Performance ratios 
were logarithmically transformed to ensure a more symmetrical distribution for statistical 
analysis (Trosset & Kaszniak, 1996) and averaged to provide summary indices separately for 
TMT and CWI (Mean Performance Ratios). Performance ratios in the three study groups 
(PwPD with and without executive impairment, and the control group) were compared 
using one-way ANOVA and Bonferroni or Games-Howell post-hoc analysis. 
The relationships between the indicators of awareness (BRIEF-A Discrepancy Scores 
and Mean Performance Ratios) and other variables of interest were explored using 
correlational analyses (Spearman’s Rho). 
6.4 Results 
6.4.1 Participants 
Sixty-five PwPD and 43 controls were included in the study. One person was excluded from 
the PwPD group due to severe hearing difficulties and one control participant aged 94 was 
excluded as there are no normative data for the D-KEFS tests and BRIEF-A for people over 
90. One-way ANOVA found no significant differences between controls and PwPD with 
regard to age (t(106) = -1.23, p = .220), years of education (t(106) = -1.91, p = .059), NART-
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estimated IQ (t(106) = 1.18, p = .240) or general cognition (as indicated by ACE-R, t(106) = 
1.17, p = .243). See Table 6.1 for demographic characteristics. 
PwPD were allocated to one of two groups on the basis of their performance on EF 
tests: PwPD with normal performance on all three EF tests (TMT 4, CWI 3, and CWI 4) were 
allocated to the group with normal EF (PwPD_EF+), and PwPD who had impaired 
performance on one or more of the above tests (scaled score ≤ 5, 1.5 SD below the mean) 
were allocated to the group with EF deficits (PwPD_EF-). Two participants who did not 
complete CWI (due to colour blindness) or TMT (due to difficulties with the alphabet) were 
allocated to PwPD_EF+ on the basis of their normal performance on the other tests. 
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Table 6.1. Demographic characteristics of the study groups. 
 PwPD (n=65) PwPD_EF- (n=23) PwPD_EF+ (n=42) Control (n=43) 
 M (SD) Range M (SD) Range M (SD) Range M (SD) Range 
Age  70.11 (8.92) 48-89 72.91(7.25) 57-86 68.57 (9.44) 48-89 72.02 (6.05) 63-86 
Education (years) 12.97 (2.98) 5-20 12.41(2.78) 8-18.5 13.27 (3.07) 5-20 13.98 (2.15) 10-16 
NART-estimated IQ 113.77 (8.04)1 92-128 113.09 (9.13) 92-127 114.15 (7.45)1 98-128 111.63 (10.65) 79-126 
MMSE 29.48 (0.92) 25-30 29.30 (0.88) 27-30 29.57 (0.41) 25-30 28.63 (1.02) 26-30 
ACE-R Total 93.83 (4.41) 82-100 91.61 (4.65) 82-100 95.05(3.80) 88-100 92.86 (3.87) 82-99 
     Attention/orientation 17.91 (0.34) 16-18 17.91 (0.29) 17-18 17.90 (0.37) 16-18 17.88 (0.32) 17-18 
     Memory 23.91 (2.32) 15-26 23.00 (2.86) 15-26 24.40 (1.81) 18-26 23.70 (1.97) 18-26 
     Verbal fluency 11.58 (2.16) 4-14 10.87 (2.49) 4-14 11.98 (1.88) 7-14 11.35 (2.24) 6-14 
     Language 25.29 (1.05) 22-26 24.87 (1.25) 22-26 25.52 (0.86) 23-26 24.56 (1.37) 21-26 
     Visuospatial abilities 15.14 (1.06) 12-16 14.96 (0.98) 13-16 15.24 (1.10) 12-16 15.37 (0.85) 13-16 
HADS-Depression 4.43 (2.51) 0-10 4.74 (2.65) 1-10 4.26 (2.44) 1-10   
HADS-Anxiety 5.42 (3.52) 1-16 5.35 (3.94) 1-16 5.45 (3.31) 1-14   
GDS       1.51 (1.59) 0-5 
(Table 6.1 continues)  
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(Table 6.1 continued) 
 PwPD (n=65) PwPD_EF- (n=23) PwPD_EF+ (n=42) Control (n=43) 
 n (%) n (%) n (%) n (%) 
Gender  (Male) 30 (46.2) 10 (43.5) 20 (47.6) 18 (41.9) 
   IQ Below average (<90) 0 0 0 1 (2.3) 
   IQ Average (90-100) 20 (30.8) 6 (26.1) 14 (33.3) 16 (37.2) 
   IQ Above average (>110) 45 (69.2) 17 (73.9) 28 (66.7) 26 (60.5) 
Socio-economical status     
    I Professional 10 (15.4) 2 (8.7) 8 (19.0) 9 (20.9) 
    II Managerial/technical  28 (43.1) 13 (56.5) 15 (35.7) 20 (46.5) 
    III N Skilled, non-manual 13 (20.0) 4 (17.4) 9 (21.4) 10 (23.3) 
    III M Skilled, manual 11 (16.9) 1 (4.3) 10 (23.8) 2 (4.7) 
    IV Partly skilled 3 (4.6) 3 (13.0) 0 1 (2.3) 
    V Unskilled 0 0 0 1 (2.3) 
Relationship with informant     
    Spouse/Partner 45 (69.2) 17 (73.9) 28 (66.7) 34 (79.1) 
    Parent/Child 3 (4.6) 1 (4.3) 2 (4.8) 3 (7.0) 
    Other family member 0 0 0 2 (4.7) 
    Friend 2 (3.1) 1 (4.3) 1 (2.4) 3 (7.0) 
    No informant 15 (23.1) 4 (17.4) 11 (26.2) 1 (2.3) 
PwPD_EF- – PwPD with EF deficits; PwPD_EF+ –  PwPD with normal EF; M – Mean; SD – Standard deviation; ACE-R – The Addenbrooke’s 
Cognitive Examination - Revised; HADS – Hospital Anxiety and Depression Scale; GDS – Geriatric Depression Scale; 1n=64 in PwPD and n=41 in 
PwPD_EF+ 
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One-way ANOVA found no significant differences between the control group, 
PwPD_EF+ and PwPD_EF- in age (F(2,105) = 3.11, p = .049, not significant in post-hoc 
analysis), years of education (F(2,105) = 2.60, p = .079) or NART-estimated IQ (F(2,105) = 
0.79, p = .457). There was a significant group difference in general cognition (ACE-R, F(2,105) 
= 6.19, p = .003; PwPD_EF-, controls < PwPD_EF+, significant at p < .05 in post-hoc analysis). 
The comparison of ACE-R subscales indicated no group effect for Attention and orientation, 
Verbal fluency and Visuospatial abilities. There was a significant group effect for Memory 
(F(2,105) = 3.35, p = .039;  not significant in post-hoc analysis) and for Language (F(2,105) = 
7.42, p = .001;  PwPD_EF-, controls < PwPD_EF+ significant at p < .001 in post-hoc analysis.  
PwPD_EF+ and PwPD_EF- were similar in terms of disease duration (t(33.99) = 1.07, p = 
.294) and the Total Daily Levodopa Equivalent Dose (t(62) = 1.11, p = 270), as indicated by 
an independent-samples t-test. See Table 6.2 for detailed PD characteristics. 
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Table 6.2. Disease characteristics and EF test performance in PwPD groups. 
 PwPD PwPD_EF- PwPD_EF+ 
 n M (SD) Range n M (SD) Range n M (SD) Range 
PD duration (months)1 65 71.97 (50.42) 7-216 23 81.93 (61.60) 7-216 42 66.51 (42.96) 11-180 
LED2 64 579.19 (556.35) 0-3125 22 685.84 (690.38) 0-3125 41 523.32 (471.36) 0-2145.75 
H&Y 59 1.34 (0.57) 1-3 18 1.53 (0.55) 1-2.5 41 1.33 (0.57) 1-3 
CBI 42 12.45 (10.55) 0-46 18 17.61 (10.38) 5-46 24 8.58 (9.08) 0-39 
TMT4 (scaled)3 64 8.77 (4.62) 1-15 23 4.04 (4.00) 1-13 41 11.41 2.18) 7-15 
CWI3 (scaled) 64 10.14 (3.74) 1-15 23 7.13 (4.33) 1-14 41 11.83 (1.89) 7-15 
CWI4 (scaled) 64 9.55 (3.47) 1-15 23 6.61 (3.38) 1-12 41 11.20 2.22) 6-15 
(Table 6.2 continues)  
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(Table 6.2 continued) 
 PwPD PwPD_EF- PwPD_EF+ 
 n (%) n (%) n (%) 
PD Medication    
Levodopa 39 (60.0) 18 (78.3) 21 (50.0) 
Dopamine agonists 40 (61.5) 11 (47.8) 29 (69.0) 
Rasagiline 33 (50.8) 10 (43.5) 23 (54.8) 
Entacapone 11 (16.9) 4 (17.4) 7 (16.7) 
Amantadine 4 (6.2) 3 (13.0) 1 (2.4) 
Apomorphine 1 (1.5) 1 (4.3) 0 
None 3 (4.6) 1 (4.3) 2 (4.8) 
Hoehn and Yahr4:     
Stage I 41 (63.1) 9 (39.1) 32 (76.2) 
Stage II 16 (24.6) 9 (39.1) 7 (16.7) 
Stage III 2 (3.1) 0 2 (4.8) 
Side of onset:      
Left 24 (36.9) 9 (39.1) 15 (35.7) 
Right 31 (47.7) 9 (39.1) 22 (52.4) 
Bilateral 10 (15.4) 5 (21.7) 5 (11.9) 
PwPD_EF- – PwPD with EF deficits; PwPD_EF+ –  PwPD with normal EF; M – Mean; SD – Standard deviation; TMT – Trail Making Test (D-KEFS); 
CWI – Color Word Interference (D-KEFS); LED – Total Daily Levodopa Equivalent Dose; H&Y – Hoehn and Yahr stage; CBI – Caregiver Burden 
Inventory; Dopamine agonists – Non ergot-derived dopamine-receptor agonists 
1Mean value of the time since first symptoms and the diagnosis, as reported by PwPD. 
2Based on Tomlinson et al. (2010). 
3TMT4 in the control group: n=42, M=10.83, SD=3.57, Range: 2-15. 
4There was no rating available for 6 participants (9.2%). 
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6.4.2 Evaluative judgment 
BRIEF-A Self-rating versus BRIEF-A Informant rating  
The largest corrected discrepancy scores were observed in PwPD_EF+ (PwPD_EF+ > 
PwPD_EF > Controls), but the differences were not statistically significant. See details of the 
one-way ANOVA in Table 6.3a and scaled scores in Figure 6.1. 
There was no significant difference in how participants in the three study groups 
rated their own executive functioning (BRIEF-A Self), or in how informants rated the 
executive functioning of the participants (BRIEF-A Informant). See details of the Kruskal-
Wallis tests in Table 6.3b. 
Self- and informant BRIEF-A ratings (compared within each study group) were similar 
in controls and PwPD_EF-, while in PwPD_EF+ participants reported significantly more 
problematic behaviours than did their informants. See details of the Wilcoxon Signed Ranks 
test in Table 6.3b. 
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Table 6.3. Comparisons of BRIEF-A self- and informant summary scales. 
a) Between-group comparisons of corrected discrepancy scores for BRIEF-A scales  
 PwPD_EF- (n=21)1 PwPD_EF+ (n=40)2 Control (n=39)3   
 M (SD) range M (SD) range M (SD) range Statistics p 
BRIEF-A CD 
-0.05 (0.20)  
-0.38–0.28 
-0.14 (0.22)  
-0.53–0.54 
0.04 (0.18)  
-0.41–0.42 
F(2,79) = 2.31 .106 
Note: The corrected discrepancy scores were calculated for both scales by subtracting the 
self-rating from the informant rating and dividing the difference by the mean value of the 
two ratings (BRIEF-A Informant – BRIEF-A Self)/[(BRIEF-A Informant + BRIEF-A Self)/2] to 
correct for between-subject differences in actual level of scoring. Possible range of scores is 
-1 to 1. 
 
b) Between-group (PwPD_EF- vs. PwPD_EF+ vs. Control) and within-group (self- vs. 
informant rating) comparisons of BRIEF-A scales 
 PwPD_EF- (n=21)1 PwPD_EF+ (n=40)2 Control (n=39)3   
 M (SD) M (SD) M (SD) Statistics p 
BRIEF-A _R 
Self 
110.38 (24.53) 105.62 (16.09) 101.59 (18.91) H(2) = 3.33 .189 
BRIEF-A _R 
Inf 
107.06 (26.57) 92.67 (19.79) 97.87 (20.98) H(2) = 3.87 .144 
    Self vs Inf4 T = 43.50, p = .348 T = 66.50, p = .001 T = 208, p = .195   
Note: Prior to the analyses, the three BRIEF-A validity scales (for both self- and informant 
ratings) were inspected. Three participants in PwPD had a marginally elevated Inconsistency 
scale and one participant in PwPD had an elevated Infrequency scale. As directed in the 
BRIEF-A manual, BRIEF-A responses from all four participants were inspected, and as no 
further evidence for atypical or unreliable answers was found, these participants’ data were 
included in further analyses. 
PwPD_EF- – PwPD with EF deficits; PwPD_EF+ –  PwPD with normal EF; M – Mean; SD – 
Standard deviation; CD – Corrected Discrepancy score  
1Informants in PwPD_EF- ni=17. 
2Informants in PwPD_EF+ ni =30.  
3Informants in Control ni =39.  
4Wilcoxon Signed Ranks test, based on positive ranks. 
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Figure 6.1. Mean age-scaled T scores on the BRIEF-A (M = 50, SD = 10) in the three study 
groups. 
Note. Informants in PwPD_EF- ni=17; Informants in PwPD_EF+ ni =30; Informants in Control 
ni =39; PwPD_EF- – PwPD with EF deficits; PwPD_EF+ – PwPD with normal EF 
 
Evaluative judgment of cognitive functioning versus objective test performance  
The correlational analyses revealed that in PwPD_EF- BRIEF-A self-rating was negatively 
related to performance on CWI 3, with poorer performance on CWI 3 related to fewer 
difficulties reported. In PwPD_EF+ both self- and informant BRIEF-A ratings were positively 
related to performance on CWI 4, with poorer performance associated with more difficulties 
reported. See details of Spearman’s Rho correlational analyses in Table 6.4. 
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Table 6.4. Bivariate correlations between ratings of executive functioning (BRIEF-A) and 
objective EF test performance. 
 PwPD_EF- PwPD_EF+ 
BRIEF-A_R Self BRIEF-A _R Inf BRIEF-A _R Self BRIEF-A _R Inf 
 rs n rs n rs n rs n 
TMT ratio -.027 21 -.217 17 .039 39 -.099 29 
CWI 3_R -.439* 21 -.315 17 .026 40 .191 30 
CWI 4_R -.359 21 -.302 17 .390* 40 .423* 30 
Note. Cases excluded pairwise in the event of missing data. 
PwPD_EF- – PwPD with EF deficits; PwPD_EF+ –  PwPD with normal EF; rs – Spearman’s 
correlation coefficient; BRIEF-A_R – BRIEF-A raw score; CWI 3_R – Color Word Interference 
(D-KEFS) raw score; TMT ratio – TMT4/TMT2 
* significant at p < .05; No Bonferroni adjustment has been made in order to minimise the 
risk of Type II error (Bender & Lange, 2001; Perneger, 1998). 
 
6.4.3 Performance monitoring  
TMT and CWI Performance Scores versus Self-ratings 
The comparison of mean Performance Ratios for TMT and CWI indicates that PwPD_EF- 
were significantly less accurate (more positive) in appraising their performance than other 
study groups. While mean test performance of PwPD_EF- was significantly worse than in 
other groups, their self-appraisals were comparable to those of other groups. See details of 
the one-way ANOVAs (TMT) and the t-tests (CWI) in Table 6.5. 
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Table 6.5. Descriptive information on variables used for calculating performance ratios and comparison of performance ratios in the study 
groups.  
a) Mean scaled scores, test performance band scores, and self-evaluation of test performance for TMT and CWI. 
 PwPD_EF- PwPD_EF+ Control  
Mean scores M (SD) Range M (SD) Range M (SD) Range p 
TMT SS 6.28 (1.91) 3.20-9.20 10.08 (2.12) 5.40-13.20 10.43 (2.31) 5.40-14.00 <.0001 
TMT TP band 1.98 (0.50) 1.40-2.80 3.05 (0.67) 1.80-4.00 3.17 (0.70) 1.40-4.20 <.0002 
TMT Self-evaluation 3.20 (0.51) 2.40-4.00 3.26 (0.50) 2.40-4.00 3.16 (0.53) 2.20-4.00 .7783 
 n=10 n=20 n=42  
CWI SS 7.70 (2.67) 2.50-11.25 10.97 (1.60) 7.50-13.50   <.0004 
CWI TP band 2.38 (0.72) 1.25-3.50 3.40 (0.59) 2.50-4.25   <.0005 
CWI Self-evaluation 3.78 (0.58) 3.00-4.75 3.80 (0.53) 3.00-5.00   .6616 
 n=11 n=23   
SS – Mean Scaled Score; TP band – Mean test performance band score based on scaled score; Self-evaluation – Mean Self-evaluation of test 
performance score  
1F(2,69) = 514.54, PwPD_EF- < PwPD_EF+, Control. 
2F(2,69) = 512.93, PwPD_EF- < PwPD_EF+, Control. 
3F(2,71) = 50.25. 
4t(32) = 524.39, PwPD_EF- < PwPD_EF+. 
5t(32) = 524.52, PwPD_EF- < PwPD_EF+. 
6t(31) = 520.44. 
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b) Between-group comparison of TMT and CWI Performance Ratios (PR). 
 PwPD_EF- PwPD_EF+ Control    
 n M (SD) n M (SD) n M (SD) F p Post-hoc1 
TMT1 PR 11 2.60 (1.43) 21 2.17 (1.04) 42 1.87 (1.09) F(2,71) = 2.56 .085 ns 
TMT2 PR 11 2.56 (1.20) 21 1.28 (0.31) 41 1.25 (0.52) 1F(2,71) = 17.22 <.000 EF->EF+,Ctrl 
TMT3 PR 11 2.13 (1.35) 21 1.23 (0.38) 42 1.28 (0.62) 1F(2,71) = 5.50 .006 ns in post-hoc 
TMT4 PR 11 1.85 (0.96) 21 1.01 (0.32) 42 1.20 (0.51) F(2,71) = 7.69 .001 EF->EF+,Ctrl 
TMT5 PR 10 1.78 (0.55) 20 1.55 (0.67) 42 1.35 (0.46) F(2,71) = 3.14 .050 ns in post-hoc 
TMT MPR  10 2.22 (0.70 20 1.41 (0.39) 41 1.37 (0.38) F(2,68) = 12.03 <.000 EF->EF+,Ctrl 
CWI1 PR 11 2.14 (1.17) 23 1.48 (0.57)   t(32) = 2.07 .047 EF->EF+ 
CWI2 PR 11 1.52 (0.56) 23 1.39 (0.38)   t(32) = 0.60 .553 ns 
CWI3 PR 11 2.03 (0.95) 23 0.95 (0.20)   t(12.90) = 4.74 <.000 EF->EF+ 
CWI4 PR 11 1.58 (0.63) 23 0.91 (0.28)   t(32) = 4.22 <.000 EF->EF+ 
CWI MPR  11 1.82 (0.66) 23 1.18 (0.26)   t(32) = 4.02 <.000 EF->EF+ 
Note. The Performance Ratio scores were transformed using natural logarithms to improve distribution prior to comparison analyses.  
PwPD_EF- – PwPD with EF deficits; PwPD_EF+ –  PwPD with normal EF; M – Mean; SD – Standard deviation; PR – Performance Ratio; TMT – 
Trail Making Test (D-KEFS); CWI – Color Word Interference (D-KEFS); TMT MPR – Mean Performance Ratio for TMT subtests; CWI MPR – Mean 
Performance Ratio for CWI subtests 
1Games-Howell post-hoc correction for unequal variances. 
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Bivariate Correlations of Awareness Indicators and Other Variables of Interest 
Table 6.6 shows Spearman’s correlations between the awareness indicators and other 
variables in the PwPD group. Higher BRIEF-A corrected discrepancy scores (greater 
differences between self- and informant ratings) were associated with higher stress 
reported on the Caregiver Burden Inventory. Higher Mean Performance Ratios (greater 
discrepancies between self-appraisal and actual test performance) were associated with 
poorer general cognition (lower ACE-R). 
Table 6.6. Spearmans’s rho correlations of awareness indicators and other variables in 
PwPD. 
Note. Cases excluded pairwise in the event of missing data. The Performance Ratio scores 
were transformed using natural logarithms to improve distribution prior to analysis. No 
Bonferroni adjustment has been made in order to minimise the risk of Type II error (Bender 
& Lange, 2001; Perneger, 1998). 
BRIEF-A CD – Corrected Discrepancy for BRIEF-A BRI; BRIEF-A MI CD – Corrected Discrepancy 
for BRIEF-A MI; logTMT_MPR –logarithm of Mean Performance Ratio for TMT subtests; 
logCWI MPR – logarithm of Mean Performance Ratio for CWI subtests; CBI – Caregivers 
Burden Inventory; HADS-A – HADS Anxiety; HADS-D – HADS Depression; LED – Total Daily 
Levodopa Equivalent Dose 
 ** significant at p < .01. 
 
  Age NART 
IQ 
CBI HADS-D HADS-A ACE-R H&Y LED PD 
duration 
BRIEF-A 
CD 
rs -.029 -.284 .526** -.065 .057 -.279 -.058 -.116 .051 
n 45 44 39 45 45 45 41 45 45 
logTMT
MPR 
rs .142 .115 .420 .102 .030 -.502** .254 .097 .101 
n 30 30 22 30 30 30 27 30 30 
logCWI 
MPR 
rs .175 .093 .046 -.116 .075 -.471** .254 .240 .105 
 n 34 34 25 34 34 34 30 34 34 
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6.5 Discussion 
The present study investigated awareness of executive functioning in PwPD with and 
without EF deficits, and in healthy controls. At the evaluative judgment level PwPD with EF 
deficits were found to be as accurate as PwPD with normal EF and healthy older people. At 
the performance monitoring level, PwPD_EF- were found to significantly overestimate their 
performance on EF tests in comparison to PwPD_EF+ and healthy older people, which is a 
novel finding in PwPD. The overestimation was particularly profound in the more 
demanding tasks, and might be related to deficits in executive control processes. Larger 
BRIEF-A discrepancies were related to higher levels of caregiver burden, and higher 
performance ratios were related to poorer general cognition. 
6.5.1 Evaluative judgment level 
Self-rating versus informant rating. At the evaluative judgment level, awareness of 
executive functioning was operationalised with a discrepancy score between self- and 
informant ratings. The BRIEF-A corrected discrepancy scores were similar in all study groups, 
suggesting that PwPD (with and without EF deficits) are as accurate in self-appraisal of their 
executive functioning as healthy older people. As far as can be determined, this is a new 
finding, as a discrepancy score approach has not been previously used to compare 
awareness in PwPD and healthy controls. The examination of the discrepancy scores is 
different from the direct comparison of self vs. informant ratings, as it clarifies whether the 
level of agreement is similar across groups, regardless of whether the two ratings in a 
particular study group are comparable or not. Sitek, Soltan, et al. (2011) used a discrepancy 
score approach to investigate memory awareness in PD, but they examined the score in 
relation to objective memory tests, and not to a control group. Clare et al. (2010) compared 
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memory awareness in people with Alzheimer’s disease (AD) and healthy controls using a 
corrected discrepancy score approach and found that the discrepancies were significantly 
greater in the AD group than in controls, suggesting decreased awareness of memory 
impairment. At the same time, the AD participants did rate their memory significantly less 
positively than controls, suggesting some acknowledgment of their deficits. In the present 
study, all three participant groups reported on average the same number of EF-related 
difficulties, while it was expected that PwPD_EF- would report more EF-related difficulties. 
Given their impaired performance in EF tests, the absence of difference may suggest that 
PwPD_EF- acknowledge their difficulties only partially. 
In the present study, all self-reports were higher than corresponding informant reports, 
which is consistent with studies comparing self- and informant ratings of executive 
functioning (Burgess, Alderman, Evans, Emslie, & Wilson, 1998; Rabin et al., 2006; Roth et 
al., 2005). The difference was statistically significant only in PwPD_EF+, in line with the study 
of McKinlay, Grace, et al. (2008), where PwPD with normal general cognition (MMSE score > 
25, no EF tests included) self-reported more difficulties than their informants. PwPD_EF+ 
may in fact have some subtle deficits experienced internally as a change in cognitive 
processing, which is impossible for the carer to observe, hence resulting in discrepant 
appraisals (McKinlay, Grace, et al., 2008). In contrast, deficits in PwPD_EF- may be more 
substantial and therefore evident to the carers, resulting in more similar ratings.  
Self- and informant ratings versus objective measures. The interpretation of discrepancies 
between self- and informant ratings in terms of degree of awareness is not straightforward, 
as it depends on the accuracy of informant ratings prone to influence by social and 
interpersonal factors or the degree of stress or burden experienced (Clare, 2004), and may 
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be affected by the impossibility of observing some aspects of internal cognitive processing 
(McKinlay, Grace, et al., 2008). It has been argued that comparing self-ratings to objective 
test performance provides a useful approach, as it eliminates that bias (Dalla Barba, Parlato, 
Iavarone, & Boller, 1995; McLoughlin, Cooney, Holmes, & Levy, 1996).  
In PwPD_EF+, higher BRIEF-A ratings (both self- and informant) were related to poorer 
performance in CWI 4, while in PwPD_EF- there was a significant correlation between BRIEF-
A self report and CWI 3.  These correlations would suggest that the BRIEF-A ratings offer a 
degree of accuracy, and that inhibition and switching abilities assessed by CWI may overlap 
with some aspects of the executive difficulties elicited in the BRIEF-A. However, the pattern 
of correlations between BRIEF-A and EF tests was not consistent, as other correlations were 
non-significant. Non-significant relationships between EF tests and questionnaire-based 
ratings have previously been reported (Koerts et al., 2012; Rabin et al., 2006), and have 
been interpreted as a consequence of the generally low ecological reliability of EF tests and 
a lack of overlap between the difficulties assessed by EF tests and the kinds of cognitive 
failures listed in the BRIEF-A (Goldberg & Podell, 2000; Manchester et al., 2004).  
6.5.2 Performance monitoring level  
As far as can be determined, this is the first study to report on the accuracy of self-appraisal 
of executive task performance in PwPD. PwPD_EF- overestimated their performance in EF 
tests significantly more than PwPD_EF+ and controls, particularly in more challenging tasks 
(TMT 4, CWI 3 & 4). While the exact values of the ratios might reflect the calculation 
method, the group comparison objectively demonstrates that PwPD_EF- were significantly 
less accurate. It has been argued that cognitive processes have greater impact on self-
appraisal of performance on a given task than on general evaluation of cognitive 
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functioning, as the former requires an EF-related ability to efficiently distribute attention 
between the task itself and self-appraisal (Clare, Marková, et al., 2011). This notion is 
supported by the present study where poorer performance monitoring was associated with 
poorer general cognition, in line with studies reporting an association between 
overestimation of test performance and poorer general cognition and EF in people with 
dementia (Bettcher, Giovannetti, Macmullen, & Libon, 2008; Clare et al., 2010; Graham, 
Kunik, Doody, & Snow, 2005). Executive control has been previously reported as impaired in 
PwPD (West, Ergis, Winocur,   Saint‐Cyr, 1998; Zgaljardic et al., 2006); it is therefore not 
surprising that PwPD_EF- exhibited difficulties in self-appraisal of task performance, even 
though they were allocated to the impaired group based on tasks which do not specifically 
assess task-monitoring abilities (Ridderinkhof, Van Den Wildenberg, Segalowitz, & Carter, 
2004; Zgaljardic et al., 2006).  
6.5.3 Correlates of decreased awareness 
Awareness is shaped by a number of factors, and might be prone to psychosocial influences, 
especially at the evaluative judgment and meta-representational levels (Clare, Marková, et 
al., 2011). This notion was illustrated in the correlational analysis; while poorer performance 
monitoring was associated with poorer general cognition, lower level of agreement 
between ratings (greater discrepancy in BRIEF-A) was related to higher levels of caregiver 
burden. Caregiver burden has not been previously examined in relation to awareness in PD, 
but it might have a profound impact on informant ratings, as is consistently reported in 
dementia studies (Clare et al., 2012; Jorm et al., 1994; Rymer et al., 2002). Discrepancy 
scores were not correlated with depression, which is different to findings from other PD 
studies (Koerts et al., 2012; Sitek, Soltan, et al., 2011) and might result from the relatively 
low levels of depression in the study groups.  
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6.5.4 Limitations 
Some limitations of the present study must be taken into account when interpreting the 
findings. The interpretation of EF test results is complicated as performance may reflect 
various lower and higher level cognitive functions. We included PwPD with normal global 
cognition and controlled for potential motor impairment on the TMT, which increases the 
reliability of test interpretation. However, the potential role of non-executive deficits for EF 
performance and awareness level in PwPD needs to be acknowledged, as the two groups 
distinguished on the basis of performance on EF tests may possibly differ from each other in 
respect to other non-executive abilities, such as language. Further research might be 
needed to clarify the relationship between awareness and non-executive abilities. Only two 
tests of EF were used to distinguish between participants with normal and impaired EF. TMT 
and CWI capture only some aspects of EF related to inhibitory control and mental switching, 
and including more tasks would facilitate more accurate identification of PwPD with EF 
deficits. Our sample of PwPD with EF impairments was relatively small, which limits the 
potential to generalise these findings. EF tests are different from tasks encountered by 
PwPD in daily life, and this might have added to the inaccuracy of self-appraisal. It would be 
interesting to examine the accuracy of performance monitoring in more ecologically valid 
tasks, and investigate how that accuracy relates to everyday functioning (e.g. driving, 
medication adherence). 
6.5.5 Conclusions 
Accurate self-appraisal and performance monitoring are crucial for independent and safe 
day-to-day functioning. This study demonstrates that while PwPD accurately acknowledge 
their deficits at the general level, they may lack capacity to recognise their limitations while 
performing specific tasks, which may have implications for functional abilities. Performance 
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monitoring is a new approach in assessing awareness in PD, with the results supporting the 
view that awareness at the evaluative judgment level involves different processes than 
those required for accurate monitoring of one’s own performance. Future studies could 
explore the potential consequences of inaccurate self-appraisal for everyday functioning 
and examine strategies to prevent possible excess disability associated with limited 
awareness of functioning and performance. 
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7.1 Introduction 
This thesis aimed to extend our understanding of executive functions in people with PD by 
clarifying the pattern of executive impairment in early stage PD, establishing the impact of 
executive deficits on quality of life in PwPD and their families, and assessing the accuracy of 
PwPD in acknowledging their limitations. These areas were important to investigate to 
facilitate better understanding of the subjective experience of PD and identification of 
specific needs. These are the key objectives for arranging health services around the 
subjective needs of PwPD, which is regarded as a priority by policy makers and service users 
(Department of Health, 2001; Institute of Medicine, 2001; Van der Eijk et al., 2011). 
In the following sections the results of the thesis will be summarised and discussed 
with regard to the research questions and existing research evidence. Then, theoretical 
implications will be considered and recommendations for future research presented. Finally, 
implications for clinical practice will be discussed.  
The thesis was focused around four overarching research questions, which are listed 
in the following sections along with the key findings for each research question. 
The research questions were addressed with a meta-analytic approach (research 
question 1) and quantitative analyses based on cross-sectional data from a sample of 65 
PwPD (research questions 2 – 4), 50 caregivers of PwPD (research questions 3 and 4), and 43 
healthy controls (research question 4). PwPD completed an assessment covering executive 
functions, awareness, QoL, and health status, and caregivers rated the executive functioning 
of PwPD and their own level of burden associated with caring for a PwPD. Healthy controls 
completed assessments of executive functions and awareness. 
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7.2 Summary of the findings 
Research question 1. What pattern of executive impairment can be identified from the 
research literature on EF in people with early stage PD without dementia, and what are the 
critical issues for improving consistency in this field?  
There is a wealth of research examining EF in PD, but studies have produced mixed findings. 
In Chapter 2 the literature on EF in PD was systematically reviewed and results from a 
homogeneous group of studies were synthesized in a series of meta-analyses. The 
complexity of the literature was demonstrated in that the EF concept was operationalised in 
terms of 30 abilities and tested by 60 measures, frequently without a clearly-articulated 
theoretical framework. Such difficulties associated with defining and assessing cognitive 
constructs are frequently listed in theoretical discussions of EF (Chan et al., 2008; Rabbitt, 
1997) and cognition in general (Cohen, 2000). The review indicated that methodological 
challenges in defining and assessing EF may have a substantial impact on the clarity of 
research evidence in PD. 
Despite these challenges, the results of the meta-analyses were surprisingly 
consistent, as they indicated that in all five tests of EF included in the analyses PwPD 
performed significantly worse than healthy controls. The study demonstrated the potential 
of a meta-analytic approach in clarifying complex literature in areas such as EF in PD. The 
approach has been employed previously in PD studies and has offered clarification for  a 
number of research questions, for example with regard to the magnitude of cognitive 
decline (Muslimovic et al., 2007), effectiveness of exercise for PwPD (Goodwin, Richards, 
Taylor, Taylor, & Campbell, 2008), or associations between PD and cigarette smoking and 
coffee drinking (Hernán, Takkouche, Caamaño‐Isorna,   Gestal‐Otero, 2002). The consistent 
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results of the meta-analyses might be related to the fact that PwPD in the included studies 
were relatively similar with regard to severity of motor symptoms, depression level and 
global cognition. As these clinical characteristics may be related to performance on EF tests 
(Locascio, Corkin, & Growdon, 2003; Uekermann et al., 2003), the homogeneity in the 
included studies could possibly contribute to less variability in the data, allowing the group 
differences to emerge more prominently. Therefore, it seems that the clarity of the research 
evidence could be improved by better precision in describing study samples, and ideally by 
employing more rigorous inclusion criteria to facilitate higher homogeneity in the individual 
study groups.  
While the consistency of the presented results might suggest impairment across the 
whole spectrum of EF, the meta-analyses synthesized only part of the existing evidence, as 
only five out of 60 measures of EF were included. There is no rationale for assuming that 
these five tests constitute a comprehensive assessment of EF. More importantly, the meta-
analysis reported only small differences between PwPD and controls, and the clinical 
significance of the reported deficits on standard tests of EF is not clear (B. A. Wilson et al., 
1997). 
Research question 2. Which areas of EF are particularly problematic in early stage PD? 
The study reported in Chapter 3 extended the results of the meta-analyses by specifying the 
areas which seem to be particularly problematic in early stage PD. Performance on the nine 
standard tests of EF was analyzed with a data-driven approach which identified two 
distinctive groups of EF tests, one consisting of attentional control tasks and the other 
consisting of abstract reasoning tasks. The study demonstrated that these two distinctive 
aspects of EF might be differentially affected in early PD, with PwPD showing more 
  Chapter 7. Discussion  168 
 
 
impairment on tasks requiring attentional control than on tasks requiring abstract 
reasoning.  These findings supplement the results of the meta-analyses reported in Chapter 
2, as most of the EF tests on which impairments were identified seem to rely predominantly 
on efficient attentional control. The results are also in line with the current understanding of 
the neuronal basis of EF and the neuropathology underlying EF impairment in PD, as 
attentional control is identified as closely related to the function of prefrontal cortex and 
the striatum, which is thought to be compromised in PD (Bonelli & Cummings, 2007; Dauer 
& Przedborski, 2003; E. K. Miller & Cohen, 2001). It has also been reported that deficits in 
attentional control in PD may be determined by COMT genotype (Williams-Gray et al., 
2009). 
The significance of the impairment on attentional control tests needs to be 
interpreted in the context of the frequency of clinically significant deficits. In the group of 
PwPD who screened positive for EF deficits, a large proportion (55%) performed within the 
normal range on all nine tests of EF. Of the remainder, around 30% had a single impaired 
score. Impaired performance was most frequent on the Trail Making (TM) test; 18.2% of 
PwPD performed at 1.5 SDs below the mean on the TM test (33% when not controlling for 
motor impairment), whereas there were no abnormal scores on the Proverb test. Only 15% 
of PwPD had impaired performance on two or more tests. It should be noted that these are 
not prevalence rates, as the analysis was based on a subgroup of a convenience sample 
(52% of the total sample of PwPD), but it demonstrated which areas of EF are particularly 
problematic in early stage PD.  
The results of Chapter 3 may inform test selection for neuropsychological 
assessment of EF in PD. To date there is no formal recommendation with regard to which 
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standard tests of EF are most sensitive to executive impairment in PD. The recently 
published diagnostic criteria for PD-MCI (Litvan et al., 2012) included examples of tests that 
might be used in PD, but the list is not based on evidence from PD studies. The results 
suggest that among the nine tasks comprising the D-KEFS, the switching conditions of the 
Trail Making, Color-Word Interference, and verbal fluency tests are most useful for 
identifying executive deficits in PD (Delis et al., 2001). This is in line with Muslimovic et al. 
(2005), who reported that the Trail Making test is the most frequently impaired test of EF in 
PwPD, and clearly discriminates between PwPD and controls.  
Research question 3. How do EF deficits affect quality of life and health status for the PwPD, 
and the caregiver stress associated with caring for PwPD? 
The study reported in Chapter 4 explored how QoL and health status in PwPD, and caregiver 
burden, are influenced by EF deficits. Previous studies have identified a number of factors 
impacting on quality of life and subjective health status in PwPD. Quality of life in PwPD and 
caregiver burden in PD are typically considered in terms of health and motor impairment, 
but there is increasing evidence that non-motor difficulties may also have a significant 
impact on quality of life in PwPD and caregiver burden (Den Oudsten et al., 2007a; Hely et 
al., 2005; Martinez-Martin et al., 2005; Soh et al., 2011). Relatively little attention has been 
given specifically to EF in this respect. The study presented in Chapter 4 contributed to our 
understanding of the complex variety of factors influencing well-being in PD by reporting 
the potential role of EF-related behavioural problems. The regression analyses showed that 
behavioural problems related to executive functioning, as assessed by the BRIEF-A 
questionnaire, may contribute to QoL and health status in PwPD, and add to burden for 
caregivers of PwPD. Similar associations between EF-related behavioural difficulties and 
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well-being in patients and caregivers were observed in people with Alzheimer’s disease (AD) 
(Bonney et al., 2007). It was also reported that EF-related behavioural difficulties  may 
negatively impact on functional abilities in AD (Boyle et al., 2003; Norton, Malloy, & 
Salloway, 2001). Better understanding of factors influencing well-being in PwPD will make it 
possible to develop and implement appropriate interventions, enhancing provision of 
person-centred care for people diagnosed with PD and their families.  
Research question 4. How accurate are PwPD in assessing their overall executive functioning 
and their performance in a given task? 
 The objective of the study reported in Chapter 5 was to explore whether PwPD can 
accurately appraise their own executive deficits. This is an important question, as the 
inability to adequately assess one’s own limitations may have negative implications for 
PwPD and their caregivers. Awareness has been extensively studied in the area of dementia 
(Bettcher et al., 2008; Clare, 2004; Clare et al., 2010; Graham et al., 2005), but there is 
limited evidence with regard to PD, and the existing studies focus on the evaluative 
judgement level only (Clare, Marková, et al., 2011). 
The study presented in Chapter 5 employed a comprehensive methodology to 
provide information about the multifaceted concept of awareness. Awareness was 
evaluated at two levels: the evaluative judgment level and the performance monitoring 
level (Clare, 2004). The evaluative judgment level of awareness was assessed with a 
discrepancy score approach. This approach, which has not been previously employed in PD 
studies, indicates not only whether self- and informant ratings are similar, but also whether 
the scope of differences is similar across the study groups. PwPD with executive deficits and 
PwPD with normal EF expressed similar levels of accuracy to healthy controls, although self-
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ratings by PwPD tended to be more negative than informant ratings in all three groups. This 
pattern is different form the one observed in Alzheimer’s disease (AD), where patients tend 
to overestimate their memory functioning, and rate themselves more positively than they 
are rated by their caregivers (Clare et al., 2010). People with traumatic brain injury (TBI) also 
tend to report less impairment than their families and clinicians, particularly with regard to 
cognitive and behavioural abilities, and to a lesser extent with regard to physical functioning 
(Sherer et al., 1998).  In AD, discrepancies in the appraisal of memory functioning were 
reported to increase stress in caregivers and impact on the quality of the caregiving 
relationship (Aalten et al., 2005; Nelis et al., 2011). In PD, despite the different direction of 
the discrepancies, a lower level of agreement between self- and informant rating was 
related to higher levels of caregiver burden, as observed in Alzheimer’s disease (Nelis et al., 
2011). Better understanding of the association between differences in appraising executive 
functioning and stress in caregivers could possibly lead to improvements in supporting 
PwPD and their caregivers, and further studies are needed to explore this relationship.    
To assess awareness at the performance monitoring level, the accuracy ratio for self-
evaluation versus objective test performance was calculated and compared across the study 
groups. The results showed that PwPD with executive impairments were less accurate than 
PwPD without executive impairments and controls. Decreased awareness at the 
performance monitoring level was observed in people with AD, who overestimated 
performance on a memory test (Clare et al., 2010), and in people with brain injury, who 
acknowledged a smaller proportion of errors than healthy controls in a naturalistic tasks 
(Hart, Giovannetti, Montgomery, & Schwartz, 1998). The results presented in Chapter 5 
suggest that PwPD who have executive deficits may lack the ability to recognise their 
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limitations while performing specific tasks, which may have implications for their functional 
abilities. Lower awareness in dementia was found to be associated with older age, less 
anxiety and lower general cognition (Clare, Whitaker, et al., 2011), and inaccurate appraisal 
of behavioural limitations in people with TBI may be related to cognitive and emotional 
disturbances (Prigatano, Altman, & O'brien, 1990). The mechanisms underlying inaccurate 
performance monitoring in PD require further investigation.  
7.3 Methodological considerations 
Researching EF is associated with a number of challenges that might have impacted on the 
presented studies, and these potential limitations should be considered when interpreting 
the results of this thesis.  
While numerous definitions and tests of EF are available, there is no consensus 
about a comprehensive theory of EF that can provide a point of reference for test selection 
and interpretation in clinical studies (Salthouse, 2005). The interpretation of EF tests is 
further complicated by the fact that performance on these tests might be influenced by 
non-executive cognitive functions also involved in test performance. To improve reliability 
of test interpretation in the present study, the participant group included only PwPD who 
performed within the normal range on a screening test of general cognition, and employed 
measures that involve minimum motor control. Nevertheless, the potential role of non-
executive deficits in EF performance needs to be acknowledged.  
 The heterogeneous pathology of PD is associated with numerous motor and non-
motor symptoms which may also influence performance on EF tests in a number of ways 
(Colman et al., 2009; Kobayakawa et al., 2008). For example, test performance involves 
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motor control and speech, which are known to be affected by PD pathology. There are also 
non-motor symptoms of PD that could affect test results, for example apathy, depression, 
fatigue, and sleep deprivation (Locascio et al., 2003). It was not possible to fully control for 
all potential confounds, but to minimize their impact only PwPD in the mild to moderate 
stages of PD with no clinically significant depression were included, and the assessment was 
completed during the ‘on medication’ phase. Nevertheless, the possible impact of PD-
related factors needs to be considered when interpreting results of this thesis.  
Time-efficient tools for identifying PwPD with potential EF deficits are important in 
clinical practice. In the studies presented here, PwPD were screened with the Frontal 
Assessment Battery (FAB), which is reported to have good psychometric properties and is 
commonly used in research and clinical practice (Lima et al., 2008). However, only a small 
proportion of PwPD identified by FAB as having EF deficits had abnormal scores on a 
detailed assessment of EF, while some PwPD who scored above the cut-off on the screening 
task had abnormal scores on the TM and Color-Word Interference tests. This suggests that 
the FAB might be sensitive to only one specific profile of executive deficits, while PwPD with 
other types of EF deficits not captured by FAB were not included in the study presented in 
Chapter 3. It would therefore be important to investigate in a future study whether the 
same pattern is evident in a larger group of PwPD not screened for EF deficits. 
Interestingly, only the behavioural ratings of EF-related difficulties (BRIEF-A), and not 
the standard tests of EF (TM test and Color-Word Interference test), made a significant 
contribution to the regression models of quality of life, health status in PwPD, and caregiver 
burden. One possible explanation for the differential contribution of EF measures relates to 
differences in the level of ecological validity. Standard tests of EF are known to have low 
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ecological validity, as it is questionable to what extent difficulties in drawing a line 
connecting numbers and letters in ascending order, while alternating between numbers and 
letters, translates into everyday life (Burgess et al., 1998; Manchester et al., 2004; Rabin et 
al., 2006; Roth et al., 2005). It is also argued that the structured nature of their 
administration removes some executive demands and makes them insensitive to some key 
aspects of EF, such as coping with novelty or organizing and prioritizing tasks (Manchester et 
al., 2004; B. A. Wilson et al., 1997). Behavioural ratings of EF focus specifically on the aspects 
of EF that are relevant for everyday functioning, and are therefore likely to be more directly 
related to well-being. Another interpretation is that the BRIEF-A and standard tests of EF 
assess different constructs (Toplak, West, & Stanovich, 2013), and that it is the aspect of EF 
assessed by the BRIEF-A that seems relevant for well-being in PD. The aspect of EF assessed 
by standard tests of EF seems not to be relevant to well-being, at least not at the level of 
severity observed in the current study (B. A. Wilson et al., 1997). This argument relates to 
the ongoing discussion about whether EF is a one executive ability or a group of related 
executive abilities (Miyake et al., 2000; Stuss & Alexander, 2007). To date, there seems to be 
no agreement with regard to what abilities should be considered as ‘executive’ (Edelstyn et 
al., 2007). Definitions of EF frequently identify successful, socially acceptable goal-oriented 
behaviour as the key contribution of EF (Burgess & Alderman, 2004; Lezak, 2004). Goal-
oriented behaviour might mean overall efficiency in identifying appropriate goals, 
maintaining motivation and employing appropriate strategies to achieve these goals within 
a complex social context. This seems to be a broad definition of EF that encompasses 
motivation, personality, and other non-cognitive abilities (Brown & Pluck, 2000), potentially 
captured by the BRIEF-A. However, goal-oriented behaviour might also have a substantially 
different meaning, as it could be interpreted as the ability to manage specific task demands 
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according to clearly-stated rules in the well-defined context of a testing situation (Ardila, 
2008; Stuss & Alexander, 2000). This seems to be the understanding of EF most commonly 
employed in the PD literature and assessed by the standard tests of EF. However, the 
behavioural aspect of EF might also need to be assessed to provide a more comprehensive 
picture of the executive impairment in PD.  
Scaled scores on standard tests of EF facilitate the interpretation of test performance 
in terms of impairment, as they provide an indication of how likely it is that a given score 
will be observed in a healthy, age-matched population. However, caution is needed when 
such scaled scores are used for determining executive impairment, as there seems to be no 
agreement with regard to what constitute a comprehensive assessment of EF, and how 
many impaired scores are required to conclude that the person has an executive 
impairment (Ingraham & Aiken, 1996; Liepelt-Scarfone et al., 2011). In the study reported in 
Chapter 3, 45% of the assessed PwPD had clinically significant impairment on at least one 
out of nine tests (1.5 SD below mean), but only 15% of PwPD had more than one impaired 
score. The rates of executive impairment in PD reported in the literature vary from 9% to 
50% (Caviness et al., 2007; Foltynie et al., 2004; McKinlay et al., 2009) and the inconsistency 
may reflect the differences in criteria used.   
 It should be noted that as PwPD included in the present study were volunteers, 
there might be under-representation of PwPD with poorer health or who are otherwise 
overwhelmed by the experience of PD (Bootsma-van der Wiel et al., 2002). The fact that all 
participants were offered home visits might possibly reduce the impact of poor health on 
the decision to participate, but nevertheless some PwPD who feel less confident in their 
cognitive abilities might be less likely to participate in a research project exploring cognition 
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and well-being in PD. Additionally, in the study presented in Chapter 3, three out of 40 
participants identified as having possible EF deficits experienced marked fatigue and 
completed only first part of the study. This possible recruitment bias could result in these 
studies reporting a lower level of deficits and distress than is actually present in people 
diagnosed with PD. 
7.4 Directions for future research 
The studies presented in this thesis have contributed to our understanding of EF in early 
stage PD. The findings also raise some further questions and suggest directions for future 
research.  
 Establishing the clinical significance of the observed deficits should be an important 
objective of studies investigating executive functioning in PD, as this seems to be the key 
information needed to adequately educate and support people who are diagnosed with PD. 
To establish the clinical significance of EF deficits in PD, future studies need to explore the 
mechanism of the association between EF-related behavioural problems and subjectively 
perceived quality of life and health status, and investigate how EF deficits documented by 
standard tests of EF translate into everyday functioning. Future research should integrate 
the caregiver’s perspective to offer a more comprehensive picture of executive functioning 
in PD. The caregiver’s perspective is particularly relevant in the context of awareness, as it 
seems that PwPD may not always accurately acknowledge some difficulties in specific tasks. 
Future studies could explore the potential consequences of inaccurate self-appraisal for 
everyday functioning, and examine strategies to prevent possible excess disability 
associated with this problem.  
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In contrast to the limited guidelines for formal neuropsychological assessment in PD, 
cognitive screening in PD has attracted considerable attention. Several PD-specific scales are 
available (Kalbe et al., 2008; Mahieux et al., 1995; Marinus, Visser, Verwey, et al., 2003; 
Pagonabarraga et al., 2008), some generic measures have been validated for use in PD 
(Athey et al., 2005; Llebaria et al., 2008; Reyes et al., 2009), and a number of reviews of the 
available measures have been published (Barone et al., 2011; Chou et al., 2010; Kulisevsky & 
Pagonabarraga, 2009). The Frontal Assessment Battery (FAB, Dubois et al., 2000) is one of 
the few scales developed specifically for screening abilities related to frontal lobe functions 
(Kulisevsky & Pagonabarraga, 2009). The scale has been validated for use in PD studies (Lima 
et al., 2008); however, future studies might need to more carefully evaluate how the FAB 
relates to standard tests of EF sensitive to PD-specific deficits, and establish the 
discriminative properties of the FAB in screening for EF deficits in PD.  
The meta-analytic approach proved useful in evaluating the complex literature on EF 
in PD, and future meta-analytic studies may bring further benefits in the area of 
understanding cognitive change in PD. This approach is, however, less helpful with regard to 
evaluating studies employing elaborate experimental paradigms and less frequently used 
tests, as evidence from such studies cannot be easily synthesized in a meta-analysis. Future 
studies need to employ more precision in defining executive functions and in selecting and 
interpreting measures of EF. It might also be beneficial if a formal recommendation of 
measures sensitive to EF deficits in PD is proposed. Likewise, developing a theoretical 
framework of EF in PD might help with organizing existing evidence and thus guide future 
studies.  
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There is extensive evidence of executive problems in PD, but the personal 
experience of living with executive deficits seems to be mostly overlooked. Questionnaire- 
based studies document the complaints of PwPD but do not fully explain the nature of these 
or the consequences for everyday life. A qualitative approach might prove particularly 
useful in exploring the subjective experience of PwPD. It could help to clarify the nature of 
the association between EF-related behavioural problems and the well-being of PwPD and 
their caregivers, and provide an explanation for the associations and effects observed in 
quantitative studies. A qualitative approach could help to facilitate better understanding of 
how PwPD with low scores on standard tests of EF function in their everyday life and could 
lead to identification of potentially helpful intervention approaches. An in-depth analysis of 
the general experience of living with PD has been achieved in a small number of interview 
studies (Bramley & Eatough, 2005; Haahr, Kirkevold, Hall, & Ostergaard, 2010; Marr, 1991), 
but to date there is no qualitative study focusing specifically on cognitive problems or on the 
group of PwPD who have cognitive deficits.  
7.5 Practical implications of the study findings 
Assessment of EF in PD requires careful planning to allow meaningful interpretation of test 
results. For example, there should be minimum involvement of motor components or the 
impact of motor function should be controlled in a baseline condition. Neuropsychological 
assessment should include tests requiring attentional control as these seem to represent 
the main area of difficulty in EF in early PD. The assessment should also include measures of 
behavioural aspects of EF, as such ratings provide relevant information about functioning 
that is otherwise not obtained from standard neuropsychological testing. Employing 
standard criteria for PD-MCI may assist in more consistent reports of the prevalence rates.  
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It is widely acknowledged that PD is associated with non-motor as well as motor 
symptoms (Chaudhuri et al., 2005), and that non-motor complications significantly impact 
on quality of life in PD (Hely et al., 2005). However, treatment for PD focuses on motor 
disability, while non-motor disturbances are frequently overlooked and rarely addressed in 
routine healthcare (Brown et al., 2011). This thesis suggests that EF-related behavioural 
difficulties might have implications for everyday life in PD and might need to be addressed 
with rehabilitative techniques, as these are likely to assist in maintaining quality of life in PD.  
When considering EF in people diagnosed with PD, the caregiver perspective should 
be included as this brings unique information relevant for health-related aspects of QoL in 
PwPD and is particularly important for understanding the burden associated with caring for 
PwPD. Caregivers’ opinions seem particularly relevant in the context of awareness of 
difficulties. It seems that despite being relatively critical of their own EF when making 
overall judgements, some PwPD with executive deficits may fail to appreciate the severity of 
their difficulties when performing specific tasks. Inaccuracies in appraising their own 
abilities may have consequences for everyday functioning and also impact on caregivers of 
PwPD, and such inaccuracies need to be considered when assessing functional abilities in 
PD.  
Litvan et al. (2012) emphasise that recognizing cognitive deficits is important 
because it facilitates early detection of PwPD who are at risk for developing dementia and 
opens the possibility of offering them appropriate interventions at the pre-dementia stage. 
So far, it is not clear what pattern of cognitive impairment predicts dementia and whether 
EF is predictive of dementia in PD; some studies have found EF deficits to be predictive of 
dementia (Janvin, Aarsland, & Larsen, 2005; Levy et al., 2002), but other studies have not 
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(Williams-Gray et al., 2009). The results presented in Chapter 4 suggest that even relatively 
mild executive deficits might be sufficient to negatively impact on PwPD and caregivers, and 
developing appropriate strategies to help alleviate the impact of these deficits on everyday 
life may offer an opportunity to improve quality of life, whether or not these deficits will 
develop into dementia later on.  
7.6 Conclusions 
Parkinson’s disease is a common neurodegenerative disease associated with a plethora of 
motor and non-motor symptoms, including cognitive decline. Despite substantial research 
activity in the area, the impact of cognitive decline on the daily lives of people with PD is 
largely unknown. The results presented in this thesis contributed new knowledge in the 
context of executive functioning in early stage PD and may lead to greater clarity in future 
studies on EF in PD.  
 The reported relationship between executive functioning and well-being in PwPD 
and caregivers suggests the need for specific rehabilitative interventions, and the findings 
on awareness of executive functioning in PwPD have practical implications for planning such 
interventions. Policy guidelines recommend person-centred care as the priority for high 
quality healthcare, and specify that services need to be arranged around the specific 
individual needs of the care recipients (Department of Health, 2001; Institute of Medicine, 
2001; Van der Eijk et al., 2011). The findings of this thesis can help to improve 
understanding of the aspects of EF that are most problematic for people diagnosed with PD 
and the specific factors affecting the subjective quality of life in PD, and may aid 
development of a PD-tailored protocol for neuropsychological assessment and specific 
rehabilitative interventions. 
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PARTICIPANT INFORMATION SHEET 
Memory, concentration and planning in Parkinson’s disease 
We would like to invite you to take part in a research study. Before you decide you need to 
understand why the research is being done and what it would involve for you. Please take 
time to read the following information carefully and talk to others about the study if you 
wish. Please ask us if there is anything that is not clear or if you would like further 
information. Take your time to decide whether you wish to take part.   
Thank you for reading this information sheet. 
 
What is the purpose of this study? 
Some people with Parkinson’s disease (PD), who have problems with walking, stability or 
precise movements due to PD, also complain about their memory and concentration. Little 
is known about these problems in PD. In our study, we aim to find out about non-physical 
difficulties caused by PD. For example, we want to know how common these difficulties are 
and whether they affect the everyday life of persons with PD. We will also talk to 
participants to find out what kind of help they might find useful.  
Why have I been invited? 
You have been invited because you were diagnosed with Parkinson’s disease and are 
attending Movement Disorders clinic. We are looking for 65 people to take part in this 
study. 
 
Do I have to take part? 
You do not have to take part. It is up to you to decide. If you decide to take part in the study, 
we will ask you to sign a consent form.  You can keep this information sheet and please 
remember you will be free to withdraw from the study at any time without giving a reason. 
A decision not to take part, or to withdraw from the study, will not affect the standard of 
care you receive in any way. 
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What do I need to do if I take part? 
We will arrange a meeting for time and place that are convenient for you and that will not 
disrupt your normal activities. You may take part in the study at Bangor University or at your 
own home.  It might be a good idea to meet during the time when you feel your medication 
is working well. We will ask you to fill out a number of questionnaires (for example, about 
your well-being, everyday functioning, mood) and perform some tasks (for example, to 
remember a list of words, to try to solve a puzzle, or explain how you understand a 
proverb). We will also ask you to tell us how you cope with your chores and activities in 
terms of remembering, concentration and planning - we would like to audio-record our 
conversation for further transcription and analysis. Your partner (or another relative or 
friend) will also be asked to complete some questionnaires. The study is in two parts. 
Initially, we would meet with you on one occasion. This visit should last no more than one 
and a half hours. After this visit, we may ask you to take part in the second stage. This would 
involve two further visits, each lasting no more than one and a half hours. Taking part in the 
study does not require any other changes to your routine. 
What are the possible risks of taking part? 
We do not anticipate that there are any risks to people taking part in this research. You may 
find some of the tasks a little tiring or frustrating.  
 
What are the possible benefits of taking part? 
We do not think you will benefit directly from taking part in this study, although you may 
find it enjoyable and stimulating to complete the tasks. Also, the results of this research may 
help improve care for people who have Parkinson’s disease in the future.  
 
Will my taking part in the study be kept confidential? 
Yes. In normal circumstances all information collected about you during the study will be 
kept confidential. All data will be stored securely and separately from any of your personal 
details. Only the researchers involved in the study will have access to this data. However, if 
the researcher observes or hears something that causes very serious concern about your 
well-being, it may be necessary to share this information with other professionals. The 
researcher would make every effort to first inform you of the need to share this 
information.  
Also, the researcher will ask your permission to inform your GP that you are taking part in 
the study.  
 
What will happen if I don’t want to carry on with the study? 
You may withdraw from the study at any time without giving a reason and this will not 
affect the standard of care you receive in any way. We may need to use the data collected 
before you decide to withdraw. 
 
What if there is a problem? 
We do not consider that taking part in the study may cause any risk to you and there are no 
special compensation arrangements if you are harmed by taking part in the study. If you are 
harmed due to someone’s negligence, then you may have grounds for a legal action, but 
you may have to pay your legal costs.  
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If you have a concern about any aspect of this study, you should speak to the researchers 
and we will do our best to answer your questions and resolve any concerns. If you remain 
unhappy and wish to complain formally, you can do this through the School of Psychology. 
The contact details are given below. 
 
Who is organising and funding the research? 
The research is being funded by the School of Psychology, Bangor University, and the 125th 
Anniversary Scholarship award. The project is being led by Mrs Aleksandra Kudlicka (PhD 
student) and supervised by Professor Linda Clare, a clinical psychologist who works at 
Bangor University, and Dr John Hindle, Consultant Physician in the Movement Disorders 
Clinic, Llandudno Hospital.  
 
What will happen to the results of the research? 
We will publish the results of the study in scientific journals. All information about 
participants will be anonymous, so you will not be identifiable in any publication. We can 
inform you of the findings of the study if you wish. 
 
Who has reviewed the study? 
All research in the NHS is analysed by an independent group of people, called a Research 
Ethics Committee, to protect your safety, rights, well-being and dignity. This study has been 
reviewed and granted approval by the North West Wales Research Ethics Committee.  
 
Who can I contact for further information? 
For more information about this research, please contact: 
Mrs Aleksandra Kudlicka 
School of Psychology, Bangor University, Bangor, Gwynedd, LL57 2AS 
Tel: 01248 383621 
Email: pspa16@bangor.ac.uk 
 
Professor Linda Clare 
School of Psychology, Bangor University, Bangor, Gwynedd, LL57 2AS 
Tel: 01248 388178 
Email: l.clare@bangor.ac.uk 
 
Dr John Hindle  
Llandudno Hospital, Hospital Road, Llandudno, Conwy, LL30 1LB 
Tel: 01492862366 
Email: j.v.hindle@nww-tr.wales.nhs.uk 
 
If you have any complaints about the conduct of this study you can contact: 
Mr Hefin Francis, School Manager 
School of Psychology, Bangor University, Bangor, Gwynedd, LL57 2AS.  
Tel: 01248 388339  
Email: h.francis@bangor.ac.uk 
 
Thank you for considering taking part in this research study! 
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Appendix C. Participant Consent Form 
 
PARTICIPANT CONSENT FORM 
Title of Project: Memory, concentration and planning in Parkinson’s disease 
Name of Researcher: Aleksandra Kudlicka  
Patient Identification Number for the study:  
 Please initial 
boxes 
1. I confirm that I have read and understand the information sheet  
(Version 1. 10/05/2010) for the above study. I have had the opportunity to 
consider the information, ask questions and have had these answered 
satisfactorily.  
 
 
2. I understand that my participation is voluntary and that I am free to withdraw 
at any time without giving any reason, without my medical care or legal rights 
being affected.  
 
 
3. I agree to provide some information in the form of an interview with researcher 
if required, and agree to this being tape-recorded. 
 
 
4. I agree to my GP being informed of my participation in the study.  
 
5. I understand that the researcher may need to inform other professionals if she 
observes or hears something that causes very serious concern about my well-
being or that of my relative/friend. The researcher would make every effort to 
first inform me of the need to share this information. 
 
 
6. I agree to take part in the above study.   
 
_______________________   _____________________      _____________________ 
Name of Patient    Date     Signature  
_______________________   _____________________       _____________________ 
Name of Researcher    Date     Signature  
School of Psychology 
Bangor University 
Brigantia Building, Penrallt Road 
Bangor, Gwynedd LL57 2AS 
Tel: (01248) 383621 
Fax: (01248) 382599 
e-mail: pspa16@bangor.ac.uk 
www.psychology.bangor.ac.uk 
Ysgol Seicoleg  
Prifysgol Bangor 
Adeilad Brigantia, Ffordd Penrallt 
Bango   Bangor, Gwynedd LL57 2AS 
Ffon: (01248) 38621 
Ffacs: (01248) 382599 
e-bost: pspa16@bangor.ac.uk 
www.psychology.bangor.ac.uk 
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INFORMANT INFORMATION SHEET  
Memory, concentration and planning in Parkinson’s disease 
We have invited your partner/another relative/friend to take part in a research study. To 
gain the full picture of his/her situation we also need to talk to someone that knows 
him/her very well. For that reason we would like to invite you to take part in the research 
study as well.  
 
Before you decide you need to understand why the research is being done and what it 
would involve for you. Please take time to read the following information carefully and talk 
to others about the study if you wish. Please, ask us if there is anything that is not clear or if 
you would like further information. Take your time to decide whether you wish to take part.   
Thank you for reading this information sheet. 
 
What is the purpose of this study? 
Some people with Parkinson’s’ disease (PD), who have problems with walking, stability or 
precise movements due to PD, also complain about their memory and concentration. Little 
is known about these problems in PD. In our study, we aim to find out about non-physical 
difficulties caused by PD. For example, we want to know how common these difficulties are 
and whether they affect the everyday life of persons with PD. We will also talk to 
participants to find out what kind of help they might find useful.  
Why have I been invited? 
You have been invited because your partner/relative/friend was diagnosed with Parkinson’s 
disease and is attending the Movement Disorders clinic, and has agreed to take part in our 
study.  We are looking for 65 people with Parkinson’s disease to take part in this study. 
 
Do I have to take part? 
You do not have to take part. It is up to you to decide. If you decide to take part in the study, 
we will ask you to sign a consent form.  You can keep this information sheet and please 
remember you will be free to withdraw from the study at any time without giving a reason. 
A decision not to take part, or to withdraw from the study, will not affect the standard of 
care your partner/relative/friend receives in any way. 
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What do I need to do if I take part? 
We will arrange a meeting time and place that are convenient for you and that will not 
disrupt your normal activities. You may take part in the study at Bangor University or at your 
own home. We will ask you to fill out some questionnaires about your well-being and your 
relative/friend’s well-being, everyday functioning, mood and how s/he copes with her/his 
chores and activities in terms of remembering, concentration and planning. It will take 
normally up to 30 minutes and can be completed during the meeting with your 
relative/friend. Taking part in the study does not require any other changes to your routine. 
What are the possible risks of taking part? 
We do not anticipate that there are any risks to people taking part in this research.  
 
What are the possible benefits of taking part? 
We do not think you will benefit directly from taking part in this study. However, the results 
of this research may help improve care for people who have Parkinson’s disease in the 
future.  
 
Will my taking part in the study be kept confidential? 
Yes. In normal circumstances all information collected about you during the study will be 
kept confidential. All data will be stored securely and separately from any of your personal 
details. Only the researchers involved in the study will have access to this data. However, if 
the researcher observes or hears something that causes very serious concern about your 
well-being or that of your relative/friend, it may be necessary to share this information with 
other professionals. The researcher would make every effort to first inform you of the need 
to share this information.  
 
What will happen if I don’t want to carry on with the study? 
You may withdraw from the study at any time without giving a reason and this will not 
affect the standard of care you receive in any way. We may need to use the data collected 
before you decided to withdraw. 
 
What if there is a problem? 
We do not consider that taking part in the study may cause any risk to you and there are no 
special compensation arrangements if you are harmed by taking part in the study. If you are 
harmed due to someone’s negligence, then you may have grounds for a legal action, but 
you may have to pay your legal costs.  
 
If you have a concern about any aspect of this study, you should speak to the researchers 
and we will do our best to answer your questions and resolve any concerns. If you remain 
unhappy and wish to complain formally, you can do this through the School of Psychology. 
The contact details are given below. 
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Who is organising and funding the research? 
The research is being funded by the School of Psychology, Bangor University, and the 125th 
Anniversary Scholarship award. The project is being led by Mrs Aleksandra Kudlicka (PhD 
student) and supervised by Professor Linda Clare, a clinical psychologist who works at 
Bangor University, and Dr John Hindle, Consultant Physician in the Movement Disorders 
Clinic, Llandudno Hospital.  
 
What will happen to the results of the research? 
We will publish the results of the study in scientific journals. All information about 
participants will be anonymous, so you will not be identifiable in any publication. We can 
inform you of the findings of the study if you wish. 
 
Who has reviewed the study? 
All research in the NHS is analysed by an independent group of people, called a Research 
Ethics Committee, to protect your safety, rights, well-being and dignity. This study has been 
reviewed and granted approval by the North West Wales Research Ethics Committee.  
 
Who can I contact for further information? 
For more information about this research, please contact: 
Mrs Aleksandra Kudlicka 
School of Psychology, Bangor University, Bangor, Gwynedd, LL57 2AS. 
Tel: 01248 383621 
Email: pspa16@bangor.ac.uk 
 
Professor Linda Clare 
School of Psychology, Bangor University, Bangor, Gwynedd, LL57 2AS 
Tel: 01248 388178 
Email: l.clare@bangor.ac.uk 
 
Dr John Hindle  
Llandudno Hospital, Hospital Road, Llandudno, Conwy, LL30 1LB 
Tel: 01492862366 
Email: j.v.hindle@nww-tr.wales.nhs.uk 
 
If you have any complaints about the conduct of this study you can contact: 
Mr Hefin Francis, School Manager 
School of Psychology, Bangor University, Bangor, Gwynedd, LL57 2AS.  
Tel: 01248 388339  
Email: h.francis@bangor.ac.uk 
 
 
Thank you for considering taking part in this research study! 
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Appendix E. Informant Consent Form 
 
 
 Please initial 
boxes 
1. I confirm that I have read and understand the information sheet  
(Version 1. 10/05/2010) for the above study. I have had the opportunity to consider 
the information, ask questions and have had these answered satisfactorily.  
 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any 
time without giving any reason, without medical care or legal rights of my 
partner/relative/friend being affected.  
 
 
3. I agree to provide some information in the form of an interview with researcher if 
required, and agree to this being tape-recorded. 
 
4.  I understand that the researcher may need to inform other professionals if she 
observes or hears something that causes very serious concern about my well-being or 
that of my relative/friend. The researcher would make every effort to first inform me 
of the need to share this information. 
 
 
5. I agree to take part in the above study.  
 
 
 
 
_______________________   _____________________      _____________________ 
Name of Patient    Date     Signature  
_______________________   _____________________       _____________________ 
Name of Researcher    Date     Signature
School of Psychology 
Bangor University 
Brigantia Building, Penrallt Road 
Bangor, Gwynedd LL57 2AS 
Tel: (01248) 383621 
Fax: (01248) 382599 
e-mail: pspa16@bangor.ac.uk 
www.psychology.bangor.ac.uk 
Ysgol Seicoleg  
Prifysgol Bangor 
Adeilad Brigantia, Ffordd Penrallt 
Bango   Bangor, Gwynedd LL57 2AS 
Ffon: (01248) 38621 
Ffacs: (01248) 382599 
e-bost: pspa16@bangor.ac.uk 
www.psychology.bangor.ac.uk 
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Appendix F. A structured form used to review articles considered for the 
literature review 
Title, author, year of publication: 
Inclusion criteria: Yes      No    Not clear 
1. The main aim of the study was to investigate EF in PD:  
EF itself or its components; relationship between EF and x; analysis of deficits (e.g. 
EF) underlying x.  
   
2. The severity of PD in patients included was mild to moderate (stage I-III H&Y)      
3. Patients were not diagnosed with: 
dementia  
   
depression    
no surgical intervention, brain injuries, other relevant conditions    
4. Reliable criteria for diagnosis of PD:    
 
Issues considered Information given/not given/details Controls 
Patients
: 
Sample size   
Mean age (SD)   
Mean education level (SD)   
Premorbid intelligence   
Illness: Severity of symptoms H&Y stage  
 Type/dose of medic.  
 Duration   
 Hallucinations  
 Laterality   
 Symptoms type  
 Tested during On/Off  
Aim of the study 
Object/s of investigation (as directly stated by author/s)  
Measured (not impaired/inconclusive)[+]  Impaired [–] lower then controls [*] 
Global cognition 
Memory 
Verbal ability 
Visuoperceptual functions/visuoconstructive skills  
Global EXECUTIVE FUNCTION 
(Working memory) 
(Attention) 
Set-maintenance 
Set-shifting/inhibition 
Cognitive/processing speed 
Reaction time  
Mental flexibility 
Verbal fluency  
Problem solving 
Reasoning 
Strategy generation 
Planning   
Decision making 
Abstract thinking 
SAS 
Mental effort 
Central executive processes 
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Measures used (not impaired/inconclusive)[+]  Impaired [–] lower then controls [*] 
FAB 
 
Stroop Test Part A Part B Part C (interference)  
Trail Making Test A, B, B/A  
 
Fluency tasks – letters, category, alternating  
COWAT 
(verbal fluency)  
 
(attention and processing speed)  
Digit span forward & backward  
Digit Ordering Test   
PASAT 
 
(mental flexibility and reasoning)  
Wisconsin Card Sorting Test  
WAIS Similarities  
Raven Progressive Matrices 
Odd Man Out Test 
MDRS Concept formation subscale 
Word relations judgment 
 
(planning, decision making) 
Tower of London etc.  
Iowa Gambling Test, Game of Dice Task 
 
Other 
  
 
Results/Conclusions 
 
 
 
EF conceptualisation 
Not existing – random test without justification 
Random test/s with some justification  
Discussion of tests choice, unjustified generalization about EF  
Directly stated dimension of EF without generalization about EF  
EF discussed and attempt to use comprehensive assessment of EF 
Other: 
 
Quality of the study / Comments 
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Appendix G. Detailed summary of studies examined at the final stage of the literature search and excluded from the review after in-
depth analysis of content 
Authors 
(year) 
Summary 
Participants 
n (men), mean age, 
years (SD or range, 
as reported) 
PD characteristics 
Diagnosis based on; H&Y stage; 
Depression, PD type, Laterality, 
Hallucinations, Medication, 
Tested on/off, MPD duration 
EF components and measures 
List of EF components  
(as specified by authors, but also other 
relevant abilities that were tested)  
and measures of EF that were used 
Reasons for 
exclusion 
Amboni, 
Cozzolino, 
Longo, 
Picillo, and 
Barone 
(2008) 
Authors compared executive functioning in two 
groups of PwPD, with and without freezing of 
gait. PwPD with freezing of gait performed 
significantly worse on most cognitive tests.   
28 PwPD  
No control group 
 
Demographic data 
available only for 
the PwPD 
subgroups.  
Diagnosis basis: UKPDSBB 
H&Y stage: < 2.5 
Dementia: no 
Depression: no 
Medication: details given 
Tested on/off: on 
MPD duration = <10 years 
Cognitive functions: Phonemic Fluency 
Tasks, Frontal Assessment Battery (FAB), 
the Ten Point Clock-Test, the Stroop Test 
 
No indication given of which tests are 
intended to measure EF.  
No control group. 
Auriacombe 
et al. (1993) 
Authors examined verbal fluency deficits in 
PwPD and suggested that deficits in verbal 
fluency may be related to lexical retrieval 
impairment.  
Experiment 1: 25 
PwPD 62.32 (11.08) 
19 Controls, 50.00 
(12.55) 
Experiment 2: 18 
PwPD, 11 Controls 
H&Y stage: I-II 
Dementia: no 
Medication: details given 
Tested on/off: on 
MPD duration = 7.74 (5.15) years 
Phonemic and Semantic Fluency Tasks, 
Design Fluency, Category Drawing. 
Rey Auditory Verbal Learning Test (RAVLT) 
 
It was not discussed which tests are 
supposed to measure EF. 
The study examined 
verbal fluency in 
terms of language 
abilities not EF.  
Depression not 
assessed. 
Bialystok et 
al. (2008) 
Authors compared performance on two 
concurrent tasks in PwPD, older controls and 
young controls. PwPD used a different strategy 
to controls, possibly reflecting reduced 
flexibility in switching between tasks, but it was 
beneficial for performance on the primary task. 
PwPD scored better than older and young 
controls on some of performance indices.  
17 PwPD (9 men) 
68.5 (6.0) 
15 older controls (5 
men) 70.4 (4.4) 
15 young controls 
(5 men) 20.9 (2.7) 
H&Y stage: I-III (not complete) 
Dementia: no (not complete) 
Medication: details given 
Tested on/off: on 
MPD duration =  5.1 (2.6) 
Switching: Experimental paradigm (the 
breakfast task) 
Short-term verbal memory: Digit Span 
Forward 
WM: Alpha Span 
 
Depression not 
assessed. 
Incomplete 
information about 
general cognition 
and PD severity. 
Experimental 
paradigm. 
Brown, 
Soliveri, and 
Jahanshahi 
(1998)  
Authors examined how EF contribute to 
performance on the Random Number 
Generation Test (RNG). Overall performance 
on the RNG was comparable in PwPD and 
controls.  
16 PwPD 61.7 (6.1) 
8 controls 58.5 
(9.1)  
H&Y stage: I-III 
Tested on/off: half in ‘off’, half 
in ‘on’ 
MPD duration = 5.8 (4.0) 
Random Number Generation Test (RNG) 
Visuomotor Tracking Task  
Authors discussed what abilities may be 
involved in performance on the above task.  
No information 
about general 
cognition or 
depression level. 
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Cameron, 
Watanabe, 
Pari, and 
Munoz 
(2010) 
Authors investigated switching between pro-
saccade eye movements (automatic) and anti-
saccade eye movements (suppressing 
automatic eye movement).  PwPD had greater 
difficulty than controls in switching to anti-
saccade eye movement, but where quicker to 
switch back to the pro-saccade eye movement. 
12 PwPD (8 men) 
60.3 
12 controls (5 men) 
59.9 
H&Y stage: I-III 
Dementia: no 
Medication: details given 
Tested on/off: on 
Switching between pro-saccade and anti-
saccade eye movements: Experimental 
paradigm 
 
No direct 
assessment of EF. 
Experimental 
paradigm.  
Depression not 
assessed. 
Crucian et 
al. (2007) 
Authors investigated response inhibition in 
PwPD. Results suggested defective response 
inhibition in PwPD, possibly related to the 
laterality of the PD symptoms. There was no 
difference between ‘on’ and ‘off’ medication 
performance. No differences were found on 
the fluency and anti-saccade tasks. 
17 PwPD (9 men) 
66.06 (12.04) 
30 controls 63.9 
(10.97) 
H&Y stage: I-III 
Dementia: no 
Tested on/off: on and off 
separately 
MPD duration = 8.87 (6.25) years 
Response inhibition: Crossed Response 
Inhibition experimental paradigm* 
Frontal-cognitive bedside tests: 
COWAT, The Anti-saccade Task 
(experimental paradigm) 
 
Depression not 
assessed. 
Experimental 
paradigm. 
 
Dalrymple-
Alford et al. 
(1994) 
Authors investigated whether PD pathology 
influences central executive. Both groups 
performed comparably in the single-task 
condition; PwPD scored significantly lower than 
controls in the dual task condition. Authors 
interpreted this as evidence for impaired 
central executive in PwPD. 
8 PwPD 65.6 (3.0) 8 
controls 62.4 (2.1) 
H&Y stage: I-III 
Dementia: no 
Depression: elevated scores 
Laterality: details given 
Medication: details given 
MPD duration = 4.4 (1.3) years 
Central executive: Dual task paradigm*  
(tracking task and digit span forward) 
Categorisation and behavioural regulation: 
WCST, Phonemic Fluency* 
Depression level 
significantly higher 
in PwPD than in 
controls. 
Experimental 
paradigm. 
 
Donovan, 
Siegert, 
McDowall, 
and 
Abernethy 
(1999) 
Authors investigated word generation 
strategies in the fluency tasks (clustering and 
switching). PwPD performed worse than 
controls on both fluency tasks, and there were 
some differences in the strategy use. 
13 PwPD (9 men) 
68.15 (45-85)  
11 Controls (3 men) 
63.81 (46-81) 
H&Y stage: I-III 
Dementia: no 
MPD duration = 0-18 (median 6) 
years 
Phonemic and Semantic Fluency Tasks 
(COWAT )*, Animal Naming Task from the 
Boston Diagnostic Aphasia Examination 
The study examined 
verbal fluency in 
terms of language 
abilities, not EF. 
Incomplete 
information about 
depression level. 
Drag, 
Bieliauskas, 
Kaszniak, 
Bohnen, and 
Glisky (2009) 
Authors investigated source memory, in 
relation to various tests related to frontal 
functioning. The EF composite score (and only 
digit span backward individually) was 
significantly lower in PwPD than in controls. 
24 PwPD 69.04 
(7.42)  
24 controls 68.67 
(8.34) 
H&Y stage: I-III 
Dementia: no 
Depression: mild to moderate 
depression in 7 PwPD 
Tested on/off: on/off separately 
Source memory:  Experimental paradigm 
Tests of frontal functioning: Verbal Fluency 
FAS (total words), mWCST (categories 
achieved), Digit Span Backward*, WMS-III 
Mental Control, WAIS-T Mental Arithmetic 
Experimental 
paradigm. 
The study included 
participants with 
elevated depression 
scores. 
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Elgh et al. 
(2009) 
Authors aimed to describe the pattern of 
cognitive functioning in early stage PD. In the 
tests listed as EF measures only one out of 
eight performance indices of WCTS indicated 
significant difference (PwPD<controls), after 
adjusting for age, gender, education and 
psychomotor function.  
88 PwPD (49 men) 
68.1 (9.3) 30 
controls (16 men) 
68.2 (6.6.) 
Diagnosis basis: Gibb et al. 1988 
H&Y stage: newly diagnosed 
Dementia: no 
Depression: yes, 14 PwPD 
Medication: 2 patients on low 
dose of dopamine, others 
without medication 
EF: WCST*, Mental Control (WMS-III) 
Working memory: Digit Span  Forward and 
Backwards 
Attention: TMT A* and B* 
Verbal function: Phonemic and Semantic* 
Fluency (COWAT), Boston Naming Test, 
Authors discussed what abilities were 
assessed with what tests. Here only the 
relevant categories are reported.  
The study included 
14 PwPD with 
elevated depression 
scores. 
Fales, Vanek, 
and 
Knowlton 
(2006) 
Authors compared backward inhibition (an 
automatic mechanism observed when 
switching between tasks) in PwPD and 
controls. Out of the 25 performance indices 
drawn from the five EF tests only two were 
significantly lower in PwPD than in controls. 
21 PwPD (13 men) 
66.9 (8.2) 
25 controls (13 
men) 68.8 (9.6) 
H&Y stage: I-III 
Dementia: no 
Depression: no 
Medication: details given 
Tested on/off: optimally 
medicated 
MPD duration = 5.8 years (3.5) 
Backward inhibition: Task-Switching Test 
(Experimental paradigm) 
EF: WCST (non-perseverative errors*), 
Stroop Test, Colour Trail test, ToL (time to 
first move*), Verbal and Semantic Fluency 
Tests 
The focus of the 
study was a non-EF 
automatic process 
involved in set-
shifting. 
Experimental 
paradigm. 
N. Fournet, 
Moreaud, 
Roulin, 
Naegele, and 
Pellat (1996) 
The study investigated whether attentional 
deficits in PwPD are related to impairment in 
central executive. PwPD had significantly 
shorter spans, but the interference did not 
affect them more than controls, which does 
not support the hypothesis of impaired central 
executive.  
15 PwPD (9 men) 
66.1 (8.2) 15 
controls 66.6 (11.5) 
H&Y stage: I-III 
Dementia: no 
Medication: details given 
MPD duration = 8.0 years (4.8) 
Working memory and central executive 
specifically: Experimental paradigm (verbal, 
visual, spatial spans with two conditions of 
articulatory suppression: repeating 
phoneme ‘da’ and counting upward in 
threes) 
Depression not 
assessed. 
Experimental 
paradigm. 
 
Graceffa, 
Carlesimo, 
Peppe, and 
Caltagirone 
(1999) 
Authors investigated verbal working memory in 
relation to the articulatory loop and central 
executive. PwPD performed similar to controls 
on articulatory loop task, but their 
performance decreased significantly more than 
in controls when concurrent task was added, 
suggesting deficits in the central executive.  
12 PwPD 65.2 (48-
82) 
12 controls 65.6 
(41-82) 
H&Y stage: I-III 
Dementia: no 
PD type: rigid-akinetic 
Laterality: bilateral 
Medication: details given 
Tested on/off: on  
Articulatory loop and central executive: 
Word Span (Brizzolara et al. 1993) and 
Brown-Peterson Paradigm  
 
Depression not 
assessed. 
Experimental 
paradigms. 
 
Hausdorff et 
al. (2006) 
Authors examined EF and attention in PD and 
elderly fallers. PwPD had significantly lower EF 
index score then control group.  
30 PwPD (70% 
men) 71.3 (7.8) 
25 controls (66% 
men)70.0 (6.1) 
18 fallers (33% 
men) 77.1 (4.9) 
Diagnosis basis: Gelb et al., 
1999) 
H&Y stage: II-III 
Dementia: no 
Go-NoGo Response Inhibition Test, Verbal 
Memory, Stroop Interference Test (no-
interference condition*), Non-Verbal 
Memory, Finger Tapping, Catch Game, 
Staged Information Processing Speed Test; 
EF index score* 
No indication was given of which measures 
were included in the EF index score. 
The main interest of 
the study was the 
group of elderly 
fallers and not 
PwPD.  
Depression not 
assessed. 
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Y.-H. Hsieh, 
Chen, Wang, 
and Lai 
(2008) 
Authors examined what contributes to  
impaired performance on the Stroop test. 
Results suggested that slower motor responses 
and greater interference effects in PwPD were 
important contributors.  
27 PD PwPD (17 
men) 63.10 (10.49)  
27 controls (14 
men) 63.48 (9.15) 
Diagnosis based on: two or 
more clinical signs of PD 
H&Y stage: I-III 
Dementia: cognitive status 
indicated by normal 
performance in the word list 
generation and digit span 
MPD duration= 3.34 (2.33) years 
Inhibitory control, WM updating: Stroop 
Test (color naming*, word reading*, colour-
word naming*, decision time, interference 
score*) 
Cognitive status 
was not assessed 
formally.  
Depression not 
assessed. 
Inzelberg et 
al. (1996) 
Authors investigated performance on motor 
and cognitive switching tasks in PwPD and 
controls. Both mental and motor switching was 
impaired in PwPD in comparison to controls, 
but there was no significant correlation 
between them. 
9 PwPD (6 men) 74 
(8)  
7 controls (4 men) 
74 (9) 
H&Y stage: II-III 
Dementia: PwPD described as 
non-demented but there is no 
further details 
Tested on/off: off 
Mental switching: Modified WCTS * 
Motor switching: Experimental paradigm* 
(upper limb reaching toward a visual target) 
Results of cognitive 
screening/tests 
were not reported. 
Experimental 
paradigm. 
Depression not 
assessed. 
Inzelberg et 
al. (2001) 
Authors investigated the relationship between 
motor and cognitive switching in PwPD. Both 
mental and motor switching were impaired in 
PwPD but not correlated. 
8 PwPD (5 men) 74 
(9)  
6 controls (3 men) 
73 (9) 
H&Y stage: II-III 
Dementia: no 
Tested on/off: off 
Mental switching: Modified WCTS  
Motor switching: Experimental paradigm* 
(upper limb reaching toward a visual target) 
Depression not 
assessed. 
Experimental 
paradigm. 
 
Kemps, 
Szmalec, 
Vandierendo
nck, and 
Crevits 
(2005) 
Authors investigated how central executive 
contributes to performance on a visuospatial 
task. 
15 PwPD (7 men) 
67.20 (4.39) 
15 controls 7 men) 
67.8 (4.44) 
H&Y stage: I-III 
Dementia: no 
Depression: no 
Medication: details given 
Tested on/off: on 
MPD duration = 11.93 (8.30) 
Visuo-spatial abilities: Corsi Blocks* 
Concurrent visuo-spatial sketch pad task: 
Spatial Tapping (experimental paradigm) 
Central executive task: 
Random Interval Repetition Task 
(experimental paradigm) 
Experimental 
paradigm.  
EF was not the main 
focus of the study.  
Depression and 
cognitive status not 
assessed  
Kim, Cheon, 
Park, Kim, 
and Jo 
(2009) 
Authors investigated the frequency and 
pattern of cognitive impairment in PwPD; 40% 
of patients showed impairment in at least one 
of 5 assessed cognitive domains, with memory 
commonly being impaired. 
141 PwPD 
No control group. 
Demographic data 
available only for 
the PwPD 
subgroups.  
Diagnosis basis: UKPDSBB 
Dementia: no 
Depression: no 
PD type: proportions of 
tremor/akinetic-rigid given 
Medication: details given 
EF: Phonemic Controlled Oral Word 
Association Test 
Attention: Digit Span Forward 
The study included a number of 
neuropsychological tests. Here only the 
relevant cognitive domains are reported. 
Test results only 
given for the PwPD 
subgroups. 
No control group. 
No exact H&Y stage 
values. 
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Lewis, Cools, 
et al. (2003) 
Authors investigated several aspects of WM in 
two PwPD groups: PwPD with good 
performance on the Tower of London (ToL) test 
and PwPD with poor performance on ToL. 
PwPD with poor ToL performance had impaired 
performance on the verbal memory tasks 
requiring information manipulation. 
41 PwPD  
24 controls (8 men) 
65.3 (8.2) 
Demographic data 
available only for 
the PwPD 
subgroups.  
Diagnosis basis: UKPDSBB 
H&Y stage: I-III 
Dementia: no 
Medication: details given 
EF: ToL 
Verbal WM: Experimental paradigm 
Neuropsychological testing:  Verbal and 
Categorical Fluency, Pattern and Spatial 
Recognition Memory Tests (CANTAB); 
Motor Latency (CANTAB Motor Screening) 
Test results only 
given for the PwPD 
subgroups. 
Incomplete control 
data. 
PwPD with elevated 
depression scores 
included. 
Lewis, 
Slabosz, 
Robbins, 
Barker, and 
Owen (2005) 
Authors investigated different aspects of 
working memory in PwPD ‘on’ and ‘off’ 
dopaminergic medication. L-dopa seemed to 
improve accuracy and response time, but not 
attentional set-shifting.  
20 PwPD 70.2 (6.0) 
19 controls in WM 
paradigm 68.3 (7.0) 
21 controls in set-
shifting paradigm 
68.2 (8.0) 
Diagnosis basis: UKPDSBB 
H&Y stage: I-III 
Dementia: no 
Depression: no 
Medication: details given 
WM (maintenance, retrieval and 
manipulation of information): Experimental 
paradigm 
Attentional set-shifting: Experimental 
paradigm 
EF was not the main 
focus of the study.  
Experimental 
paradigms. 
McDonald, 
Brown, and 
Gorell 
(1996) 
Authors examined two hypotheses of slower 
reaction times on the lexical decision task in 
PwPD: semantic deficit and set-shifting deficit. 
PwPD did not differ from controls in language 
tests, but scored significantly lower on the 
WCST test.  
28 PwPD (18 men) 
63.68 (7.73)  
28 controls (18 
men) 64.18 (5.75) 
H&Y stage: 0.5 – 2.5 
Dementia: no 
Depression: depression level 
significantly higher in PwPD 
than controls 
Medication: details given 
MPD duration = 66 month (4-160) 
Lexical Decision Task: Experimental 
paradigm (making word/nonword 
judgments about target letter strings)  
Tendency to perseverate: WCST*  
Semantic processing: Shipley-Hartford 
Vocabulary Test, Boston Naming Test, 
Spelling Test  
EF was not the main 
focus of the study.  
Depression level 
significantly higher 
in PwPD than in 
controls 
 
Monetta 
and Pell 
(2007) 
Authors investigated potential correlates of 
impaired metaphor comprehension in PwPD. 
Performance on neuropsychological tests was 
compared in PwPD with good vs. poor 
metaphor comprehension, and controls. 
Results suggested less efficient processing of 
metaphors in PwPD, possibly related to deficits 
in WM. 
17 PwPD 66.4 
(11.6) 
17 controls 67.4 
(9.8) 
Diagnosis basis: motor criteria 
H&Y stage: mild to moderate, 
but no H&Y stage given 
Dementia: no 
Depression: yes 
Laterality: details given 
Medication: details given 
Tested on/off: on 
Metaphor comprehension: Experimental 
paradigm 
EF/frontal: Digit Span Forward, Verbal 
Working Memory Span, Colour Trail Making 
Test, Verbal Fluency Test, ToL, Warrington 
Recognition Memory Test (faces and 
words), the Benton Phoneme Discrimination 
and Face Recognition Subtests 
Experimental 
paradigm. 
Tests’ results only 
for the PwPD 
subgroups. 
Depression level 
significantly higher 
in PwPD. 
Ozer et al. 
(2007) 
Authors investigated relationship between 
several disease characteristics and cognitive 
functioning in two groups of PD patients: with 
and without visual hallucinations (VH). PwPD 
with VH scored significantly lower than PwPD 
without VH group on the Stroop test, semantic 
fluency and clock drawing, but not in 
‘alternating category’ fluency or WCST 
(category). 
63 PwPD  
No control group 
 
Demographic data 
available only for 
the PwPD 
subgroups.  
Diagnosis basis: UKPDSBB 
H&Y stage: I-II 
Dementia: no 
Hallucinations: yes, see groups 
Medication: details given 
Tested on/off: on 
Frontal functions: Stroop Test, WCST, 
Categorical Verbal Fluency, Clock Drawing. 
 
The study included a number of 
neuropsychological tests. Here only the 
relevant cognitive domains are reported. 
Test results only 
given for the PwPD 
subgroups. 
No control group. 
Depression not 
assessed. 
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Possin, 
Filoteo, 
Song, and 
Salmon 
(2009) 
Authors examined performance of PwPD on 
the Inhibition of Return task with and without 
cues. PwPD exhibited impaired performance 
on the task without cues, but not when cues 
were provided.  
18 PwPD (11 men) 
67.0 (8.3) 
18 controls (9 men) 
69.4 (8.2) 
Diagnosis basis: 2 of 3 cardinal 
symptoms  
H&Y stage: I-III 
Dementia: no 
Depression: no 
Laterality: details given 
Medication: details given 
Tested on/off: on 
MPD duration = 5.4 (3.8) years 
Inhibition of Return Task: Experimental 
paradigm 
No EF measure. 
Inhibition and 
attention discussed 
in terms of 
involuntary 
processes.  
Experimental 
paradigm 
 
Raskin, 
Sliwinski, 
and Borod 
(1992) 
Authors investigated semantic and phonemic 
clustering in verbal fluency tasks. PwPD 
produced more semantic clusters in the 
semantic retrieval task. 
25 PwPD (12 men) 
65.9 (10.2)  
22 Controls (10 
men) 62.0 (9.6) 
H&Y stage: I-III 
Dementia: no 
PD type: details given 
Semantic and phonemic clustering in letter 
retrieval: Phonemic Fluency (COWAT)  
Semantic* and phonemic clustering in 
semantic retrieval: Semantic Fluency  
(Animal Naming from the Boston Diagnostic 
Aphasia Examination) 
Only the linguistic 
aspects of verbal 
fluency tasks were 
considered.  
Depression not 
assessed. 
Raskin, 
Borod, and 
Tweedy 
(1992) 
Authors examined shifting and spatial-
orientation abilities in PwPD and controls. 
PwPD performed poorer than controls on the 
majority of the set-shifting tests.  
 
20 PwPD (10 men) 
64.60 (10.29) 
20 controls (8 men) 
62.60 (10.98) 
H&Y stage: I-III 
Dementia: no 
Medication: details given 
Tested on/off: on 
Set-shifting functions: 
COWAT (alternating*), Uses of Objects 
Test*, Digits Forwards and Backwards 
(difference), Competing Program*, Go/No-
Go, Motor Programs I*, Motor Programs II* 
The study included a number of spatial-
orientation tests not reported here. 
Depression not 
assessed. 
Rogers et al. 
(1998) 
Authors compared, PwPD, people with frontal 
lobe damage and controls with regard to the 
efficiency of executive control, understood as 
efficient switching between two simple tasks. 
Switching abilities appeared as relatively 
preserved in PwPD.  
12 PwPD (6 men) 
59.2 (1.8)  
12 controls (5 men) 
58.5 1.8 
Data from people 
with frontal lobe 
damage are not 
included here. 
H&Y stage: I-II 
Medication: details given 
Tested on/off:  
MPD duration = 2.4 years (0.3) 
Executive control processes: Task-Switching 
Task (Experimental paradigm, switching 
between digit and letter-naming) 
Background neuropsychology: Phonetic 
and Semantic Fluency, Spatial Working 
Memory Task, Recognition Memory 
(pattern, spatial*) 
Depression and 
cognitive status not 
assessed. 
Experimental 
paradigm. 
 
Santangelo 
et al. (2009) 
Authors investigated correlations between 
cognitive functioning and pathological 
gambling in PwPD with and without 
pathological gambling. PwPD with pathological 
gambling performed significantly worse on a 
number of frontal lobe function tests.  
30 PwPD 
No control group 
 
Demographic data 
available only for 
the PwPD 
subgroups.  
 
Diagnosis basis: UKPDSBB 
Dementia: no 
Depression: yes 
Medication: details given 
Tested on/off: on 
EF: Frontal Assessment Battery 
Frontal lobe functions: flexibility (WCST), 
WM (Corsi Blocks), logical abstract thinking 
(Raven’s Coloured Progressive Matrices), 
spatial planning (Rey-Osterrieth Complex 
Figure, ROCF), set-shifting (TMT) 
Memory: ROCF, Rey Auditory Learning Test 
PwPD with elevated 
depression scores 
included. 
No exact H&Y stage 
indicated. 
No control group. 
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Siri et al. 
(2009) 
Authors compared PwPD with and without 
pathological gambling with regard to cognitive 
functioning. PwPD with pathological gambling 
performed better than PwPD without 
pathological gambling on several cognitive 
tests, but their caregivers reported more 
behavioural disturbances. 
63 PwPD 
No control group. 
 
Demographic data 
available only for 
the PwPD 
subgroups. 
Diagnosis basis: UKPDSBB 
Medication: details given 
Tested on/off: on 
EF: Phonemic and Semantic Fluency, 
Raven’s Coloured Progressive Matrices Sets, 
Frontal Assessment Battery 
Short term memory: Rey Auditory Verbal 
Learning Test 
Attention: attentive matrices 
Behavioural disturbances: Neuropsychiatric 
Inventory (NPI) 
No exact H&Y stage 
indicated. 
No exact MMSE 
scores. 
Authors mentioned 
using a depression 
screening tool, but 
no values were 
reported. 
No control group. 
Sobreira et 
al. (2008) 
Authors analysed relationships between 
various tests of EF in PwPD.   
35 PwPD 63.1 
(12.4) 
Diagnosis basis: Gelb at al. 1999 
H&Y stage: <III 
Dementia: yes, MMSE 18-29 
Depression: no 
Tested on/off: on 
Attention, Initiation/Perseveration, and 
Conceptualisation subscales of Mattis 
Dementia Rating Scale, SCOPA-COG, WCST, 
FAB, Digit Span Backward, Verbal Fluency.  
Abilities assessed by each test were 
described in detail. 
PwPD with mild 
dementia were 
included. 
No control group. 
Tamura, 
Kikuchi, 
Otsuki, 
Kitagawa, 
and Tashiro 
(2003) 
Authors aimed to investigate the differential 
contribution of attentional set-shifting and 
attention resources to performance on WM 
tests. PwPD scored poorer than controls on 
several tasks of WM and attention. 
Performance on tasks requiring set-shifting was 
not specifically analysed.  
24 patients (15 
men) 60.9 (9.72) 
24 controls (11 
men) 61.7 (9.58) 
H&Y stage: I-III 
Dementia: no 
Medication: details given 
Tested on/off: on 
MPD duration = 6.00 years (5.98) 
Verbal memory: Digits Forward, Digits 
Backward*, Five Times Rehearsal, Mental 
Calculation (WAIS-R)*, Delayed Recall of 
Words 
Visual memory: Forward and Backward 
Visual Memory Span Test (WMS-R) 
Attention: Kana Pick-Out Test, TMT A, B*, 
A-B* 
None of the tests 
were specified as 
measuring EF or 
set-shifting. 
Depression not 
assessed. 
Rachel 
Tomer, 
Aharon-
Peretz, and 
Tsitrinbaum 
(2007) 
Authors assessed whether symptoms 
asymmetry (left/right onset of PD) is related to 
spontaneous and reactive flexibility in PwPD. 
35 PwPD (21 men)  
12 controls 59.5 
(8.4)  
Demographic data 
available only for 
the PwPD 
subgroups.  
Diagnosis basis: UKPDSBB 
H&Y stage: I-III 
Dementia: no 
Depression: yes, 50% of PwPD  
PD type: details given 
Laterality: yes, see groups 
Medication: details given 
Spontaneous flexibility: Alternate Uses Test  
Reactive flexibility: Intradimensional/ 
Extradimensional Attentional Set-Shifting 
Task from CANTAB 
Test results only 
given for the PwPD 
subgroups. 
PwPD with elevated 
depression scores 
included. 
R. S. Wilson, 
Gilley, 
Tanner, and 
Goetz (1992) 
Authors investigated dissociation between the 
visuospatial and executive functions. PwPD 
showed deficits only on the ideational fluency 
tasks, while deficits on spatial orientation tasks 
seem to be related to age and verbal 
intelligence rather than PD.  
10 younger PwPD 
(4 men) 53.6 (7.7)  
7  young controls (2 
men) 46.4 (7.7) 
10 older PwPD (4 
men) 68.9 (5.3) 
8 older controls (3 
men)  69.3 (6.3) 
Diagnosis basis: 2 of 3 cardinal 
PD symptoms  
H&Y stage: I-III 
Dementia: no 
Hallucinations: no  
EF aspects: ideational fluency (Topics Test, 
Things Categories Test); flexibility of use 
(Making Groups, Different Uses) 
Visuospatial: spatial orientation (Card 
Rotations Test, Cube Comparison Test) 
Verbal comprehension: Extended Range 
Vocabulary 
Depression not 
assessed. 
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 van 
Spaendonck, 
Berger, 
Horstink, 
and 
Buytenhuijs 
(1996) 
Authors investigated the relationship between 
EF (verbal fluency and cognitive shifting) and 
several PD characteristics. Cognitive shifting 
was correlated with motor symptoms (rigidity), 
while there were no such correlations with 
fluency tasks.  
45 PwPD (23 men) 
57.4 (10.5) 
33 controls 57.4 
(8.7) 
Diagnosis basis: 2 of 3 cardinal 
symptoms  
H&Y stage: newly diagnosed 
Medication: no anticholinergic 
drugs, 34 de novo patients 
MPD duration= 5.8 (3.7) 
EF: fluency (Semantic and Phonemic); 
cognitive shifting (WCST, Animal Sorting 
Test, Spatial Sorting Test) 
Reference tests: intelligence (WAIS-R: 
Vocabulary, Similarities, Picture 
Competition, Block Design), memory 
(RAVL), attention (Stroop Test parts B & C) 
No formal 
comparison of 
PwPD and control 
group. 
PwPD with elevated 
depression scores 
included. 
Zamarian et 
al. (2006) 
Authors examined the role of EF in arithmetic 
abilities in PwPD. PwPD scored significantly 
lower than controls on all EF measures and one 
of WM tests (digit span backward). PwPD 
scored poorer than controls in only three out 
of over 30 measures reported.  
15 PwPD (13 men) 
66.1 (7.1) 28 
controls (7 men) 
63.1 (5.6)  
H&Y stage: <III 
Dementia: no 
Medication: details given  
Tested on/off: no motor 
fluctuations 
MPD duration= 5.3 (3.4) 
EF: semantic and alternating fluency 
(Regensburger Wortflussigkeitstest, 
CERAD);  Interference Naming (Nürnberger-
Alters-Inventar); divided attention and 
cognitive flexibility (TMT-B); set shifting 
(Odd-Man-Out) 
WM: Digit Span Backward 
The study included a number of 
neuropsychological tests. Here only the 
relevant cognitive domains are reported 
Arithmetic abilities: Number Processing and 
Calculation Battery 
Depression not 
assessed. 
Zec et al. 
(1999) 
Authors investigated semantic, phonemic and 
alternating fluency in PwPD. PwPD performed 
similar to controls in phonemic fluency tasks, 
scored lower then controls in 2 out of 3 
semantic fluency trials, and were impaired in 
all 3 alternating trials. 
45 PwPD (29 men) 
66.4 (10.2) 
45 controls (11 
men) 63.1 (10.6) 
H&Y stage: I-III, one PwPD = IV 
Dementia: no 
Semantic Fluency (animals, boy’s names, 
states) 
Phonemic Fluency (letters F, A, and S) 
Alternating Fluency (colours/occupations, 
animals/states, words beginning with C/P) 
The study included 
PwPD in H&Y > III 
Depression not 
assessed. 
* Significant difference between PwPD and controls; PwPD – people diagnosed with Parkinson’s disease  UKPDSBB - UK PD Society Brain Bank; H&Y – 
Hoehn and Yahr, EF – Executive functions; WM – Working memory; WCST – Wisconsin Card Sorting Test, TMT AB - Trail Making Test A, B, ToL - Tower 
of London test  
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Appendix H. Detailed summary of articles included in the systematic review. 
Author (year) Aim of the study 
Participants 
n (men), mean age, years 
(SD or range, as reported) 
PD characteristics 
Diagnosis based on; H&Y 
stage; Depression, PD type, 
Laterality, Hallucinations, 
Medication, Tested on/off, 
MPD duration 
EF components and measures 
List of EF components (as specified by authors, but also other 
relevant abilities that were tested) and measures of EF that 
were used (if it was not clear whether authors considered a 
test as an EF measure that measure was included (in italics), if 
clearly not related to EF it was omitted). 
Studies focused on executive or frontal functions as a whole, selectively or in relation to other factors. 
 Bondi et al. 
(1993) 
 
To examine whether PwPD exhibit 
Frontal System Dysfunction, and 
whether this impairment may 
contribute to memory and 
visuoperceptual deficits. Frontal 
System Dysfunction was 
considered as a whole and more 
specific abilities were only 
mentioned. 
19 PwPD (16 men), 67.32 
(6.85) 
19 controls (7 men), 69.26 
(5.36) 
H&Y stage: I-III 
Dementia: no 
Depression: no 
Tested on/off: on 
Median PD duration = 8 years (1-
17) 
Frontal system tasks (composite score*): 
Phonemic, and Semantic Fluency*, Modified WCST *, California 
Sorting Test*, Verbal Temporal Ordering*. 
Colman et al. 
(2009) 
To investigate the relationship 
between EF and language problems 
(verb production). 
28 PwPD (16 men), 61.39 
(8.8) 
28 controls(16 men), 62.93 
(9.04) 
Diagnosis based on: UKPDSBB 
H&Y stage: I-III 
Dementia: no 
Depression: no 
Laterality: details given 
Medication: details given 
Tested on/off: on 
MPD duration = 6.04 years (4.55) 
Attention: 3 subtests of Testbatterie zur 
Aufmerksamkeitsprufung (Sustained Visual*, Sustained 
Auditory and Divided Attention),  
WM: Digit Span Forward and Backward, 
Cognitive set-switching: TMT A and B + Odd Man Out 
(composite score*) 
Inhibititory control: Stroop Test 
Verbal Fluency: Phonemic, Semantic, and Action Fluency 
Abstract structure processing: Experimental paradigm 
Dujardin et al. 
(2001) 
To compare executive functioning 
and memory in sporadic and 
familial Parkinson’s disease. 
#12 sporadic PwPD (7 men), 
65.92 (51-74)  
12 familial PwPD (5 men), 
63.42 (44-76) 
12 controls (6 men), 59.25 
(47-73) 
Diagnosis based on: UKPDSBB 
H&Y stage: I-III 
Dementia: no 
Depression: no 
PD type: familial/sporadic 
Medication: details given 
MPD duration = 103/74 months 
Planning: Verbal Fluency, Spatial Sequences Generation* 
Resistance to interference: Set shifting: WCST, Alternate 
Fluency*, Motor Sequences*, Brown-Peterson Paradigm* 
Memory: Immediate (Digit Span Forward and Backward, 
Spatial Span, Word Span); working memory (Decline Of Storage 
Abilities %)  
The study included a number of long-term memory tests not 
reported here. 
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Farina et al. 
(1994) 
To investigate performance of 
PwPD in a task sensitive to 
impairment resulting from 
unilateral frontal cerebral excision. 
22 PwPD (11 men), 52.86 
(39-72) 
19 controls (6 men), 53.42 
(33-66) 
H&Y stage: I-III 
Dementia: no 
Depression: no 
Medication: details given  
MPD duration = 57.7 months (12-
132) 
Organization, planning and memory:  
Classification* and Recall of Pictures 
Farina et al. 
(2000)  
To examine frontal functions (set-
shifting) and explicit memory in 
early PD. 
20 PwPD (13 men), 57.9 
(8.3) 
18 controls (10 men), 56.6 
(6.4) 
H&Y stage: I-II 
Dementia: no 
Depression: no 
Medication: details given 
MPD duration=28 months (3-96) 
Abstract behavior and shifting ability: WCTS (2*/4 variables) 
Concept formation and free recall: Test of Categorization and 
Recall (2*/5 variables) 
Abstract non-verbal reasoning: Ravens Progressive Matrices* 
Short-term verbal memory and attention: Digit Span  
Short-term visuo-spatial memory and attention: Corsi’s Block-
Tapping  
Visuospatial long-term memory: Corsi’s Supra Span Tapping* 
Verbal long-term memory: Paired Associated Learning Test  
(Measures not discussed: Odd Man Out (1*/2 variables), 
Phonemic Fluency) 
Uekermann et al. 
(2004) 
To investigate executive 
functioning in relation to motor 
and affective symptoms in early 
PD. 
20 PwPD (8 men), 55.9 
20 controls (9 men), 53.2  
H&Y stage: I-II 
Dementia: no 
Depression: controlled in the 
analysis 
Medication: details given 
Tested on/off: no fluctuations 
MPD duration= 4.6 years (3.0) 
Initiation: (Phonemic*, Semantic, Alternating Fluency) 
Planning and problem solving: Key Search, Six Elements* and  
Zoo Map Test (BADS, Behavioral Assessment of the 
Dysexecutive Syndrome)  
Reasoning: Temporal Judgment* and Cognitive Estimation task 
(BADS),  
Inhibition: Rule Shift Cards* (BADS), Hayling test* 
Self-reported behavioral problems: Dysexecutive 
Questionnaire (BADS) 
Price and Shin 
(2009) 
To clarify how PD pathology 
influences sequence learning and 
underlying processes, including EF. 
12 mild PD patients (H&Y 
stage I) 71.9 (2.0)  
10 moderate PD patients 
(H&Y stage II-III)  71.4 (1.4)  
10 controls 70.5 (3.2) 
H&Y stage: I-III 
Dementia: no 
Depression: no 
Medication: details given 
Tested on/off: on 
MPD duration=4.0 (0.9)/9.7 (1.1) 
years 
Mental set-shifting: Modified WCTS (perseverative errors)  
Concept formation: Modified WCST (number of categories) 
Spontaneous cognitive flexibility: Semantic Fluency (COWAT)* 
Working memory: CSpan Test 
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Price (2010) To examine the contribution of EF 
to problem-solving abilities. 
15 PwPD (10 men), 67.67 
(1.42)  
12 controls (8 men), 64.2 
(1.67) 
H&Y stage: I-III 
Dementia: no 
Depression: no 
Laterality:  details given 
Medication: details given 
MPD duration= 6.47 (1.2) 
Problem solving: Anagram Task (baseline* and cued) 
Executive functions: Set shifting (WCST-64, perseverative 
errors), inhibitory control (Stroop Test - Interference, response 
time) 
Semantic verbal fluency: COWAT* 
Working memory: CSpan (total correctly recalled)  
Zgaljardic et al. 
(2006) 
 
To explore the pattern of executive 
impairment in PD patients based 
on the current understanding of 
frontostriatal circuits. 
Neuropsychological measures were 
assigned to three circuits: the 
anterior cingulate cortex (ACC), 
the dorsolateral prefrontal cortex 
(DLPFC), and the orbitofrontal 
cortex (OFC). 
32 PwPD (19 men), 66.9 
(8.1) 
29 controls (15 men), 66.7 
(5.7) 
H&Y stage: I-III 
Dementia: no 
Depression: no 
Medication: details given 
ACC* (response monitoring, inhibition, initiation, apathy): 
Apathy Scale, Initial Fluency, Stroop Test (interference index) 
DLPFC* (set-shifting, working memory, intrinsic response 
generation, and conditional associate 
learning): Category Fluency, Digit Span, Frontal Systems 
Behavior Scale (executive scale), Phonemic Fluency, Odd Man 
Out, Petrides Conditional Associate Learning – Criterion (no. 
trials), Petrides Conditional Associate Learning – Errors, Spatial 
Span, Verbal Fluency Switching Accuracy;  
OFC (disinhibition, decision-making, impulsivity, and 
perseveration, depression): Beck Depression Inventory, Frontal 
Systems Behavior Scale (disinhibition scale), Alternating Loops 
(no. errors), Twenty Questions Test (abstraction score), Total 
Questions (weighted score) 
Studies investigating subcomponents of executive (or frontal) functions; selectively or in relation to other factors. 
Altgassen et al. 
(2007) 
To explore four components of 
working memory (including the 
central executive) and  clarify 
which of them contributes to the 
observed planning deficits in PD. 
16 patients (11men), 61.1 
(6.9) 
16 controls (8 men), 62.6 
(9.1) 
H&Y stage: I-III 
Dementia: no 
Depression: no 
Laterality: details given 
Medication: details given, 
Tested on/off: no medication 
12h prior to testing 
MPD duration = 4.81 (3.0) 
Planning: ToL* 
Working memory: Phonological loop (Digit SpanForward), 
visuospatial sketchpad (Block Span Forward), episodic buffer 
(Logical Memory*), 
Central executive processes (N-back Task*) 
Bouquet et al. 
(2003) 
To investigate the nature of 
executive impairment in PD by 
testing abilities known to be 
involved in the Supervisory 
Attentional System (SAS): internal 
strategy generation and inhibition 
of unwanted responses. 
20 PwPD (12 men), 66.1 
(7.6) 
20 controls (13 men), 63.5 
(10.1) 
Diagnosis basis: UKPDSBB 
H&Y stage: I-III 
Dementia: no 
Depression: no 
Tested on/off: on  
MPD duration =10.25 years (5.83)  
Internal strategy generation and inhibition of unwanted 
responses:  
Hayling test*, * Phonemic*, Semantic*, and Alternating 
Fluency*, TMT 
Bublak et al. 
(2002) 
To explore working memory in PD 
by investigating how the level of 
demand influences performance in 
14 PwPD (5 men), 55.1 
(14.7) 
14 controls 55.2 (14.7)  
H&Y stage: I-III 
Dementia: no 
Depression: no 
Digit Ordering Test, Working Memory Capacity Test, Response 
Time Test 
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a task requiring the manipulation 
of a constant number of items. 
Working memory resources seem 
to diminish excessively with the 
increasing complexity of the task. 
Medication: details given 
Tested on/off: on, 2-4h after 
the last dose of medication  
MPD duration=47.3 months (50.0) 
Cools et al. (2001) To assess set-shifting abilities while 
controlling for concept formation, 
rule learning, working memory and 
general cognitive slowing. 
43 PwPD (31 men), 62.1 
(1.2)  
27 controls (18 men), 59.4 
(1.8)  
Diagnosis based on: UKPDBB 
criteria 
H&Y stage: I-III 
Depression: additional 
analysis with non-depressed 
only 
Medication: details provided 
Tested on/off: on 
MPD duration= 6.9 years (7.2) 
Set-shifting: Set-switching Task  
Background assessment: The One-Touch ToL Planning*, Verbal 
Fluency, Intra/Extra-Dimensional Set-Shifting Task* (CANTAB), 
Pattern* and Spatial Recognition Memory (CANTAB) 
Cronin-Golomb et 
al. (1994) 
To investigate whether problem 
solving deficits can be explained by 
set-shifting impairment only or 
whether there is a more complex 
underlying pathology. 
15 non-medicated patients 
(14 men), 62.5 (44-73) 
15 medicated patients  (11 
men), 63.9 (44-79) 
15 controls (10 men), 63.9 
(42-77) 
H&Y stage: I-III 
Dementia: no 
Depression: no 
Laterality: details given 
Medication: details given 
Tested on/off: on 
MPD duration = 1.9 years (1-4) 
Problem solving: Poisoned Food Problems*  (set-shifting 
component), Hukok Logical Thinking Matrices Test, Mental 
Calculation; 
Concept formation and comprehension: WAIS-R Similarities, 
Concept Comprehension Test, Proverb Interpretation 
Downes et al. 
(1993) 
To examine the hypothesis that the 
primary deficit in PD is related to 
impaired internal control of 
attention. 
20 PwPD (11 men), 60.05 
(10.23) 
14 controls (7 men), 60.0 
(10.53) 
Diagnosis basis: 2 of 3 cardinal 
symptoms  
H&Y stage: I-III 
Dementia: no 
Depression: no 
Medication: details given 
Median PD duration =  30 months 
(15-156) 
Set shifting and attention: Verbal Fluency (2x  single 
semantic/letter, 2x alternating semantic, 2x alternating letter, 
2x alternating semantic/letter*) 
Euteneuer et al. 
(2009)  
To investigate decision-making and 
emotional processing in PD by 
examining performance on two 
gambling tasks; to assess cognitive 
functions in the area of EF. 
21 PwPD (7 men), 67.60 
(7.31) 
23 controls (12 men), 64.4 
(8.56) 
H&Y stage: I-III 
Dementia: no 
Depression: no 
PD type: details given 
Medication: details given 
MPD duration=85.7 months 
(72.70) 
EF and working memory: Modified Card Sorting Test, 
Phonemic and Semantic Fluency*, (Digit Span Backward, 
DEMTect subtests (2* of 5 variables)) 
Reasoning: subtest of Leistungsprüfsystem (German 
intelligence scale) 
Decision-making under risk: Game of Dice Task* Decision 
making under ambiguity:  Iowa Gambling Test; 
ToM: Reading the Mind in the Eyes 
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Gabrieli et al. 
(1996) 
To examine the relationship 
between working memory and 
strategic memory in early stage 
unmedicated PwPD. Authors 
attempted to clarify the nature of 
WM performance in early 
unmedicated PD, in the verbal 
dimension in particular.  
10 PwPD (6 men), 60.1 (7.5) 
10 controls (2 men), 55.5 
(9.7) 
H&Y stage: I-II 
Dementia: no 
Depression: no 
Medication: unmedicated  
MPD duration= 2.9 years (1.6) 
Working memory: Verbal span*, arithmetic span* 
Strategic memory: self-ordering pointing*, temporal ordering*, 
word recall*  
Gilbert et al. 
(2005) 
To clarify the mechanism of 
working memory impairment in PD 
by investigating three possible 
causes: a limited storage capacity, 
an impaired executive component, 
and a reduction of psychomotor 
speed. 
14 patients (5 men), 66.29 
(11.08)  
14 controls 65.79 (10.33) 
H&Y stage: I-III 
Dementia: no 
Depression: no 
Medication: details given 
Tested on: on 
MPD duration= 7.29 years (4.53) 
Executive tasks: Alphabetical Recall* and Updating Memory 
Tasks 
Storage Task: Digit Span 
S. Hsieh et al. 
(1995) 
To investigate set-shifting aptitude 
using modified version of odd-man-
out task. Authors compared 
reaction times for shift trials and 
non-shift trials, in cued and non-
cued conditions. 
12 PwPD (8 men), 64.8 (7.1) 
12 controls (5 men), 61.1 
(8.6) 
H&Y stage: I-III 
Dementia: no 
Depression: no 
Set-shifting: Odd Man Out * 
Kehagia et al. 
(2009) 
To investigate the effects of PD on 
mental control. Authors aimed to 
clarify how disease severity 
influences set-switching task 
performance, and to address 
problems of paradigm 
heterogeneity. 
13 PwPD (H&Y stage I) (10 
men), 62.2 (9.1)  
#11 H&Y stage II (7 men), 
66.6 (8.5) 
16 controls (10 men), 63.6 
(8.3) 
Diagnosis based on: UKPDBB  
H&Y stage: I and II 
Dementia: no 
Depression: no  
Tested on/off: on and off 
Background neuropsychological profile: Phonemic Fluency, 
Spatial and Pattern (H&Y stage II group*) Recognition Memory 
Switching: Set-switching task (H&Y stage II group*) 
Kliegel et al. 
(2005) 
To examine prospective 
memory/memory for intentions 
and self-initiated implementation 
in PD. 
16 PwPD (11 men), 61.2 
(6.9) 
16 controls (11 men), 62.6 
(9.1) 
H&Y stage: I-II 
Dementia: no 
Depression: no 
Medication: details given 
Tested on/off: off 
MPD duration=4.81 (3.00) 
Prospective memory (formation, retention, initiation and 
execution of intention): Prospective Memory Task (planning 
phase*) 
Divided attention: Tests of Attention Battery 
Short-term memory span: Digit Span Forward 
Working memory*: Operation Span Measure 
Inhibition: Stroop Test* 
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Kobayakawa et al. 
(2008) 
To clarify the pattern of decision-
making in gambling task. 
34 PwPD (12 men), 69.9 
(8.9) 
22 controls (13 men), 67.6 
(6.9)  
H&Y stage: I-III 
Dementia: no 
Depression: no  
Medication: details given  
Tested on/off: on 
MPD duration=6.4 (3.4) 
Decision making: Iowa Gambling Task*  
EF: WCTS 
Short-term memory and attentional ability: Digit Span 
Emotional arousal: Skin Conductance Responses* 
McKinlay, Grace, 
et al. (2008) 
To explore planning abilities in PD 
by systematic manipulation of ToL 
test parameters:  search depth, 
sub-goal moves and goal hierarchy. 
There was no evidence for general 
planning difficulties in PwPD when 
compared to controls. When the 
ambiguity of goal hierarchy 
increased (sub-goal sequence was 
less predictable) PwPD performed 
worse than controls. 
30 PwPD 65.77 (6.6);  
30 controls 66.43 (5.3) 
H&Y stage: I-III 
Dementia: no 
Depression: no 
Tested on/off: on 
MPD duration =  7.3 (4.6) 
Planning: ToL 
Mimura et al. 
(2006) 
To examine decision-making in 
PwPD and its relationship to the 
ability to infer mental states of 
other people and to executive 
functions. 
13 PwPD (5 men), 68.9 (7) 
40 controls (age-matched)  
H&Y stage: II-III 
Dementia: no 
Depression: controlled in 
analysis  
Tested on/off: on 
Set-shifting:  WCTS (2* of 3 variables) 
Planning: Maze-tracing of WISC-R*, Inhibition: Stroop test*, VF 
phonemic* and semantic 
Decision making: Iowa Gambling Test * 
Mind-reading: Reading the mind in the eyes test* 
R. Tomer et al. 
(2002) 
To examine relationship between 
motor impairment and cognitive 
flexibility. 
28 PwPD (18 men), 66.4 
(9.5) 
19 controls (10 men), 67.1 
(9.1) 
H&Y stage: newly diagnosed 
Dementia: no  
Depression: controlled in 
analyses 
PD type: details given 
Medication: unmedicated 
Reactive flexibility (set-shifting): WCST (3* of 4 variables) 
Spontaneous flexibility (ideas generation):  Alternate uses* 
Witt et al. (2006) To examine the effects of 
foreknowledge on task switching 
performance. Authors controlled 
for the influence of age and tested 
the relationship between task 
switching and performance on the 
WCTS. 
20 PwPD (14 men), 59.25 
(8.58) 
 20 older controls (12 men), 
59.00 (5.70) 
20 young controls (12 men), 
25.90 (2.57) 
Diagnosis based on: UKPDBB  
H&Y stage: I-III 
Dementia: no 
Depression: no 
Medication: details given 
Tested on/off: on 
MPD duration = 3.25 years (4.40) 
EF: Stroop test* (reading time and reading error only), VF* 
(semantic, phonemic), WCTS* 
Switching abilities in the predictable (cued) and unpredictable 
conditions: Task-switching Test* 
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Studies focused on the overall cognition with executive or frontal functions clearly distinguished. 
Muslimovic et al. 
(2005) 
To describe the pattern of cognitive 
impairment in newly diagnosed PD 
patients. EF were specifically 
addressed. 
115 PwPD (61 men), 66.2 
(10.1) 
70 controls (37 men), 63.7 
(7.30) 
H&Y stage: I-III 
Dementia: no 
Depression: HADS-D  
Medication: details given 
MPD duration = 18.8 (10.7 ) 
months 
EF*: Modified WCST (number of categories achieved, errors, 
perseverative errors); Semantic Fluency, WAIS-III Similarities; 
ToL-Drexel Test (problems solved in minimum number of 
moves) 
Attention: Digit Span Forward and Backward*; TMT-B*, Stroop 
Test (interference) 
Studies investigating executive/frontal functioning, but with two or more of the following weaknesses: 1) background theories of executive/frontal domains were not discussed; 2) 
subcomponents of EF/frontal functions were not distinguished; 3) It was not clear which tests were intended to measure which subcomponents. 
Cooper et al. 
(1991) 
To assess cognitive functions in a 
homogeneous group of early 
untreated PwPD. 
60 PwPD (31 men) 59.8 
(37.3-77.6) 
37 controls (20 men), 59.6 
(40.2-76.1) 
Diagnosis based on: PD 
Society criteria 
H&Y stage: newly diagnosed 
Dementia: no 
Depression: depressed 
analyzed separately 
Medication: never treated 
MPD duration = 15.75 months (3-
48) 
Frontal tasks: WCST (1*/9), Picture Arrangement (WAIS); 
Cognitive sequencing and working memory: Digit Ordering* 
Memory: Digit Span Forward and Backward*, Rey-Osterreith 
and Taylor Figures, Brown-Peterson Paradigm; 
Language: Semantic and Alternating Fluency* 
Costa et al. 
(2008) 
To clarify the relationship between 
prospective memory and EF. Almost 
50% of patients were impaired in 
digit span tasks and almost 40% 
showed impairment in card sorting 
task. No formal group comparison 
for particular tests. 
23 PwPD (12 men), 63.5 
(10.0) 
25 controls (12 men), 65.0 
(7.7) 
Diagnosis based on: 2 of 3 
cardinal symptoms and good 
response to levodopa 
H&Y stage: I-III 
Dementia: no 
Depression: no 
Medication: levodopa  
Tested on/off: on 
MPD duration = 7.69 (8.5) years 
EF: Modified Card Sorting Test, Phonological Fluency 
Short-term and working memory: Digit Span Forward and 
Backward, Corsi Test Forward and Backward 
Prospective memory: Prospective Memory Task 
 
Edelstyn et al. 
(2007) 
To investigate a number of cognitive 
abilities, including executive 
functions. In depth analysis of 
recognition memory and its 
components/ underlying processes, 
including role of EF in organization of 
material during encoding and 
retrieval. 
17 PwPD (11 men), 65.4 
(8.9) 
17 controls (9 men), 64.5 
(7.4) 
H&Y stage: II-III 
Dementia: no 
Depression: no  
Hallucinations: no 
Medication: details given 
Tested on/off: on 
MPD duration = 7.7 years (8.6) 
EF (fluid intelligence): Matrix Reasoning*, the Hayling* and 
Brixton* Tests 
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Pagonabarraga 
et al. (2007) 
To examine relationship between 
decision-making (limbic function) 
and cognitive functions (including 
EF). 
35 PwPD (22 men), 67.2 
(8.0)  
(19 stable and 16 
fluctuating) 
31 controls (16 men), 70.2 
(10) 
H&Y stage: I-III 
Dementia: no 
Depression: no 
Medication: details given  
Tested on/off: on 
MPD duration = 8.4 years (5) 
Attention and executive prefrontal function: Digit Span 
Forward and Backward, Stroop Test  
Limbic function: Iowa Gambling Test* 
Global cognition: MMSE, Mattis Dementia Rating Scale, VF 
Phonemic and Semantic Fluency 
Saltzman et al. 
(2000) 
To explore the possibility of acquired 
ToM impairment in PD and examine 
the relationship between ToM and 
EF. 
11 PwPD (6 men), 70.98 
(13.43) 
8 older controls (3 men), 
71.61 (9.42) 
9 young controls (3 men), 
20.87 (2.53) 
Diagnosis based on: UKPDSBB 
H&Y stage: II-III 
Dementia: no 
Depression: no 
Medication: details given 
EF: California Card Sorting Task* (correct sorts), VF* 
(phonemic), Five-Point Fluency task* (figural fluency) 
Theory of mind: (composite score*)  
Woods and 
Tröster (2003) 
To examine cognitive functioning of 
non-demented PwPD and compare 
data with 1-year follow up to 
determine cognitive risk factors for 
dementia. 
18 PwPD (12 men), 69.39 
(5.80) 
18 controls (12 men), 68.76 
(6.44) 
Diagnosis based on: 3 cardinal 
PD features and positive 
response to levodopa  
H&Y stage: I-III 
Dementia: no 
Depression: no 
MPD duration = 5.50 (3.35) 
EF: WCST (number of categories), Mattis Dementia Rating Scale 
(Conceptualization) 
Language: COWAT, Boston Naming Test  
*PwPD significantly lower than controls; #PD group included in the meta-analyses; PwPD – people diagnosed with Parkinson’s disease  DS - digit 
span, H&Y - Hoehn and Yahr, WCST - Wisconsin Card Sorting Test, VF - verbal fluency, TMT AB - Trail Making Test A, B, ToL - Tower of London Test, 
UKPDSBB - UK PD Society Brain Bank 
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Appendix I. Questions on Life Satisfaction Scale 
Questions about your Satisfaction with Life 
The following questions are about how satisfied you are with your life and individual areas 
of you life. You should also indicate how important individual areas of your life are (for 
example, your occupation or leisure activities) for your satisfaction and your well-being. 
Please answer all of the questions, including those which do not seem to apply to 
you. For example, for the question about your “relationship with your partner” if you do not 
have a partner you can still indicate how important this would be to you and how satisfied 
you are with the current situation (without partner). 
Do not be influenced by whether you feel good or bad now. Think about the last four 
weeks when answering the questions. 
 
FIRST, PLEASE CHECK HOW IMPORTANT EACH INDIVIDUAL AREA OF LIFE IS FOR YOU. 
BEFORE YOU BEGIN, PLEASE READ QUESTIONS 1-8 BELOW. 
 
How important for you is (are) your… 
Not 
important 
Slightly 
important 
Moderately 
important 
Very 
important 
Extremely 
important 
1. friends/acquaintances       
2. leisure activities      
3. health      
4. income/financial security      
5. occupation/work       
6. living condition      
7. family life/ children      
8. relationship with your partner/sex life      
 
NOW PLEASE CHECK HOW SATISFIED YOU ARE WITH THESE INDIVIDUAL AREAS OF YOUR LIFE. 
 
How satisfied are you with your…  Dissatisfied 
Slightly 
dissatisfied 
Slightly 
satisfied 
Moderately 
satisfied 
Very 
satisfied 
1. friend/acquaintances       
2. leisure activities      
3. health      
4. income/financial security      
5. occupation/work       
6. living condition      
7. family life/ children      
8. relationship with your partner/sex life      
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As shown below, the section about ‘Health’ is divided into various areas.  
Again, you should indicate how important the individual areas are to you, and 
how satisfied you are with them. 
 
PLEASE ANSWER AL OF THE QUESTIONS. DO NOT BE INFLUENCED BY WHETHER YOU FEEL GOOD OR 
BAD NOW. THINK ABOUT THE LAST 4 WEEKS WHEN ANSWERING THE QUESTIONS.  
 
How important for you is your… 
Not 
important 
Slightly 
important 
Moderately 
important 
Very 
important 
Extremely 
important 
1. physical condition      
2. ability to relax      
3. energy level/enjoyment of life      
4. ability to get around (for 
example walking, driving) 
     
5. ability to see and hear      
6. being free from anxiety       
7. being free from discomfort and 
pain 
     
8. not needing help/care      
 
Please now mark how satisfied you are with these individual areas. 
 
How satisfied are you with your…  Dissatisfied 
Slightly 
dissatisfied 
Slightly 
satisfied 
Moderately 
satisfied 
Very 
satisfied 
1. physical condition      
2. ability to relax      
3. energy level/enjoyment of life..      
4. ability to get around ( for 
example walking, driving) 
     
5. ability to see and hear      
6. being free from anxiety ………….      
7. being free from discomfort and 
pain  
     
8. not needing help/care      
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The following aspects of health are worth considering particularly in people with movement 
disorder. As with the previous questions, please indicate how important the individual 
aspects are to you personally and how satisfied you have been with them. 
 
Again, please answer all questions and think about how you have been feeling over the past 
4 weeks and no how you feel at this precise moment.  
 
FIRST, PLEASE CHECK HOW IMPORTANT EACH INDIVIDUAL ASPECT ID FOR YOUR HEALTH. BEFORE 
YOU BEGIN, PLEASE READ QUESTIONS 1-12 BELOW. 
 
How important for you is (are)… 
Not 
important 
Slightly 
important 
Moderatel
y 
important 
Very 
important 
Extremely 
important 
1. controllability/fluidity of 
movement  
     
2. absence of dizziness/steadiness 
when standing and walking ……… 
     
3. hand dexterity throughout the day 
(e.g. when eating and writing) 
     
4. articulation/fluency of speech      
5. ability to swallow      
6. absence of bodily sensations…..      
7. bladder/intestinal function      
8. sexual excitability      
9. undisturbed sleep      
10. memory/clear thinking      
11. independence from help (e.g. 
when dressing and getting washed 
     
12. inconspicuousness of illness      
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PLEASE NOW MARK HOW SATISFIED YOU ARE WITH THESE SAME ASPECTS. 
 
 
How satisfied are you with …  
Dissatisfie
d 
Slightly 
dissatisfie
d 
Slightly 
satisfied 
Moderatel
y satisfied 
Very 
satisfied 
1. controllability/fluidity of 
movement 
     
2. absence of dizziness/steadiness 
when standing and walking 
     
3. hand dexterity throughout the day 
(e.g. when eating and writing) 
     
4. articulation/fluency of speech      
5. ability to swallow      
6. absence of bodily sensation      
7. bladder/intestinal function      
8. sexual excitability      
9. undisturbed sleep       
10. memory/clear thinking      
11. independence from help (e.g. 
when dressing and getting washed) 
     
12. inconspicuousness of illness      
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Appendix J. Caregiver Burden Inventory 
Caregiver Burden Inventory                              
 
For each item circle a number in the columns to the right that 
represent how often the statement describes your feelings. 
0  never 
1  rarely 
2  sometimes 
3  quite frequently 
4  nearly always 
1 He/she needs my help to perform many daily tasks.  0      1      2      3      4 
2 He/she is dependent on me.       0      1      2      3      4 
3 I have to watch him/her constantly.   0      1      2      3      4 
4 I have to help him/her with many basic functions. 0      1      2      3      4 
5 I don’t have a minute’s break from his/her chores.  0      1      2      3      4 
6 I feel that I am missing out on life.   0      1      2      3      4 
7 I wish I could escape from this situation.     0      1      2      3      4 
8 My social life has suffered.   0      1      2      3      4 
9 I feel emotionally drained due to caring for him/her. 0      1      2      3      4 
10 I expected that things would be different at this point in my life 0      1      2      3      4 
11 I’m not getting enough sleep.      0      1      2      3      4 
12 My health has suffered.   0      1      2      3      4 
13 Caregiving has made me physically sick.     0      1      2      3      4 
14 I’m physically tired.   0      1      2      3      4 
15 I don’t get along with other family members as well as I used to. 0      1      2      3      4 
16 My caregiving efforts aren’t appreciated by others in my family. 0      1      2      3      4 
17 I’ve had problems with my marriage (or other significant 
relationship). 
0      1      2      3      4 
18 I don’t get along as well as I used to with others. 0      1      2      3      4 
19 I feel resentful of other relatives who could but do not help. 0      1      2      3      4 
20 I feel embarrassed over his/her behavior.   0      1      2      3      4 
21 I feel ashamed of him/her.     0      1      2      3      4 
22 I resent him/her.   0      1      2      3      4 
23 I feel uncomfortable when I have friends over. 0      1      2      3      4 
24 I feel angry about my interactions with him/her. 0      1      2      3      4 
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Appendix K. Geriatric Depression Scale (GDS-15) 
 
GDS 
 
Instructions: Choose the best answer for how you felt over the past week. 
 
1 Are you basically satisfied with your life? Yes / No 
2 Have you dropped many of your activities and interests? Yes / No 
3 Do you feel that your life is empty? Yes / No 
4 Do you often get bored? Yes / No 
5 Are you in good spirits most of the time? Yes / No 
6 Are you afraid that something bad is going to happen to you? Yes / No 
7 Do you feel happy most of the time? Yes / No 
8 Do you often feel helpless? Yes / No 
9 
Do you prefer to stay at home, rather than going out and doing new 
things? 
Yes / No 
10 Do you feel you have more problems with memory than most? Yes / No 
11 Do you think it is wonderful to be alive now? Yes / No 
12 Do you feel pretty worthless the way you are now? Yes / No 
13 Do you feel full of energy? Yes / No 
14 Do you feel that your situation is hopeless? Yes / No 
15 Do you think that most people are better off than you are? Yes / No 
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Appendix L. Performance Rating 
 
Performance Rating Scoring Sheet 
Prediction and post-diction 
 
 
Before: ‘How well do you think you will do this task?’ Choose from the list below  
(Ask AFTER the practice task, present the show card) 
After: ‘How well do you think you did this task?’ Choose from the list below 
(Ask immediately AFTER the completing the task, present the show card) 
 
 
Trail Making Test 
  Very 
Poor 
Poor Alright Good Very 
Good 
TMT 1 – Scanning Before 0 1 2 3 4 
After 0 1 2 3 4 
TMT 2 – Numbers Before 0 1 2 3 4 
After 0 1 2 3 4 
TMT 3 – Letters Before 0 1 2 3 4 
After 0 1 2 3 4 
TMT 4 – Switching Before 0 1 2 3 4 
After 0 1 2 3 4 
TMT 5 –Speed Before 0 1 2 3 4 
After 0 1 2 3 4 
Colour-Word Interference 
  Very 
Poor 
Poor Alright Good Very 
Good 
CWI 1 – Naming  Before 0 1 2 3 4 
After 0 1 2 3 4 
CWI 2 – Reading Before 0 1 2 3 4 
After 0 1 2 3 4 
CWI 3 – Inhibition Before 0 1 2 3 4 
After 0 1 2 3 4 
CWI 4 – Switching Before 0 1 2 3 4 
After 0 1 2 3 4 
  
  Appendix L. Performance Rating 258 
 
 
  Very Good 
 
  Good 
 
  Alright 
 
  Poor 
 
  Very Poor 
 
 
 
